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INTRODUCTION
Noonan syndrome
Noonan syndrome (NS) is a relatively common genetic disorder. Its prevalence is estimated 
to range from 1 in 1,000 to 1 in 2,500 live births (Noonan, 2005; Nora, Nora, Sinha, Spangler, 
& Lubs, 1974), although a higher prevalence of 1:100 for mild symptoms of NS and 1:1000 
for severely affected individuals also has been suggested (Mendez & Opitz, 1985). NS is 
characterised by a phenotypic triad of distinctive facial features (e.g., ocular hypertelorism, 
antimongoloid slant of the palpebral fissures, ptosis, a deep philtrum, mild retrognathia, 
low-set posteriorly rotated ears with thick helixes, malar hypoplasia, and a short and 
sometimes webbed neck), congenital heart defects, and short stature (Allanson & Roberts, 
2016; Noonan, 2005). Other features include chest deformity, cryptorchidism, varying 
degrees of developmental delay, bleeding abnormalities, and lymphatic dysplasia 
(Allanson & Roberts, 2016). NS is considered to be an autosomal dominant condition, 
although the presence of a rare autosomal recessive variant also has been suggested 
(Johnston et al., 2018; Van der Burgt & Brunner, 2000). In 60% of patients with NS, the 
condition is caused by a de novo mutation (Tajan, Paccoud, Branka, Edouard, & Yart, 2018). 
A genetic mutation can be identified in approximately 70 to 80% of the patients with NS, 
although the diagnosis is still primarily based on clinical grounds by observation of key 
features (Aoki, Niihori, Inoue, & Matsubara, 2016; Van der Burgt, 2007). For an overview of 
the clinical criteria, see Table 1. 
Table 1  Scoring System for Noonan Syndrome (NS).
Feature A = Major B = Minor
1. Facial Typical face dysmorphology Suggestive face dysmorphology
2. Cardiac Pulmonary valve stenosis, hypertrophic 
obstructive cardiomyopathy, and/or  
ECG typical of NS
Other defect
3. Height < percentile 3 according to age < percentile 10 according to age
4. Chest wall Pectus carinatum/excavatum Broad thorax
5. Family history First degree relative with definite NS First degree relative with suggestive NS
6. Other Mental retardation, cryptorchidism,  
and lymphatic dysplasia
One of mental retardation, 
cryptorchidism, lymphatic dysplasia
Note:  Definite NS, 1 ‘A’ plus one other major sign or two minor signs or 1 ‘B’ plus two major signs or three minor signs. 
From Van der Burgt, 2007.
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RAS/MAPK pathway
NS is one of the RASopathies, a term referring to a group of related developmental disorders 
caused by gene mutations resulting in dysregulation of the RAS/mitogen-activated 
protein kinase (RAS/MAPK) pathway (see Figure 1). The RAS/MAPK pathway is involved in 
the signal transduction of extracellular stimuli (e.g., growth factors, hormones, cytokines) 
to the intracellular environment and is essential for cell cycle regulation, differentiation, 
growth, cell ageing, and programmed cell death (Roberts, Allanson, Tartaglia, & Gelb, 2013; 
Tidyman & Rauen, 2008, 2016a). The RAS/MAPK pathway plays an important role in normal 
development and dysregulation of this pathway can have profound developmental 
consequences (e.g., abnormal brain development and function) (Rauen, 2013; Samuels et al., 
2009; Tidyman & Rauen, 2016a). There is accumulating evidence that the pathway also has 
a homeostatic function in regulating endocrine and metabolic systems (Tajan et al., 2018). 
To date, mutations in 17 different genes (PTPN11, SOS1, RAF1, KRAS, NRAS, SHOC2, CBL, RRAS, 
RIT1, BRAF, RASA2, SOS2, MAP3K8, SPRY1, MYST4, LZTR1, A2ML1) are associated with NS. 
Mutations in PTPN11 (50%), SOS1 (10%), and RAF1 (10%) are most common (Tajan et al., 2018). 
 Other RASopathies, besides NS, include: Noonan syndrome with multiple lentigines 
(NS-ML), Noonan syndrome with loose anagen hair (NS-LAH), Legius syndrome (LS), 
Costello syndrome (CS), cardio-facio-cutaneous syndrome (CFC), and neurofibromatosis 
type 1 (NF1) (Tajan et al., 2018). Mutations in genes functioning more downstream in the 
RAS/MAPK pathway (e.g., BRAF, MEK1, MEK2, HRAS), which mainly cause CFC and CS, are 
associated with more severe impairments in neurological, intellectual, cognitive, and 
adaptive functioning, and with a higher prevalence of autistic traits than mutations in 
genes acting more upstream in the pathway (e.g., PTPN11, SOS1, RAF1, NF1), causing NS 
and NF1. Although studies to date have only been performed in small samples, it appears 
that within the group of patients with NS, individuals with a mutation in SOS1 have more 
favourable outcomes regarding intellectual functioning than individuals with PTPN11 or 
unknown mutations (Pierpont, 2016). Some studies suggest that a mutation in KRAS or 
SHOC2 is associated with more severe neurologic deficits and developmental delay 
(Pierpont, 2016). Individuals with mutations in SHOC2 and CBL seem to display higher 
frequencies of neurological features and MRI abnormalities (Gripp et al., 2013; Martinelli 
et al., 2015).
11
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Somatic and neurologic features 
While at birth, weight and length of children with NS are usually normal or only slightly 
subnormal, a rapid decline in growth is seen in the first year of life (Croonen, Draaisma, van 
der Burgt, Roeleveld, & Noordam, 2018). Feeding difficulties are frequent, which can lead 
to a failure-to-thrive (Allanson & Roberts, 2016; Roberts et al., 2013). Puberty is typically 
delayed (with approximately two years) and is characterised by an attenuated growth 
spurt (Romano et al., 2010). Bone maturation is usually delayed, enabling growth to be 
prolonged into the 20s. Final adult height is described to be low average (161-167 cm in 
men and 150-155 in women), but there are also reports of -2 SDs for both sexes (Allanson 
& Roberts, 2016; Tajan et al., 2018). A short stature is present in 80% of individuals with NS 
and body mass index is usually low from childhood to adulthood (Tajan et al., 2018). 
Figure 1  The RAS/MAPK pathway and the RASopathies disease genes. Simplified scheme 
depicting the canonical RAS/MAPK signalling pathway activated by receptors tyrosine 
kinase (RTK). Grey rectangles represent proteins (with corresponding genes italicised). 
From “The RASopathy family: Consequences of germline activation of the RAS/MAPK pathway”, 
by M. Tajan et al., 2018, Endocrine Reviews, 39, p. 682. Copyright 2018 by Endocrine Society. 
Reprinted with permission.
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Cryptorchidism is frequently present in men with NS. Fertility can be diminished in men, 
while it is usually normal in women (Allanson & Roberts, 2016). A congenital heart defect 
is present in 50-80% of patients with NS, with pulmonary valve stenosis and hypertrophic 
cardiomyopathy being the most frequent cardiac problems. Electrocardiographic 
abnormalities are present in approximately 90% of patients (Allanson & Roberts, 2016). 
Most patients with NS have bleeding abnormalities and lymphatic dysplasia is also 
common. Chest deformities are present in most patients (pectus excavatum or pectus 
carinatum) (Allanson & Roberts, 2016). Muscular hypotonia is frequent, leading to hyper- 
extensible joints (Noonan, 2005). Chronic pain has been identified as an under-recognised 
but frequently occurring feature in NS (Reinker, Stevenson, & Tsung, 2011; Smpokou, 
Tworog-Dube, Kucherlapati, & Roberts, 2012; Vegunta, Cotugno, Williamson, & Grebe, 
2015). Ocular abnormalities are common (up to 95%, i.e., refractive errors, amblyopia, 
strabismus, and nystagmus), as well as hearing loss (Allanson & Roberts, 2016; Sharland, 
Burch, McKenna, & Paton, 1992). Increased RAS/MAPK signalling has been related to 
oncogenesis and several haematological cancers have been reported in patients with NS 
(Roberts et al., 2013). Jongmans et al. (2011) reported a 3.5-fold increased risk for developing 
cancer in individuals with NS and a PTPN11 mutation compared to the general population.
 Studies in mice have shown that the RAS/MAPK pathway plays a critical role in 
cognitive function, especially in learning and memory, as well as in regulating prefrontal 
and striatal inhibitory networks in the brain (Ryu & Lee, 2016; Shilyansky et al., 2010). In 
humans with NF1, functional magnetic resonance imaging (fMRI) studies indeed revealed 
hypoactivation of cortico-striatal networks, associated with working memory performance 
(Shilyansky et al., 2010). In a recent study of Johnson et al. (2018), MRI data most notably 
showed reduced grey matter volume in the striatum, reduced surface area of the 
grey-white boundary in temporal regions, increased cortical thickness in frontal regions, 
and reduced cortical thickness in limbic regions (including structures that are part of the 
hippocampal circuitry) in a group of children with NS with a PTPN11 mutation compared 
with neurotypical controls. The striatum is responsible for motor and action planning, 
motivation, decision-making, and reinforcement. Dysfunction and reduced volume of this 
brain structure has been linked to inattentiveness and hyperactivity (Johnson et al., 2018). 
Increased cortical thickness in frontal regions, which has also been reported in other 
neurogenetic condition, might indicate a developmental delay (Johnson et al., 2018). In a 
study of Smith et al. (2018) in typically developing individuals, cortical thickness in limbic 
structures was found to be related to emotional awareness. Smith et al. (2018) suggest that 
increased cortical thickness in these structures may reflect the capacity to generate 
stronger affective reactions, more differentiated emotional reactions, and/or the capacity 
to generate these affective reactions to imagined situations (reflecting elements of Theory 
of Mind). Based on transcranial magnetic stimulation (TMS), Mainberger et al. (2013) found 
impaired synaptic plasticity of the primary motor cortex in a sample of 10 patients with 
NS, possibly related to RAS/MAPK dysregulation. Abnormalities of the central nervous 
13
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system have been reported in a minority of NS cases, with brain structure being typically 
normal (Green, Naylor, & Davies, 2017; Romano et al., 2010). Several studies suggest that 
Chiari I malformations are associated with NS, but sufficient structural neuroimaging data 
is not yet available (Holder-Espinasse & Winter, 2003; Keh, Abernethy, & Pettorini, 2013; 
Mitsuhara, Yamaguchi, Takeda, & Kurisu, 2014; Noonan, 2005; Romano et al., 2010; Smpokou 
et al., 2012; Zarate et al., 2014). Furthermore, there are reports of hydrocephalus, abnormal 
cerebrovascular pathology (including moyamoya syndrome), and agenesis of the corpus 
callosum, of which the relation with NS is yet unclear (Choi, Kim, Lee, & Green, 2009; 
Gupta et al., 2016; Hung, Wang, & Wong, 2011; Samanta, 2016; Zarate et al., 2014). Reports of 
convulsions are present in 13 to 24% of cases of NS (Duenas et al., 1973; Shaw, Kalidas, 
Crosby, Jeffery, & Patton, 2007). The cognitive impairments of patients with NS will not be 
completely explained by brain malfunction, because so far structural neuroanatomical 
abnormalities seem to be absent in NS (Pierpont, 2016).
Neuropsychological characteristics 
Previously, scientific research focused predominantly on the genetic and medical aspects 
of NS, but over the past decade studies regarding cognitive and behavioural characteristics 
of the syndrome have gained ground (see Table 2 for an overview). Cognitive, social, 
or behavioural difficulties could even be the most impacting components of NS on daily 
life in individuals with less pronounced somatic complications (Pierpont, 2016). The neuro-
psychological perspective has proven to be essential in the study of NS by investigating 
the relation between brain functioning and behaviour through cognitive processes. 
A growing body of research over the past ten years has shown cognitive and behavioural 
problems in patients with NS (Pierpont, 2016; Wingbermühle, Egger, Van der Burgt, 
& Verhoeven, 2009) and neuropsychological assessment has provided important insight 
into information processing, as well as suggestions for counselling and treatment. 
Most studies regarding cognitive functioning in NS have been focused on children and 
adolescents. However, since NS is a developmental disorder, more information regarding 
cognitive development and neuropsychological functioning at later ages is still very much 
needed. A better understanding of cognitive functioning and development in patients 
with NS is essential for improving (mental) health care for patients with this condition. 
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CHAPTER 1
Intelligence and adaptive functioning
Although intelligence levels tend to vary in the NS population, from intellectual disability 
to superior levels of functioning, most patients with NS show intellectual abilities within 
the (low)average range (full-scale IQ 85 – 95). The estimated prevalence of intellectual 
disability in NS ranges between 6 and 23%, compared to about 1% in the general population 
(American Psychiatric Association, 2014). There is no consistent pattern regarding verbal 
and performance capacities (Pierpont, 2016). Although learning disabilities are frequent in 
patients with NS, most adults attain similar educational levels as their parents (Maccora, 
Monica, Traficante, Filippo, & Stagi, 2017; Smpokou et al., 2012). Approximately one third of 
adults with NS attends special education schools and an additional 20% needs extra help 
at regular education (Shaw et al., 2007). Adaptive functioning in children and adults with 
NS has been found to be lower than in the normative population (Pierpont, Pierpont, 
et al., 2010). At ages 1 to 6, in a sample of 33 children with NS, a delay in motor (gross < fine) 
and daily living skills was found, based on a parent-report questionnaire. Social and 
communication skills did not differ significantly from the normative population. At ages 
7 to 24, an evenly distributed pattern of abilities was found regarding communication, 
daily living skills, and social skills, although adaptive functioning was still significantly 
lower than in the normative population. Although patients with NS tend to develop more 
adequate adaptive skills over time, the gap between their abilities and those of typically 
developing peers may become more pronounced. Gestational age at birth and parental 
education were found to be significant predictors of adaptive functioning in a group of 
patients with NS and CFC (Pierpont, Pierpont, et al., 2010). 
Language
Language skills tend to develop slower in children with NS. The average age at first words 
is around 15 months and simple two-word phrases are formed at an average age of 
31-32 months (Pierpont, Weismer, et al., 2010; Sharland et al., 1992). Studies using clinical 
assessment and parent reports, find a language impairment in 30-77% of children with NS 
(Pierpont, Weismer, et al., 2010; Selås & Helland, 2016). Language impairments are more 
frequent in NS than in the general population and have been associated with a higher risk 
of reading and spelling difficulties (Pierpont, Weismer, et al., 2010). Language functioning 
in NS seems to be strongly correlated to nonverbal cognition, auditory working memory 
performance, articulation, hearing ability, and motor skills (Pierpont, Weismer, et al., 2010). 
Parent reports of adaptive functioning suggest that expressive language skills fall behind 
with respect to receptive skills in younger children with NS (1-6 years), although this 
delay in expressive skills is no longer present in an older age group (7-24 years) (Pierpont, 
Pierpont, et al., 2010). In a study of children and adolescents with NS (aged 4-18 years), 
the majority (76%) did not show a significant difference between receptive and expressive 
language ability (Pierpont, Weismer, et al., 2010). Articulation problems have been 
described in 20% of children and adolescents with NS (Pierpont, Weismer, et al., 2010), 
21
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although Selås & Helland (2016) found articulation to be a relative strength, based on 
parent-reports and performance was not significantly different from typically developing 
controls. Most children with NS (70%) receive speech or language therapy at some point 
in their development (Pierpont, Weismer, et al., 2010). Studies in children with NS also 
provide evidence for problems in social aspects of language and communication (i.e., 
pragmatic language impairment). Pierpont, Weismer, et al. (2010) found that approximately 
40% of children and adolescents with NS did not reach the age-appropriate level regarding 
social- pragmatic aspects of language, based on parent reports. Pragmatic language 
difficulties appeared to be particularly frequent in boys with NS. Seventy-seven percent of 
the children in the study of Selås & Helland (2016) displayed communication impairments 
and pragmatic language skills were significantly lower in the patient group than in 
the control group. In adulthood, language problems seem to be no longer present 
(Wingbermühle et al., 2009).
Visual processing 
Problems in the processing of visual information are common in NS, although motor 
ability may be a mediator. NS is associated with ocular anomalies, such as ptosis and 
hypertelorism, as well as refractory errors, amblyopia, strabismus, and nystagmus 
(Pierpont, 2016). Children with NS have demonstrated to perform worse on tests of form 
coherence in comparison to motion coherence, which may suggest more difficulties in 
the ventral processing stream (‘what’ route, used for object identification) in children with 
NS, compared with dorsal stream processing (‘where’ or ‘how’ route, used for spatial and 
action processing). Performance on form coherence was significantly lower than in 
typically developing controls, although no IQ data was available for the control group 
(Alfieri, Cesarini, De Rose, et al., 2011). Piccini et al. (2017) confirmed these results in a group 
of patients with NS and patients with 22q11.2 deletion syndrome (22q11.2DS) and 
suggested that in these patients the ventral stream may be more vulnerable during 
development than the dorsal stream, while in other developmental disorders (such as 
Williams syndrome, fragile X syndromes, and autism spectrum disorder) abnormalities in 
the dorsal stream have been found. Regarding visual-motor integration, impaired to 
average performances have been found in children with NS (Alfieri et al., 2008; Van der 
Burgt et al., 1999), while in adults, the performance on tasks of visuoconstruction is 
comparable to that of typically developing controls (Wingbermühle, Roelofs, et al., 2012).
Motor functioning
The development of motor skills is usually delayed in children with NS (especially during 
infancy and preschool years), likely due to a combination of NS-related medical factors 
like musculoskeletal abnormalities (decreased muscle strength and endurance, pain, 
hypermobility), failure to thrive, heart defects, but also problems in visuoperception, and 
cognitive impairments (attention, planning) (Allanson & Roberts, 2016; Croonen et al., 2017; 
22
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Pierpont, 2016; Tartaglia, Gelb, & Zenker, 2011). The average age for sitting unsupported is 
ten months and 21 months for first steps (Sharland et al., 1992). Gross motor skills seem to 
be more delayed than fine motor skills in young childhood, while school-aged children 
commonly show coordination and fine motor problems (Pierpont, 2016). In a cohort of 
48 patients with NS with a mean age of 9.1 years, 51% of children attained scores reflecting 
the presence of a developmental coordination disorder (e.g., clumsiness, motor 
impairments) (Lee, Portnoy, Hill, Gillberg, & Patton, 2005). On a test of visuomotor abilities 
in a sample of 18 children and adolescents with NS (aged 4-17 years), 72% of the patients 
showed impaired scores (Alfieri, Cesarini, De Rose, et al., 2011). Pierpont et al. (2009) found 
fine motor skills to be impaired (>2 SD below the mean) in 34% of the children and 
adolescents with NS in their study, below average scores (>1 SD below the mean) were 
found in 72%. They also found manual motor dexterity to correlate significantly with 
verbal and nonverbal intellectual functioning. While motor performance, strength, and 
endurance are found to be impaired in children with NS and continue to be affected 
throughout childhood and adolescence (Croonen et al., 2017; Pierpont, 2016), motor 
functioning in adults has not yet been investigated, although these skills usually increase 
with age and practice (Wingbermühle et al., 2009). 
Attention and executive functioning
Attention problems as well as executive difficulties, and – on a behavioural level – 
symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD), are frequently reported in 
children with NS. However, most studies did not use matched control groups and 
executive performance has been based primarily on parent-based observational 
instruments. Neuropsychological assessment of attention in children with NS shows a 
poorer performance in auditory attention, sustained attention, and response inhibition 
compared to unaffected siblings (Pierpont, Tworog-Dube, & Roberts, 2015). In a study of 
Garg et al. (2017), 34 to 59% of the children and adolescents with NS showed a below 
average performance (defined as > 1 SD below the normative mean or age scaled scores 
< 7) on one of the attention tasks in their study, with the largest deficits found in (auditory) 
sustained attention. Performance on attention measures appears to be significantly 
correlated with intellectual functioning in NS (Pierpont, 2016; Pierpont et al., 2015). Studies 
using observational data have also frequently described attention problems in children 
and adolescents with NS, although clinically significant scores are not present in all studies 
(Alfieri et al., 2014; Duenas et al., 1973; Pierpont et al., 2015; Sarimski, 2000; Van der Burgt 
et al., 1999; Wood, Massarano, Super, & Harrington, 1995). A recent study of Johnson et al. 
(2018) found more parent-based reports of attention problems and hyperactivity in 
children with NS in comparison with neurotypical controls (with significantly higher IQ 
scores). In 42% of the patients with NS clinically impaired scores were found, while none of 
the neurotypical controls showed impairments. There are some indications, based on 
parent-based questionnaires and neuropsychological tasks, that working memory 
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performance may be weaker in children and adolescents with NS (Garg et al., 2017; 
Johnson et al., 2018; Pierpont, Tworog-Dube, & Roberts, 2013; Pierpont et al., 2015). Parents 
of children with NS reported clinically significant impairments in executive functioning in 
42.8%, especially in working memory and initiation (Garg et al., 2017). Pierpont et al. (2015) 
mentioned that children with NS showed a weaker performance on inhibitory control, 
and parents reported significantly more problems in working memory and self-monitor-
ing in comparison to sibling controls. In the study of Johnson et al. (2018) lower working 
memory performance was found in children with NS in comparison with a control group 
with a significantly higher full-scale IQ. Planning and organisation abilities may be 
vulnerable (Van der Burgt et al., 1999). To date, only one study systematically investigated 
attention and executive functioning in adults with NS. Wingbermühle, Roelofs, et al. (2012) 
found a significantly lower speed of information processing in adults with NS compared 
with matched controls. No differences were found regarding selective attention/
inhibition, working memory, and planning abilities, although the amount of self-reported 
executive problems was higher in the patient group.
Memory
While animal models have demonstrated that the RAS/MAPK pathway plays an important 
role in learning and memory, only a few studies have focused on memory in patients with 
NS. In an uncontrolled study of Alfieri, Cesarini, Mallardi, et al. (2011), 30% of children with 
NS showed impairments (<5th percentile) on immediate verbal free recall and immediate 
visual recognition, while 20% showed impaired scores on delayed verbal free recall and 
delayed visual recognition. No impairments were found on immediate and delayed 
visual-spatial recognition. However, Pierpont et al. (2013) found average scores on a 
general memory index in children and adolescents with NS. In this study, verbal memory 
performance was higher than visual memory performance and children with NS scored 
significantly lower on tests of visual memory in comparison with a normative sample. 
Verbal delayed recall performance was significantly worse than verbal delayed recognition, 
which is hypothesised to be related to deficits in strategic retrieval (Pierpont et al., 2013). 
Johnson et al. (2018) found lower scores on immediate and delayed memory of auditory 
verbal information and delayed memory of faces in children with NS in comparison with 
controls, although it should be noted that IQ was significantly higher in the control group. 
In adults with NS, no memory impairments have been found in comparison with matched 
controls. A composite delayed recall score (including both a verbal and a visual memory 
task) was even significantly higher in patients with NS and no differences were found 
between immediate or delayed recall performance on these tasks (Wingbermühle, 
Roelofs, et al., 2012). 
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Social cognition
While social difficulties have been frequently reported in patients with NS, they are mainly 
described at the behavioural level and have been scarcely studied systematically. 
Observations of social immaturity, lack of interaction with peers, diminished insight into 
social situations, problems in verbalising and explaining experiences, overfriendliness 
with strangers, less social competence, and difficulties in social behaviour have been 
described (Lee et al., 2005; Sarimski, 2000; Van der Burgt et al., 1999; Wingbermühle et al., 
2009; Wood et al., 1995). On a checklist of behavioural problems, children with NS generally 
show most problems in the social and attentional domains (Pierpont et al., 2015; Van der 
Burgt et al., 1999; Wood et al., 1995), although scores are not clinically significant in all 
studies. Parent-based reports of problems in social and emotional adjustment were 
present in 92% of the sample of Lee et al. (2005), while teacher-based scores only showed 
clinically significant scores in 12% of (a subset of) the sample. A controlled study by 
Pierpont et al. (2018) regarding social skills showed below average scores (-1 to -2 SD) in 
26% of the children and adolescents with NS (compared to 13% in unaffected siblings) and 
severely impaired scores (< -2 SD) were present in 15% of the patients (and in none of the 
sibling controls). Social skills in the NS group were significantly poorer than in the control 
group. Better pragmatic language abilities and fewer symptoms of ADHD appeared to be 
predictive of stronger social skills in patients with NS and NF1 (Pierpont et al., 2018). Shaw 
et al. (2007) reported that a poor quality of life in NS was related to a lack of social life and 
an inability to fit in. In a case-control study of adults with NS, Wingbermühle, Egger, 
Verhoeven, van der Burgt, & Kessels (2012) found difficulties in the ability to identify and 
verbalise their own feelings (i.e., alexithymia), a slight impairment in overall emotion 
recognition, no differences in basic Theory of Mind (ToM) abilities, and higher levels of 
social distress, but no higher levels of social avoidance. 
Mental health
Personality and psychopathology
Personality characteristics and psychopathology have been studied very limitedly in 
patients with NS. Mood and anxiety problems, symptoms of ADHD and Autism Spectrum 
Disorders (ASD), and higher levels of alexithymia have been reported most frequently.
 There are only a few studies concerning personality characteristics in patients with 
NS. Collins & Turner (1973) typified children with NS as confident, happy, talkative, and 
reminiscent of the cocktail party manner, while observations of adults showed remarkable 
friendliness, cooperativeness, and willingness to please, reflecting a social desirable 
attitude (Verhoeven, Wingbermühle, Egger, Van der Burgt, & Tuinier, 2008). Noonan (2005) 
reported that adults with NS frequently consider themselves as ‘fighters’, as their struggles 
at school and dealing with bullying by their peers made them stronger. Noonan (2005) 
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also stated that the great majority of patients with NS seemed to be very articulate and 
outgoing. No differences in self-esteem have been found between a group of children 
and adolescents with NS and a standardised population (Lee et al., 2005). A recent study 
regarding the Big Five personality traits in children and adults with NS showed lower 
levels of Extraversion and Openness to experience in patients with NS in comparison with 
sibling controls (Bizaoui, Gage, Brar, Rauen, & Weiss, 2018). Compared to other patients 
with RASopathies (i.e., CFC, CS, and NF1), patients with NS showed higher levels of 
 Conscientiousness. Although the study of Bizaoui et al. (2018) was the first to systematically 
assess personality in NS, the study has some important limitations. The sample consisted 
mostly of children – whose personalities are still in development -, only parent-based 
reports were used, and no information regarding the level of intellectual functioning was 
available. The presence of higher levels of alexithymia (i.e., problems in the identification 
and verbalisation of one’s own emotions) in adults with NS was first described by 
Verhoeven et al. (2008) and later confirmed in a larger, controlled sample by Wingbermühle, 
Egger, et al. (2012). Alexithymia is described as a dimensional personality trait, reflecting 
weaknesses in the cognitive processing and regulation of one’s own emotions (Taylor & 
Bagby, 2012). Also, alexithymia can be viewed as an inadequate coping strategy, reflecting 
a proneness to suppressive emotion regulation strategies instead of reappraisal strategies, 
in which an inability to express feelings can lead to mood and anxiety problems 
(Wingbermühle, Egger, et al., 2012). 
 Behavioural problems (both internalising as well as externalising), based on parent- 
based observations, are present in approximately half of the children with NS, with 
percentages ranging from 17 to 75 (Alfieri et al., 2014; Garg et al., 2017; Pierpont et al., 2015; 
Sarimski, 2000; Van der Burgt et al., 1999; Wood et al., 1995). Reports of anxiety and 
depressive symptoms in children with NS, based on parent observations, tend to vary. 
Some studies report no significant problems (Pierpont et al., 2015; Wood et al., 1995), while 
Alfieri et al. (2014) mentioned heightened levels of anxiety/depression in 32% of their 
sample. Duenas et al. (1973) reported observations of psychological problems, such as 
inappropriate affect, crying, and emotional lability in 12% of their sample of children and 
adults with NS.
 Perrino et al. (2018) described that an anxiety disorder was present in 7.4% of their 
sample of children and adolescents with NS (i.e., general anxiety, separation anxiety, or 
specific/social phobias). According to the DSM-5, the estimated prevalence of anxiety 
disorders in the general population of children and adolescents ranges from 0.9 to 16%, 
depending on the specific diagnosis (estimated prevalence of specific phobia is 5-16%, 7% 
for social phobia, 1.6-4% for separation anxiety disorder, 0.9% for general anxiety) 
(American Psychiatric Association, 2014). Sub-syndromal anxiety traits were present in 
29.6% of the sample of Perrino et al. (2018), which is higher than the 10% prevalence that 
was found in previous community studies. Noonan (2005) reported that 23% of adults 
with NS suffered from depression (versus 7% in the general population, American 
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Psychiatric Association, 2014). Smpokou et al. (2012) even found that 49% of the adult 
patients with NS in their sample reported a lifetime diagnosis or treatment for depression 
and/or anxiety. Wingbermühle, Egger, et al. (2012) mentioned that adults with NS showed 
higher levels of social distress in comparison with matched controls. Although no 
differences were found regarding general psychological well-being, adults with NS 
reported higher levels of anger-hostility and cognitive-performance difficulty compared 
with matched controls, but no anxiety or depression. Furthermore, there are incidental 
reports of schizophrenia, bipolar disorder, panic disorder, obsessive compulsive disorder, 
alcoholism, oppositional disorder, and anorexia nervosa in NS (Arvaniti, Samakouri, 
Keskeridou, & Veletza, 2014; Krishna, Abrams, Taylor, & Behar, 1977; Mahendran & Aw, 1989; 
Noonan, 2005; Verhoeven et al., 2004; Verhoeven et al., 2008). 
 Symptoms of ADHD - both inattention as well as hyperactivity - seem to be present 
in 35 to 75% of children and adolescents with NS, and 22-52% of patients were classified as 
having ADHD (according to the DSM-IV or 5) (Garg et al., 2017; Perrino et al., 2018; Pierpont 
et al., 2015, 2018). Based on these percentages, the prevalence of ADHD seems to be 
higher in NS patients than the 5% prevalence in the general population (American 
Psychiatric Association, 2014). 
 It has been suggested that dysregulation of RAS/MAPK signalling may be related to 
ASD and there is evidence that children with NS show more autism traits than the general 
population (Packer, 2012; Pierpont, 2016; Pinto et al., 2010). However, systematic studies 
regarding ASD in adults with NS are scarce. Using parent-based questionnaires, children 
and adults with NS were found to have significantly more autism traits in comparison with 
a matched control group (Adviento et al., 2014). In another study, 12% of children with NS 
attained scores above the threshold on a screening instrument for autistic features, but 
none of these patients met the criteria of ASD according to the fourth edition of the DSM 
(Alfieri et al., 2014). Since ADHD-like behaviour was also present in this sample of children 
with NS, it was suggested that higher scores on screening instruments of ASD could be 
related to social impairment, impulsivity, and socially inappropriate behaviour that is 
characteristic for ADHD. Pierpont et al. (2018) also found that all children with NS that 
showed severely impaired social skills (n = 8), were previously diagnosed with ADHD. A 
prior diagnosis of ASD was present in 5% of the patients with NS in this study. Garg et al. 
(2017) found 30% of children with NS to meet the Collaborative Programs of Excellence in 
Autism (CPEA) criteria for ASD, and another 30% met the CPEA criteria for broad ASD (i.e., 
sub-diagnostic threshold partial phenotype, this group is generally accepted to include 
many individuals who would have met the criteria for autism, Asperger, or PDD-NOS if 
additional data were available, Garg et al., 2017; Lainhart et al., 2006). ASD was more 
prevalent in boys with NS (5:1) in this study. Although autism traits are rather frequent in 
NS, most patients in these studies do not meet the full criteria of ASD. However, the 
number of patients classified as having ASD is still higher than the 1% prevalence in the 
general population (American Psychiatric Association, 2014). 
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Psychological risk factors and quality of life
Regarding psychological functioning in NS, a possibly relevant risk factor may be the 
higher level of bullying victimisation. Wingbermühle, Roelofs, et al. (2012) mentioned that 
83% of the adult patients in their sample reported a history of being bullied. A deviant 
physical appearance in combination with social problems and less social resilience may be 
related to this finding. Most children and adolescents with NS mention that they do not 
want to be ‘different’. Bullying victimisation in childhood or in adolescence has been 
associated with mental health problems, especially with symptoms of anxiety and 
depression (Arseneault, 2018). Furthermore, living with a chronic physical illness (such as 
a heart disease) has been related to elevated levels of behavioural problems (both 
internalising and externalising) and psychiatric abnormalities, especially mood and anxiety 
disorders (Green, 2004; Karsdorp, Everaerd, Kindt, & Mulder, 2006; Pinquart & Shen, 2011).
 In general, patients with NS rate their quality of life as satisfactory to good, with 
physical functioning and general health attaining the lowest scores (Binder et al., 2012; 
Shaw et al., 2007; Verhoeven et al., 2008). In comparison with the general population, 
patients with NS have higher mortality rates, lower levels of education, and relatively 
many patients are without a partner (Binder et al., 2012).
Aim and outline of thesis
Although our knowledge of the cognitive profile of patients with NS has increased during 
the past decade, no specific interventions aimed to improve neuropsychological 
functioning are yet available for this population. Existing social cognitive interventions for 
other patient groups are not suitable for patients with NS, because alexithymia is not 
targeted by these treatments. Also, in the Dutch health care system, these interventions 
might not be accessible for patients with NS, because the social cognitive problems 
frequently exist in the absence of a classification of a specific psychiatric disorder (e.g., 
ADHD or ASD). A neuropsychological treatment, based on the (social) cognitive profile of 
patients with NS, may greatly improve psychological well-being. Therefore, the objective 
of this thesis is to expand our knowledge of the neuropsychological and psycho-
pathological phenotype of adult patients with NS and to subsequently develop a neuro-
psychological treatment based on the specific cognitive profile of NS patients. In Chapter 2, 
cognitive development in NS is studied in a retrospective longitudinal design by 
comparing intellectual functioning in childhood with IQ in adulthood. The specificity of 
the social cognitive profile is addressed in Chapter 3, in which social cognitive functioning 
is compared between women with NS, women with Turner syndrome, and typically 
developing women. Personality and psychopathology in adults with NS is investigated in 
Chapter 4. In Chapter 5, a meta-analysis of the effects of social cognitive interventions in 
patients with neuropsychiatric disorders is presented. A proof-of-principle controlled 
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study, addressing the development and feasibility of the first NS-specific social cognitive 
training is provided in Chapter 6.  Finally, in Chapter 7, conclusions and directions for future 
research are discussed.
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Abstract
Introduction: Although cognitive impairments in adults with Noonan syndrome seem to 
be limited to a low-average intelligence and slower processing speed, studies in children with 
Noonan syndrome have demonstrated more extensive cognitive problems. These include 
deficits in language skills, memory, attention, and executive functioning. This longitudinal 
study is the first to investigate intellectual development in a group of individuals with 
Noonan syndrome. 
Methods: Sixteen patients with Noonan syndrome underwent intelligence assessment 
both in childhood and in adulthood, using Wechsler’s intelligence scales. IQ scores and 
Wechsler standard scores achieved in childhood and adulthood were compared. 
Subsequently, verbal and performance IQ in childhood were used as predictors for adult 
IQ and index scores.
Results: Compared with childhood scores, adult full-scale IQ and performance IQ significantly 
increased. Adult performance IQ was higher than verbal IQ. Childhood performance IQ 
and verbal IQ together predicted all adult IQ and index scores, except for the processing 
speed index.
Discussion: Childhood IQ was a significant predictor of adult intelligence in patients with 
Noonan syndrome. Performance IQ advanced to a normal level in adulthood, while verbal 
IQ did not develop proportionately, resulting in a discrepancy between adult performance 
IQ and verbal IQ. This finding could suggest a delay in the development of executive 
functioning in patients with Noonan syndrome, which seems to be outgrown in adulthood.
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Introduction
Noonan syndrome (NS) is a common autosomal dominant genetic disorder, caused by 
gene mutations in the RAS/mitogen-activated protein kinase (RAS/MAPK) pathway, a 
signal transduction cascade involved in cell proliferation, differentiation, survival, and 
metabolism (Roberts et al., 2013). So far, mutations in fourteen genes (PTPN11, SOS1, SOS2, 
RAF1, RIT1, KRAS, BRAF, NRAS, A2ML1, LZTR1, SHOC2, CBL, MAP2K1, RRAS) have been associated 
with NS or Noonan-like disorders (Aoki et al., 2013; Cordeddu et al., 2015; Flex et al., 2014; 
Mitsuhara et al., 2014; Pasmant et al., 2009; Yamamoto et al., 2015). With regard to the 
phenotypic presentation, NS is characterised by short stature, distinct facial features, 
a webbed neck, and heart defects (Tartaglia, Zampino, & Gelb, 2010). Although the main 
research topics in NS include genetic aspects and somatic complications, cognitive 
functioning has received increased scientific attention during the past decade. 
 Intelligence has been studied most frequently. In general, low-average scores are 
found, with a wide range from intellectual disability to superior intelligence present in 
some patients. Overall, verbal and performance intellectual capacities seem to be evenly 
distributed (Wingbermühle et al., 2009). Despite only a low-average mean intelligence, 
almost half of the children with NS have special educational needs (Shaw et al., 2007; Van 
der Burgt et al., 1999; Wingbermühle, Roelofs, et al., 2012).
 In previous studies measuring cognitive performance in children with NS, impairments 
have been reported in one or more of the following domains: visual processing, memory, 
language functioning, communication, attention, motor functioning, and executive 
functioning (Alfieri, Cesarini, De Rose, et al., 2011; Alfieri, Cesarini, Mallardi, et al., 2011; 
Pierpont, Weismer, et al., 2010; Pierpont et al., 2013, 2015; Wingbermühle et al., 2009). It 
should be noted, however, that most studies in children with NS did not include controls 
matched on age, sex, and intelligence level. Therefore, the reported cognitive problems in 
children with NS could be related to their lower intellectual abilities rather than reflect 
Noonan-specific cognitive impairments.
 Regarding cognition in adults with NS, Wingbermühle, Roelofs et al. (2012) only found 
a slower speed of information processing in comparison with controls matched with 
respect to age, sex, intelligence, and education level. Performance on objective measures 
of other cognitive domains such as memory, executive functioning, and visuoconstruc-
tion was relatively intact, although patients reported more cognitive complaints on 
self-report questionnaires than controls.
 In sum, children with NS seem to display more diffuse cognitive deficits as compared 
to adults with NS. Children with NS possibly outgrow their cognitive impairments, but to 
date, no longitudinal group studies have been performed to confirm this. Through a 
collaboration with the department of Human Genetics of Radboud University Medical 
Centre (Nijmegen, The Netherlands), unique intelligence data was gathered from of a 
sample of patients with NS who were tested both in childhood and in adulthood. The 
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aims of this study are twofold. First, intelligence of adults with NS is compared with their 
childhood scores. In normally developing children, intelligence is considered to be a 
relatively stable construct after age six, although there is evidence for significant individual 
variation and change during development (McCall, Appelbaum, & Hogarty, 1973; 
Sternberg, Grigorenko, & Bundy, 2001). Since the NS literature suggests more cognitive 
problems in children with NS compared with adults, it is hypothesised that this discrepancy 
will be reflected in the IQ scores. Therefore, lower IQ scores are expected in childhood in 
comparison with adult scores. Considering the slower speed of information processing 
that has been found in adults with NS, larger differences are expected in verbal IQ in 
contrast to performance IQ. Second, it is investigated whether adult IQ and index scores 
can be predicted based on childhood intelligence. As intelligence at age six is considered 
to be highly correlated with adult IQ (Bayley, 1949), it is assumed that childhood intelligence 
in patients with NS will be predictive of adult IQ, despite the anticipated discrepancy 
between intellectual functioning in childhood and adulthood.
Materials and Methods
Participants
Inclusion criteria for participants comprised a confirmed clinical diagnosis of NS (Van der 
Burgt et al., 1994) and the availability of intelligence assessment both in childhood and in 
adulthood. In adulthood (> 16 years), approximately fifty patients with NS underwent neu-
ropsychological assessment at the Centre of Excellence for Neuropsychiatry of the Vincent 
van Gogh Institute for Psychiatry in Venray between 2006 and 2012. This assessment was 
part of the studies of Wingbermühle, Egger et al. (2012) and Wingbermühle, Roelofs, et al. 
(2012). If present, childhood neuropsychological data of these patients were retrieved. For 
a total of 16 patients, both childhood as well as adult intelligence data were available. 
Fourteen of these patients participated as children in the study of Van der Burgt et al. 
(1999), for which neuropsychological assessment was administered at the department of 
Paediatrics of Radboud University Medical Centre, Nijmegen, between 1995 and 1997. Two 
participants underwent intelligence testing at other locations in 2002. 
 Out of the 16 included patients with NS (seven males/nine females), eight individuals 
had a confirmed mutation in PTPN11 gene (50%), one in SOS1, and one in MAP2K1. In four 
patients with NS, no known mutation was found and in two patients no mutation analyses 
had been performed or completed yet. Mean age at assessment in childhood was 10.48 years 
(SD = 3.26, range = 6–16) and the average age at adulthood examination was 20.63 years 
(SD = 3.63, range = 16–27). The mean difference between the age at childhood assessment 
and adult examination was 10.15 years (SD = 2.15, range 5–15). Twelve patients (75%) 
attended special education and 13 (81.25%) needed some kind of social support (e.g., 
assisted living facilities, social services). The level of education in adulthood was coded 
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using seven categories according to the Dutch educational system, ranging from category 
1 (1–5 years of education) to 7 (19–20 years of education) (Bouma, Mulder, Lindeboom, & 
Schmand, 2012). The level of education of adults with NS in the current sample ranged 
from 2 (only primary school completed) to 6 (5 years of high-level secondary education).
 Participation was voluntary and all participants and/or their legal representatives 
provided written informed consent prior to participation. In accordance with the 
Declaration of Helsinki, the study was approved by the Institutional Review Board of 
Vincent van Gogh Institute for Psychiatry.
Materials and procedure
Full-scale IQ, verbal IQ, and performance IQ in childhood (cFSIQ, cVIQ, cPIQ) were assessed 
by the Dutch Version of the Wechsler Intelligence Scale for Children Revised (WISC-R: Van 
Haassen et al., 1986). The WISC-R consists of six verbal subtests (Information, Similarities, 
Arithmetic, Vocabulary, Comprehension, and Digit Span) and six performance subtests 
(Picture Completion, Picture Arrangement, Block Design, Object Assembly, Coding, and 
Mazes) (Van Haassen et al., 1986). In 14 children, besides IQ scores, also Wechsler subtest 
scores were available.
 In adulthood, IQ scores (aFSIQ, aVIQ, aPIQ) and index scores (Verbal Comprehension, 
Working Memory, Perceptual Organisation, Processing Speed) of the Dutch version of the 
Wechsler Adult Intelligence Scale Third Edition were administered (WAIS-III: Wechsler, 
2005). aVIQ is composed of six subtests (Vocabulary, Similarities, Arithmetic, Digit Span, 
Information, and Comprehension) and measures acquired knowledge, verbal reasoning, 
and attention to verbal material. aPIQ is constructed from five subtests (Picture Completion, 
Digit Symbol, Block Design, Matrix Reasoning, and Picture Arrangement) and is considered 
to be a measure of fluid reasoning, spatial processing, attention to detail, and visuomotor 
integration. aFSIQ is the sum of aVIQ and aPIQ and provides an estimation of the general 
level of intellectual functioning (Wechsler, 2005). The Verbal Comprehension Index (aVCI) 
consists of three subtests and measures acquired verbal knowledge and reasoning. The 
aVCI is considered to be a more pure measure of verbal comprehension than aVIQ. The 
Perceptual Organisation Index (aPOI) is composed of three subtests and measures fluid 
reasoning, attention to detail, and eye-hand coordination. The aPOI is less sensitive for a 
slower processing speed than aPIQ, and is more focused on fluid reasoning and 
visual-spatial problem-solving skills. The Working Memory Index (aWMI) is constructed 
from three subtests and measures the ability to briefly memorise and process verbal 
information in order to repeat it. The Processing Speed Index (aPSI) is composed of two 
subtests and measures the speed by which visual information is being processed 
(Wechsler, 2005).
 Although the WISC-R and WAIS-III are both validated instruments, highly comparable 
and structured, there are differences between the two tests (e.g., number of subtests). In 
order to assess the agreement between the WISC-R and WAIS-III, the literature was 
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searched for correlation studies. In addition, Pearson, the publisher of the WISC-R and 
WAIS-III, has been consulted, but unfortunately no correlational data were available. 
Instead, the technical manual of the WAIS-III only described the correlations between the 
WAIS-III and WISC-III (successor of WISC-R). To get an impression, correlations between 
these IQ scores are high and range between 0.78 and 0.88. At subtest level, the correlations 
are moderate to high and range between 0.31 (Picture Arrangement) and 0.83 (Vocabulary) 
(Psychological Corporation, 1997).
Statistical analysis
All statistical procedures were performed using SPSS version 22.0 (IBM Corp., Armonk, NY). 
Paired-sample t-tests were used to compare childhood and adult performance on the 
Wechsler intelligence scales. Seven multiple linear regression analyses were performed to 
predict adult IQ and index scores, based on cVIQ and cPIQ. cVIQ and cPIQ were included 
as predictors in the analyses and aFSIQ, aVIQ, aPIQ, aVCI, aWMI, aPOI, and aPSI were 
included as outcome variables. Preliminary analyses were conducted before performing 
the multiple regression analyses to ensure that the assumptions of normality, multi-
collinearity, and singularity were not violated. According to the Kolmogorov–Smirnov test, 
all variables were normally distributed.
Results
Comparison of IQ
After a qualitative comparison of the IQ scores in childhood and adulthood, a higher aFSIQ 
was found in 11 patients (68.75%), a lower aFSIQ in four patients, and the performance of 
one patient remained the same. The mean difference between childhood and adult 
scores was 5.13 (SD = 7.11). For aVIQ, the score of seven patients improved (46.75%), 
while it diminished in nine patients. The difference between the scores was on average 
-1.00 (SD = 8.15). Regarding aPIQ, 14 patients (87.5%) showed improved scores and only 
two patients achieved a lower score. The mean difference was 11.25 (SD = 8.20). 
 Childhood intelligence and the Wechsler subtest standard scores were statistically 
compared with adult performance by means of paired-sample t-tests (see Table 1). 
After Bonferroni correction (α = 0.02), FSIQ and PIQ appeared to be significantly higher 
in adulthood than in childhood (respectively, t(15) = 2.88, p = 0.01, η2p = 0.36; t(15) = 5.49, 
p < 0.001, η2p = 0.67). The difference in VIQ was not statistically significant (t(15) = -0.49, 
p = 0.63). At subtest level (adjusted α = 0.005), it appeared that only the performance on 
Vocabulary was significantly lower in adulthood than in childhood (t(13) = 3.74, p = 0.002, 
η2p = 0.48). The difference on the subtest Comprehension almost reached significance 
(t(13) = 3.22, p = 0.007, η2p = 0.41). There were no differences between childhood and adult 
performance on the other subtests.
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Within the childhood scores, the difference between VIQ and PIQ did not reach significance 
(t(15) = -1.75, p = 0.10). However, within the adult scores, PIQ was significantly higher than 
VIQ (t(15) = -2.23, p = 0.04, η2p = 0.25). For a graphical display of the results, see Figure 1.
Prediction of IQ scores
When cVIQ and cPIQ were simultaneously included in the regression analysis, the predictors 
combined had significant predictive power, explaining 79% of the variance in aFSIQ 
(F(2, 13) = 28.95, p < 0.001). However, only cPIQ made a significant contribution to the 
prediction (β = 0.77, p < 0.001), while the predictive value of cVIQ did not reach significance 
(β = 0.21, p = 0.17). For all test statistics, see Table 2. 
 cVIQ and cPIQ together significantly predicted aVIQ, explaining 79% of the variance 
(F(2, 13) = 28.74, p < 0.001). Both cVIQ and cPIQ made significant contributions to the 
Table 1  Mean, Range, and Standard Deviation of Wechsler IQ and Standard Scores of 
Children and Adults with Noonan Syndrome.
  Children (WISC-R) Adults (WAIS-III)
  Mean Range SD Mean Range SD
Full scale IQ1 83.50* 57-110 14.55 88.63 68-115 13.17
Verbal IQ1 87.88 59-110 14.39 86.88 65-113 12.55
Performance IQ1 81.75*** 56-108 16.01 93.00 68-114 16.33
Picture Completion2 9.36 5-14 2.76 10.00 4-15 3.40
Vocabulary2 8.29** 5-11 2.02 7.21 3-11 2.55
Digit Symbol2 8.29 1-19 4.68 7.64 1-15 3.71
Similarities2 8.71 4-15 3.52 8.00 5-13 1.88
Block Design2 7.07 2-11 2.62 8.43 4-13 3.06
Arithmetic2 7.71 2-13 3.43 8.43 4-13 2.74
Digit Span2 8.36 3-11 2.53 8.71 4-14 2.84
Information2 8.36 4-11 2.56 8.29 5-14 2.40
Picture Arrangement2 7.93 3-13 2.89 10.07 3-15 3.79
Comprehension2 8.93 5-12 2.46 7.36 2-13 3.05
Mazes 7.00 3-14 3.28 - - -
Object Assembly 7.14 1-14 3.76 - - -
Matrix Reasoning - - - 9.50 4-15 3.48
Note: WISC-R, Wechsler Intelligence Scale for Children Revised; WAIS-III, Wechsler Adult Intelligence Scale Third 
Edition, SD, standard deviation. All p-values are Bonferroni corrected, * p < 0.05, ** p < 0.01, *** p < 0.001. 
1 Wechsler intelligence scores were available for 16 patients.
2 Wechsler subtest standard scores were available for 14 patients.
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prediction (respectively, β = 0.56, p = 0.002; β = 0.45, p = 0.009). Subsequently, two separate 
regression analyses were performed on the index scores underlying aVIQ: aVCI and aWMI. 
cVIQ and cPIQ together significantly predicted both index scores, explaining, respectively, 
62% and 70% of the variance (aVCI: F(2, 13) = 13.32, p = 0.001; aWMI: F(2, 13) = 18.62, 
p < 0.001). cVIQ made a significant contribution to the prediction of aVCI (β = 0.62, 
p = 0.008), while cPIQ was not significant (β = 0.29, p = 0.16). Regarding aWMI, both cPIQ 
and cVIQ made significant contributions to the prediction (respectively, β = 0.58, p = 0.005; 
β = 0.38, p = 0.05).
 The combination of cVIQ and cPIQ significantly predicted aPIQ as well, explaining 
74% of the variance (F(2, 13) = 22.71, p < 0.001). cPIQ made a significant contribution (β = 0.97, 
p < 0.001), but cVIQ did not (β = -0.17, p = 0.33). Next, the performance index scores aPOI 
and aPSI were included in two regression analyses. aPOI could significantly be predicted 
by cVIQ and cPIQ together, explaining 68% of the variance (F(2, 13) = 16.61, p < 0.001). 
cPIQ appeared to have a strong significant contribution to the prediction (β = 0.84, 
p < 0.001), but the contribution of cVIQ was not significant (β = 0.02, p = 0.91). However, 
cVIQ and cPIQ together only showed a trend toward significance for predicting the aPSI 
(adjusted R2 = 0.24, F(2,13) = 3.40, p = 0.07).
Figure 1  Boxplot of full scale, verbal, and performance IQ scores (FSIQ, VIQ, PIQ)  
of the Wechsler Intelligence Scale for Children Revised (WISC-R) and Wechsler Adult 
Intelligence Scale Third Edition (WAIS-III).
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Discussion
In this study, intellectual development was investigated in a group of patients with NS by 
comparing childhood IQ with adult intelligence levels. FSIQ and PIQ were significantly 
higher in adulthood compared with childhood scores, and a significant discrepancy was 
found between aVIQ and aPIQ, to the advantage of aPIQ. Furthermore, cVIQ and cPIQ 
together significantly predicted all adult IQ and index scores, except for aPSI. 
 Partly in accordance with the hypothesis, FSIQ and PIQ were significantly higher in 
adulthood in comparison with childhood scores. The FSIQ change was five IQ points on 
average, which is considered to be a small difference in clinical terms and would probably 
not result in a different classification. While PIQ appeared to increase to a normal level, VIQ 
did not develop proportionately, resulting in a VIQ-PIQ discrepancy in adulthood. PIQ 
improved on average 11 IQ points, which is almost one standard deviation. VIQ on average 
decreased one IQ point. Although changes in FSIQ are often found in longitudinal studies 
of normally developing individuals, this specific increase in PIQ is remarkable and not in 
accordance with our hypothesis. Since Wingbermühle, Roelofs, et al. (2012) found a lower 
speed of information processing in adults with NS, only a modest improvement in PIQ was 
anticipated. Effects of repeated administration are mentioned as an explanation for 
improvements in PIQ in longitudinal studies (WISC-III: Siders, Kaufman, & Reynolds, 2006; 
WISC-R: Tuma & Appelbaum, 1980). However, the retest interval in this study is significantly 
larger than the maximum interval of six months that was used in these studies. Moreover, 
since different tests for childhood and adult testing were used, practice effects are 
considered to be highly unlikely.
 The specific improvement in PIQ that was found in this sample may reflect a developmental 
delay in executive functioning in NS. PIQ is considered to be a measure of fluid reasoning, 
reflecting nonverbal problem-solving skills in novel situations (Wechsler, 2005), which 
strongly overlaps with the construct of executive functioning. Executive functioning 
includes various cognitive processes, necessary for planning, organising, and monitoring 
goal-directed behaviour (Decker, Hill, & Dean, 2007; Van Aken et al., 2014), and is known to 
evolve gradually into adulthood. Moreover, childhood performance on the subtest Mazes, 
which is considered to represent planning capacities in children, was the lowest compared 
with the other subtests. An alternative explanation for finding a higher PIQ in adulthood 
concerns the maturation of motor functioning in NS. Mild motor delay has been frequently 
described in children with NS. These motor skills are thought to improve during 
development and could therefore provide an explanation for the increase in PIQ as well.
 While PIQ improved in adulthood, VIQ did not develop proportionately. At subtest 
level, a significantly lower score on the subtest Vocabulary was found in adulthood. Verbal 
skills of children with NS are known to develop slower and many children with NS have 
articulation problems, for which they often receive speech therapy (Pierpont, Weismer, et 
al., 2010). It is often assumed that the process of getting more skilled in the use of language 
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and speech through intensive repetition (naturally or by means of speech therapy) would 
resolve these difficulties in adulthood. However, the results of this study show that verbal 
reasoning remains weak in adulthood. There are indications that language and social 
cognition are interrelated domains and that language plays an important role in acquiring 
notion of abstract constructs such as emotions (Lindquist, MacCormack, & Shablack, 2015). 
Fujiki, Brinton, & Clarke (2002) also suggested that children with language impairments 
lack differentiation in the verbal expression of emotions and tend to simplify their internal 
feelings into broad terms. This is in accordance with a study of Lamberty and Holt (1995), 
in which a relation is described between deficits in developmental verbal skills and 
alexithymia. Future studies should investigate the predictive power of childhood verbal 
capacities on the development of alexithymic problems, which have been previously 
described in adults with NS.
 The results of the regression analyses are in accordance with the general assumption 
that childhood intelligence is predictive of adult IQ. It was found that the combination of 
cVIQ and cPIQ could significantly predict aFSIQ, but only cPIQ made a significant 
contribution to the prediction. This finding could suggest that for patients with NS, (the 
development of) cPIQ, reflecting nonverbal reasoning abilities, may be a better indication 
of overall intellectual functioning later in life than acquired verbal knowledge. However, 
there could be a power problem due to the relatively small sample size in this study. 
Furthermore, the combination of cVIQ and cPIQ could also significantly predict aVIQ, aPIQ, 
aVCI, aWMI, and aPOI. Only aPSI could not be predicted by the combination of the two 
predictors, which could again reflect a lack of statistical power. Overall, it appeared that 
the predictor cPIQ had larger contributions than cVIQ to the prediction of aPIQ, aPOI, and 
aWMI, while cVIQ had larger contributions than cPIQ to the prediction of aVIQ and aVCI. 
 A significant strength of this study is its longitudinal design, since no other longitudinal 
group studies concerning intellectual or neuropsychological functioning have yet been 
performed in NS. In addition, the error variance associated with individual differences is 
reduced, because of the use of a within-subject design. 
 Nonetheless, the results should also be interpreted in light of some limitations. First, 
even though a within-subject study requires less participants than a between-subject 
design to achieve good statistical power, the sample size of this study may still be 
considered relatively small, especially considering the heterogeneity that has been found 
in the neuropsychological phenotype of patients with NS. While a larger number of 
participants would allow more powerful statistical analyses, it should be noted that neuro-
psychological studies in NS mostly rely on convenience samples, and despite the fairly 
small sample, significant and relevant results could be reported here. Second, the presence 
of a selection bias cannot be ruled out, possibly affecting the generalisation of these 
findings to the overall NS population. Children and adults with cognitive problems may 
have been more inclined to participate in these studies than those without subjective 
problems, which could have led to an over representation of individuals with cognitive 
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complaints. Third, given the nature of this retrospective longitudinal study, no control data 
was available for the childhood IQ scores. Although the inclusion of a matched control 
group would be informative in terms of normal development, this study design still 
provides unique information concerning intellectual development in this specific 
population. Moreover, it is notable that this intelligence study in patients with NS again 
demonstrated a discrepancy between childhood and adult performance, which has been 
described in studies of cognitive functioning as well. This strengthens the belief that the 
current findings could reflect a typical NS-related cognitive developmental delay that is 
outgrown in adulthood. However, controlled longitudinal studies should be performed to 
confirm this. Fourth, the non-overlapping subtests of the WISC-R and WAIS-III could lead 
to subtle differences between the two tests in the extent to which they appeal to motor 
and executive functioning. Fifth, it is noted that both age groups contain an individual 
who was 16 years of age during the assessment. This overlap does, however, not impede 
our findings, as the age difference between childhood and adult assessment was at least 
five years for each individual, with a mean age difference of a little more than 10 years. 
Therefore, the presented predictive values are applicable for a period of at least five years.
 In conclusion, the results of this study showed that childhood intelligence is a 
significant predictor of adult intelligence in individuals with NS and that PIQ develops 
more strongly than VIQ. This could suggest a developmental delay in underlying executive 
functioning in NS. Possibly, future neuroimaging studies may be of help to substantiate 
this neuropsychological hypothesis. Because VIQ tends to lag behind and does not 
develop proportionately with PIQ/executive functioning, monitoring and stimulating 
verbal skills in children with NS is recommended. As soon as the language skills in children 
with NS improved satisfactorily, educational attention should still go out to verbal 
reasoning abilities, because a deficit in this domain seems to persist in adulthood and may 
also hamper the verbalisation of emotions. Although evaluation of cognitive functioning 
is implied in the clinical guidelines for the management of NS (DYSCERNE- Noonan 
Syndrome Guideline Development Group, 2010), the present results highlight the 
importance of periodic re-evaluation of cognitive functioning in NS.
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Abstract
Noonan syndrome (NS) and Turner syndrome (TS) are associated with cognitive problems 
and difficulties in affective information processing. While both phenotypes include 
short stature, facial dysmorphisms, and a webbed neck, genetic aetiology and neuro-
psychological phenotype differ significantly. The present study examines putative 
differences in affective information processing and social assertiveness between adult 
women with NS and TS. Twenty-six women with NS, 40 women with TS, and 40 female 
controls were matched on age and intelligence, and subsequently compared on (1) 
alexithymia, measured by the Bermond-Vorst Alexithymia Questionnaire, (2) emotion 
perception, evaluated by the Emotion Recognition Task, and (3) social assertiveness and 
social discomfort, assessed by the Scale for Interpersonal Behaviour. Women with TS 
showed higher levels of alexithymia than women with NS and controls (p-values < 0.001), 
whereas women with NS had more trouble recognising angry facial expressions in 
comparison with controls (p = 0.01). No significant group differences were found for the 
frequency of social assertiveness and the level of social discomfort. Women with NS and 
TS demonstrated different patterns of impairment in affective information processing, 
in terms of alexithymia and emotion perception. The present findings suggest neuro-
psychological phenotyping to be helpful for the diagnosis of specific cognitive-affective 
deficits in genetic syndromes, for the enhancement of genetic counselling, and for the 
development of personalised treatment plans.
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Introduction
In 1938, Henry Turner described females with sexual infantilism, a webbed neck, and short 
stature. Two decades later, many women with these characteristics appeared to have a 
partial or complete aneuploidy of the second X chromosome, which was named Turner 
syndrome (TS) (Sybert & McCauley, 2004). Later, males and females with normal sex 
chromosomes were identified who showed phenotypical resemblances to TS. This led to 
confusing and incorrect terms such as “male TS,” “female pseudo-Turner,” or “XX and XY 
Turner phenotype” (Collins & Turner, 1973). Noonan and Ehmke (1963) recognised this 
disorder, now known as Noonan syndrome (NS), to be essentially different from TS in 
terms of genetic aetiology. NS is caused by germline mutations in the RAS/mitogen-acti-
vated protein kinase (RAS/MAPK) pathway, a signal transduction cascade involved in 
several developmental processes (Tartaglia et al., 2011). Although the genotypes differ, the 
phenotypes of NS and TS are quite similar, sharing several physical features, such as short 
stature, facial anomalies, a webbed neck, skeletal malformations, and cardiac problems 
(Elsheikh, Dunger, Conway, & Wass, 2002). 
 Cognitive functioning in adults with NS has recently been studied by Wingbermühle, 
Roelofs et al. (2012). In comparison with matched healthy controls, they found a lowered 
speed of information processing in individuals with NS, but no impairments in other 
cognitive domains. Intelligence scores were slightly lower in comparison with the average 
population. In contrast, a review concerning cognitive functioning in NS suggested a 
more diffuse pattern of cognitive problems in children and adolescents (Wingbermühle 
et al., 2009). Intelligence levels in the low-average range were reported, with verbal and 
performance capacities fairly evenly distributed. In addition, group studies in children 
with NS found impairments in one or several of the following areas: language skills, motor 
functioning, working memory and memorising, selective or sustained attention, and 
organisational and planning capacities (Pierpont et al., 2013; Wingbermühle et al., 2009). 
Thus, children with NS seem to display more diffuse cognitive deficits compared to adults, 
but longitudinal studies have not yet been performed to confirm this.
 Studies on cognitive deficits are more numerous in individuals with TS than in NS and 
typically report a low-average to average full-scale intelligence, with (nearly) normal levels 
of verbal intelligence, and a lower performance intelligence (Nijhuis-van der Sanden, 
Eling, & Otten, 2003). Impaired visuospatial information processing is considered the 
hallmark cognitive deficit in TS, but difficulties in executive functioning, (visual)memory, 
perceptual organisation, math processing, motor abilities, specific aspects of language 
(e.g., verbal fluency), attention deficits, and hyperactivity have been reported frequently 
(Elsheikh et al., 2002; Hong, Scaletta Kent, & Kesler, 2009; Knickmeyer, 2012; Nijhuis-van der 
Sanden et al., 2003; Rovet, 2004). Planning skills seem to improve with age, while visuospatial 
and visual memory deficits remain in adulthood (Romans, Stefanatos, Roeltgen, Kushner, 
& Ross, 1998).
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Besides cognitive impairments, both NS and TS have been associated with problems in 
affective information processing, notably social cognition (Burnett, Reutens, & Wood, 
2010; Wingbermühle, Egger, et al., 2012), that is, constructing representations of the 
relations between oneself and others, and to use those representations flexibly to guide 
social behaviour (Adolphs, 2001). Studies addressing social cognition in children with NS 
are mainly limited to single-case studies and report below-average social skills, diminished 
social insight, and social immaturity (Lee et al., 2005; Sarimski, 2000; Troyer & Joschko, 
1997). Adviento et al. (2014) found a higher prevalence of social impairment in children 
and adults with RASopathies in comparison with sibling controls. In adults with NS, 
difficulties in identifying and describing feelings (i.e., alexithymia), slight overall problems 
in the perception of emotional facial expressions, and social discomfort (but no avoidance 
of social situations) have been described (Wingbermühle, Egger, et al., 2012). TS has been 
associated with social immaturity, problems in social relations, difficulties in expressing 
emotions, social anxiety, and impairments in facial emotion recognition, most notably fear 
(Burnett et al., 2010; Hong, Bray, Haas, Hoeft, & Reiss, 2014). Despite similarities in phenotypic 
presentation between women with NS and TS, it should be noted that within the groups 
heterogeneity in cognitive and social-emotional problems is present.
 Impairments in social cognition are associated with psychological distress, social 
isolation, and reduced self-esteem (Beauchamp & Anderson, 2010). Moreover, alexithymia 
is known to constitute a risk factor for developing mood and anxiety problems (Larsen, 
Brand, Bermond, & Hijman, 2003). Studies mention the presence of mood and anxiety 
problems in individuals with NS (Alfieri et al., 2014; Mahendran & Aw, 1989; Noonan, 2005; 
Verhoeven et al., 2004; Verhoeven et al., 2008; Wingbermühle et al., 2009). However, 
besides studies reporting autism traits and ADHD symptoms in individuals with NS in 
comparison with siblings (Adviento et al., 2014; Pierpont et al., 2015), to our knowledge, no 
controlled studies have been performed concerning psychopathology in NS. Depressive 
problems and anxiety have been reported in individuals with TS in addition to lowered 
levels of self-esteem (Delooz, Van den Berghe, Swillen, Kleczkowska, & Fryns, 1993; Downey, 
Ehrhardt, Gruen, Bell, & Morishima, 1989; Kiliç, Ergür, & Ocal, 2005; Saad et al., 2014). Other 
studies, in contrast, mention that the frequency of emotional problems in individuals with 
TS is not higher than in comparable populations (Cardoso et al., 2004; Ross, Zinn, & 
McCauley, 2000; Schmidt, Rubinow, & Bondy, 2006).
 The aim of the current study was to compare alexithymia, emotion perception, and 
social assertiveness of females with NS with that of females with TS and female controls. 
This may lead to the discrimination of specific profiles of affective information processing 
in NS and TS, which could contribute to the development of tailored clinical approaches. 
We hypothesised that (1) women with TS show lower levels of alexithymia than women 
with NS, specifically less problems in verbalising emotions due to their relatively higher 
verbal skills, whereas women with NS will show higher levels of alexithymia than controls; 
(2) women with TS perform worse on facial emotion perception (especially for recognising 
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fear) than both women with NS and controls, women with NS show a slightly lower overall 
emotion perception performance in comparison with controls; and (3) women with TS 
and women with NS will show more social discomfort than controls because of their 
deviant physical appearance. A deviant appearance, deviant behaviour, deviant character-
istics, and disabilities were identified as causes of childhood bullying (Thornberg, 2010). 
Many individuals with NS have been bullied in childhood (76.92% in the current sample). 
Bullying victims are at risk for developing mood and anxiety disorders, and show problems 
in social relationships (Takizawa, Maughan, & Arseneault, 2014). Women with TS will display 
more avoidance in social situations than controls, women with NS show equal levels of 
avoidance in comparison with controls.
Materials and Methods
Participants
Twenty-six females with NS, 40 females with TS, and 40 female controls participated in this 
study. All participants took part in larger on-going investigations (Freriks et al., 2015; Menke 
et al., 2010; Wingbermühle, Egger, et al., 2012; Wingbermühle, Roelofs, et al., 2012). 
Participation was voluntary and written informed consent was obtained from all 
participants or their legal representatives. The study was approved by the Institutional 
Review Board of the Vincent van Gogh Institute for Psychiatry and by the Committee on 
Research involving Human Subjects Arnhem/Nijmegen of the Radboud University 
Medical Centre, in accordance with the Declaration of Helsinki. Women with NS were 
consecutively referred to the Vincent van Gogh Institute for Psychiatry by the Department 
of Human Genetics of the Radboud University Medical Centre. Inclusion criteria were a 
confirmed clinical diagnosis of NS and a minimum age of 16 years. Women with TS were 
recruited by the Department of Medical Psychology of the Radboud University Medical 
Centre. They were included if they had a karyotype result consistent with TS and a 
chronological age of 16 years or more. For the distribution of the karyotypes and molecular 
test results, see Table 1. A female control group of adult community-dwelling volunteers 
was recruited via the network of the researchers involved in the data collection. Exclusion 
criteria for the controls were a (known) diagnosis of a genetic or neurological disorder or a 
current psychiatric illness.
 In view of the controversy regarding the contribution of intelligence to social emotional 
constructs such as alexithymia (Ibanez et al., 2013; Parker, Taylor, & Bagby, 2001; Parker, 
Taylor, & Bagby, 1989; Taylor et al., 1988), women with TS and controls were carefully 
matched to the group of women with NS on age and full-scale IQ on the Wechsler Adult 
Intelligence Scale (WAIS-III), supported by statistical between group testing of these 
variables. Full-scale IQ (FSIQ), verbal IQ (VIQ), and performance IQ (PIQ) were estimated 
with an abbreviated version of the WAIS-III, derived from the seven-subtest short form of 
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Ward (1990). The present short form included eight subtests: four verbal subtests (Information, 
Digit Span, Arithmetic, and Similarities), and four performance subtests (Picture Completion, 
Picture Arrangement, Block Design, and Digit Symbol). The seven-subtest short form of 
Ward is known to generate reliable estimates of FSIQ, as well as satisfactory estimates of 
VIQ and PIQ (Axelrod, Dingell, Ryan, & Ward, 2000; Axelrod, Ryan, & Ward, 2001; Pilgrim, 
Meyers, Bayless, & Whetstone, 1999). The sum of the scaled sores of the verbal subtests 
was multiplied by 1.5 and the sum of the performance subtests was multiplied by 1.25 in 
order to obtain the estimated VIQ, PIQ, and FSIQ (Wechsler, 2005).
 Descriptive information of the groups is presented in Table 2. As a result of the 
matching process, no significant group differences were found on age (F(2,103) = 1.01, 
p = 0.37) and WAIS-III FSIQ (F(2,103) = 0.05, p = 0.95). There were significant group effects for 
VIQ (F(2,103) = 3.14, p= 0.05) and PIQ (F(2,103) = 7.25, p = 0.001), but Bonferroni post-hoc 
analyses failed to reach significance for VIQ (p = 0.07). Post-hoc tests showed that PIQ of 
women with TS was lower than that of women with NS (p = 0.002) and controls (p = .01). 
Within the groups, we found VIQ to be higher than PIQ in the TS group (t(39) = 6.42, 
p < .001) and PIQ higher than VIQ in the NS group (t(25) = -2.23, p = 0.04). No significant 
difference was found between VIQ and PIQ in the control group. Education level was 
Table 1  Distribution of the Karyotypes of Women with Noonan and Turner Syndromes.
Karyotype Number (%)
Noonan syndrome (n = 26)
PTPN11 14 (53.85)
SOS1 4 (15.38)
KRAS 1 (3.85)
No mutation found 2 (7.69)
Unknown 5 (19.23)
Turner syndrome (n = 40)
45,X 17 (42.5)
45,X/46,XX 5 (12.5)
45,X/47,XXX 2 (5)
45,X/46,Xi(Xq) 5 (12.5)
45,X/46,X,del(X) 2 (5)
45,X/46,XX/47,XXX 1 (2.5)
45,X/46,X,r(X) 2 (5)
46,X,i(Xq) 4 (10)
46,X,del(X) 1 (2.5)
46,X,Xp-/46,X,i(Xq) [10/6] 1 (2.5)
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coded according to the Verhage system, ranging from category 1 (1–5 years of education) 
to 7 (19–20 years of education) (Bouma et al., 2012). Education levels differed significantly 
between the three groups (H(2) = 3.15, p < 0.001). Follow-up tests indicated that, despite 
their equal full-scale intelligence levels, women with TS were better educated than 
women with NS (p < 0.001) and controls (p = 0.001).
 Since anxiety and mood problems are known to impede affective information 
processing (Bourke, Douglas, & Porter, 2010; Plana, Lavoie, Battaglia, & Achim, 2014), 
we included the anxiety and depression scales of the Dutch version of the Symptom 
Checklist-90 Revised (SCL-90-R) (Arrindell & Ettema, 2003) for control purposes. Women 
with NS (n= 25) reported significantly higher levels of anxiety (F(1,63) = 7.52, p = 0.01, 
η2p = 0.11) and depression than women with TS (F(1,63) = 6.77, p = 0.01, η2p = 0.10).
Alexithymia
To assess alexithymia, the Bermond-Vorst Alexithymia Questionnaire (BVAQ) (Vorst & 
Bermond, 2001) was administered. The BVAQ is a self-report questionnaire designed to 
measure five factor-based dimensions of alexithymia: (1) Emotionalising (the degree to 
which someone is emotionally aroused by emotion inducing events); (2) Fantasising (the 
degree to which someone is inclined to fantasise, imagine, and daydream about virtual 
Table 2  Descriptive Information of Women with Turner Syndrome, Noonan Syndrome, 
and Controls.
Turner syndrome  
(n = 40)
Noonan syndrome  
(n = 26)*
Controls  
(n = 40)
M/
mode
Range SD M/
mode
Range SD M/
mode
Range SD
Age 25.44 19-33 3.27 27.85 16-52 12.05 28.28 17-52 11.46
WAIS-III FSIQ 90.68 75-106 9.30 91.42 71-119 11.82 91.05 75-106 6.97
     VIQ 96.25 75-116 9.97 90.35 67-121 12.85 92.00 74-108 8.04
     PIQ 86.00 67-106 10.39 94.77 74-113 11.97 92.45 78-113 7.86
Education level 6 4-6 - 5 2-7 - 5 3-7 -
SCL-90-R
     Anxiety 13.08 10-27 3.75 16.60 7-35 6.62 - - -
     Depression 22.93 16-46 7.83 29.52 16-59 12.65 - - -
Note: M, mean; SD, standard deviation; WAIS-III, Wechsler Adult Intelligence Scale Third Edition; FSIQ, full-scale 
intelligence quotient (estimated by eight subtests); VIQ/PIQ, estimated verbal/performance intelligence 
quotient; SCL-90-R, Dutch version of the Symptom Checklist-90 Revised.
*The sample size for the SCL-90-R analyses was 25.
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matters); (3) Identifying (the degree to which one is able to define the nature of one’s own 
emotions); (4) Analysing (the degree to which one seeks explanations of one’s own 
emotional reactions); and (5) Verbalising (the degree to which one is able or inclined to 
describe or communicate about one’s emotional reactions). The subscales Emotionalising 
and Fantasising together constitute the higher order Affective Component and the 
subscales Identifying, Analysing, and Verbalising compose the higher order Cognitive 
Component. The BVAQ consists of 40 items (e.g., “when something totally unexpected 
happens, I remain calm and unmoved” or “when I am distressed, I know whether I am 
afraid or sad or angry”), which are rated on a five-point Likert scale ranging from 1 to 5. 
Each of the five dimensions is measured by eight items. The scores on the subscales range 
from 8 to 40 and the total alexithymia score ranges from 40 to 200. Higher scores are 
indicative of higher levels of alexithymia (Vorst & Bermond, 2001).
Emotion Perception
The Emotion Recognition Task (ERT), developed by Montagne, Kessels, De Haan and 
Perrett (2007), is a computer-generated paradigm for the recognition of six basic facial 
emotional expressions: anger, disgust, fear, happiness, sadness, and surprise. Participants 
are presented with dynamic images of the faces of four actors (two males and two 
females) expressing the aforementioned emotions in different intensities. A computer 
program enables real-time interactive morphing between neutral expression and the 
facial expression of diverse emotional intensities, presented as video clips (Kessels, 
Montagne, Hendriks, Perrett, & De Haan, 2014; Montagne et al., 2007). After each video clip, 
the participant is asked to make a forced choice between the six emotions, displayed in 
labels on the test computer. The emotion recognition scores of women with NS, women 
with TS, and controls were compared on the intensities 40, 60, 80, and 100%. Performance 
was defined by the number of correctly labelled emotional expressions. For each emotion, 
scores may range from 0 to 16. Higher scores represent better emotion perception.
Social Assertiveness and Social Discomfort
The Scale for Interpersonal Behaviour (SIB) was used as an index for the engagement in 
social behaviour and the amount of discomfort evoked by these situations (Arrindell et al., 
2001). The SIB includes 50 items (e.g., “start a conversation with a stranger” or “tell someone 
that you like him/her”), which the participant has to evaluate on two separate five-point 
scales; one for the probability of engagement in specific social situations (performance) 
and one for the amount of discomfort experienced in these situations (distress). Besides a 
total performance and total distress score, the SIB results in four factorially based subscales: 
(1) Display of negative feelings; (2) Expression of and dealing with personal limitations; (3) 
Initiating assertiveness; and (4) Praising others and the ability to deal with compliments/
praise of others (Arrindell et al., 2001). For this study, the total performance score and total 
distress score were calculated.
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Statistical Analysis
A multivariate analysis of variance (MANOVA) was performed to compare the results on 
the BVAQ and SIB of women with NS, TS, and controls. BVAQ and SIB scores were included 
as dependent variables, and Group (NS, TS, C) was included as a factor. The ERT was 
analysed with a mixed between-within subjects ANOVA, with Emotion (Fear, Happiness, 
Sadness, Surprise, Disgust, Anger) and Intensity (40, 60, 80, 100) as within-subject factors, 
and Group (NS, TS, C) as between-subject factor. This analysis was followed up by six 
mixed between-within subjects ANOVAs, one for each of the emotions, with Intensity 
(40, 60, 80, 100) as within-subject factor and Group (NS, TS, C) as between-subject factor, 
to investigate the influence of group on emotion perception scores for the six emotions 
separately. Effect sizes were computed, expressed as partial eta-squared. All analyses have 
been performed with SPSS 22 for Windows.
Results
Alexithymia
Significant group differences were found on the total BVAQ score, the Affective 
Component, the Cognitive Component, and on the dimensions Identifying, Emotionalizing, 
and Analysing. All F-values were larger than 9.80 (p-values< 0.001, η2p ranged between 
0.16 and 0.35). Bonferroni post-hoc analyses revealed that women with TS reported more 
alexithymic features than both women with NS and controls, and that women with NS did 
not differ from controls with respect to alexithymia levels, with exception of the scale 
Emotionalising. Women with NS showed lower levels of alexithymia on this scale than 
controls. An overview of the BVAQ results is displayed in Table 3.
Social Assertiveness and Social Discomfort
No significant group differences were found for the reports on the performance scale and 
distress scale of the SIB. An overview of the results is displayed in Table 3.
Emotion Perception
Mauchly’s test indicated that the assumption of sphericity had been violated for the main 
effect of Emotion (χ2(14) = 35.54, p = 0.001) and for the interaction effect of Emotion and 
Intensity (χ2(119) = 286.19, p < 0.001). Therefore, the degrees of freedom were corrected 
using Greenhouse-Geisser estimates of sphericity. The mixed between-within subjects 
ANOVA revealed no significant effect of Group, indicating that the three groups did not 
significantly differ in accuracy of emotion perception. Significant main effects were found 
for Emotion (F(4.50, 463.67) = 187.23, p < 0.001, η2p = 0.65) and Intensity (F(3, 309) = 85.09, 
p < 0.001, η2p = 0.45), indicating that some emotions were more difficult to recognise than 
others and that performance varied between the different levels of emotion intensity. 
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A small interaction effect was found for Emotion and Intensity (F(11.26, 1159.86) = 4.77, 
p < 0.001, η2p = 0.04), indicating that intensity did not affect the recognition of each 
emotion in the same way, which is in accordance with previous findings (Montagne et al., 
2007). Moreover, there was a small interaction effect of Emotion and Group (F(9.00, 463.67) 
= 2.10. p = 0.02, η2p = 0.04), but the interaction effect of Intensity and Group, and the 
three-way interaction between Emotion, Intensity, and Group were not significant.
 To further examine the significant interaction effect of Emotion and Group, six mixed 
between-within subjects ANOVAs were performed, one for each emotion. These analyses 
showed a significant group effect only for the emotion anger (F(2, 103) = 5.44, p = 0.01, 
Table 3  Mean Scores and Standard Deviations of the BVAQ and SIB Variables for 
Women with Turner Syndrome, Noonan Syndrome, and Controls.
Turner 
syndrome
(n = 40)
Noonan 
syndrome
(n = 26)
Controls
(n = 40)
Post-hoc tests
Alexithymia BVAQ Total score 137.78 
(12.82)
104.77 
(18.89)
116.25 
(24.33)
TS vs. NS**  
TS vs. C**
Affective component 51.93 
(8.78)
41.62 
(9.92)
46.75 
(9.47)
TS vs. NS**  
TS vs. C*
Fantasising 23.65 
(6.93)
23.15 
(6.34)
24.87 
(6.82)
-
Emotionalising 28.28 
(4.21)
18.46 
(5.04)
21.87 
(6.75)
TS vs. NS**
TS vs. C**
NS vs. C*
Cognitive component 85.85 
(11.55)
63.15 
(13.05)
69.50 
(19.52)
TS vs. NS**  
TS vs. C**
Verbalising 25.03 
(5.58)
24.88 
(5.90)
23.73 
(6.94)
-
Identifying 30.55 
(5.33)
18.69 
(7.07)
22.85 
(8.62)
TS vs. NS**  
TS vs. C**
Analysing 30.28 
(4.64)
19.58 
(4.67)
22.92 
(7.96)
TS vs. NS**  
TS vs. C**
Social 
Assertiveness 
& Social 
Discomfort
Scale of Interpersonal Behaviour
Performance score 154.40 
(25.89)
142.96 
(34.28)
155.85 
(33.91)
-
Distress score 116.38 
(33.77)
120.19 
(47.90)
101.30 
(26.34)
-
Note: BVAQ, Bermond-Vorst Alexithymia Questionnaire; SIB, Scale for Interpersonal Behaviour; TS, Turner syndrome; 
NS, Noonan syndrome; C, Controls.
* p < 0.05,** p < 0.001, all p-values are Bonferroni corrected.
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η2p = 0.10). Bonferroni post-hoc comparisons indicated that women with NS were less accurate 
in recognising anger than controls (p = 0.005). For a graphical display of the ERT results, 
see Figure 1.
Figure 1  Percentage of correctly recognised facial emotional expressions on the Emotion 
Recognition Task, for the different levels of intensity (40-100%) of the six emotions. Results were 
displayed for 26 women with Noonan syndrome (NS), 40 women with Turner syndrome (TS), 
and 40 controls (C). Error bars represent the standard error of the mean. *p < 0.01.
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Discussion
This first comparative study of affective information processing in women with NS, TS, and 
female controls, showed differential patterns of impairment for women with NS and 
women with TS. Women with TS demonstrated higher levels of alexithymia than women 
with NS and controls, whereas women with NS only showed problems in recognising 
angry facial expressions in comparison with controls.
 Surprisingly, women with TS reported higher levels of alexithymia than women with 
NS and controls. They particularly reported lower emotional arousal, more difficulties in 
defining the nature of their emotions, and more problems in seeking explanations for 
emotional reactions. No significant group differences were found in the ability to verbalise 
emotional experiences or in the ability to fantasize. The pattern of reported alexithymic 
problems in women with TS is indicative of “affective” alexithymia (as opposed to the 
“cognitive” variant), in which problems in the awareness of the arousal of emotions are 
thought to hamper the interpretation of emotions (Vorst & Bermond, 2001). Although it 
was hypothesised that women with TS would specifically show fewer problems in 
verbalising emotions, finding substantially higher levels of general alexithymia was 
unexpected. Considering earlier reports of higher levels of cognitive alexithymia in men 
and women with NS in comparison with controls (Wingbermühle, Egger, et al., 2012), we 
expected that these findings would be replicated in the current study. However, the 
present sample of women with NS did not report more alexithymic traits than controls or 
women with TS. A meta-analysis on sex differences in alexithymia (Levant, Hall, Williams, & 
Hasan, 2009) concluded that higher levels of alexithymia are present in men, especially in 
those with a traditionally masculine gender-role socialisation. Consequently, males with 
NS may report higher levels of alexithymia than females with NS, which could explain why 
the previously mentioned effects in a mixed-sex sample were not replicated in the current 
study.
 Moreover, women with NS demonstrated specific difficulty in recognising angry 
facial expressions in comparison with controls; the accuracy of the recognition of other 
emotional expressions was at control level. This is not in accordance with the findings in a 
previous study of our research group, in which individuals with NS showed a lower 
emotion recognition score in general, but no specific emotion perception problems 
(Wingbermühle, Egger, et al., 2012). Mood and anxiety problems are known to impede 
affective information processing. Our sample of women with NS reported higher levels of 
depression and anxiety on the SCL-90-R than women with TS, which could have led to a 
response bias toward negative stimuli. However, this is less likely to affect the response to 
angry facial expressions in isolation. In order to investigate the relation between depression 
and anxiety symptoms on the SCL-90-R and emotion recognition on the ERT in women 
with NS, Pearson correlation coefficients were calculated. Only a significantly positive 
correlation between reported depression and the total ERT score was found (r(23) = 0.42, 
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p = 0.04). The correlations between depression and anxiety scores, and the mean anger 
recognition score did not reach significance (anxiety r(23) = -0.13, p = 0.53; depression r(23) 
= 0.19, p = 0.36). This is in contrast with our suggestion that higher levels of depression and 
anxiety could explain the poor recognition of angry faces in women with NS. In fact, these 
results indicate that women with NS who reported more depressive symptoms were 
more accurate in recognising facial emotions. However, the meaning and relevance of the 
specific anger recognition impairment in women with NS remains unclear and requires 
replication. In contrast to our hypothesis, women with TS did not demonstrate the 
frequently reported deficit in fear recognition (Hong et al., 2014; Lawrence, Campbell, et 
al., 2003; Lawrence, Kuntsi, Coleman, Campbell, & Skuse, 2003; Mazzola et al., 2006; Romans 
et al., 1998; Skuse, Morris, & Dolan, 2005). These studies used facial emotional expressions 
of fixed intensities to measure affect recognition. However, the ERT we used presented 
moving images of facial expressions of different emotional intensities. Perhaps, women 
with TS benefitted from the presentation of fearful faces in the lower intensities, explaining 
why their performance on the recognition of fearful faces is higher in the current study 
than in previous reports.
 Women with NS, women with TS and controls reported equal levels of distress in 
social situations and described comparable frequencies of engaging in these situations 
on the SIB. Despite the lack of group differences on the total performance and total 
distress scores, we found that women with NS experienced more distress than controls 
while initiating assertiveness (p = 0.01), and that they were less likely to express and deal 
with personal limitations (p = 0.01) in comparison with women with TS. This could indicate 
a tendency toward a socially anxious behaviour style in women with NS. This is in 
accordance with the results of a previous study of (Wingbermühle et al., 2012), reporting 
that individuals with NS experienced more social discomfort than controls, but did not 
avoid social interaction. 
 A major strength of this study is that it represents the first systematic investigation 
comparing affective information processing between women with NS, women with TS, 
and female controls. Other strengths are the inclusion of sizeable same-sex groups, 
matched on age and intelligence. However, education levels differed between the groups, 
as women with TS were able to complete higher levels of education than both other 
groups. The lag in education level of the NS group is in line with previous studies, which 
demonstrated a higher need of special education in individuals with NS compared to 
IQ-matched controls, possibly due to additional cognitive difficulties (Shaw et al., 2007; 
Wingbermühle, Roelofs, et al., 2012). In turn, TS women may benefit from their relative 
verbal strength during education. A second limitation of this study concerns the fact that 
the outcome measures were confined to the visual perception of emotional expressions 
and to self-reports of alexithymia and social assertiveness. These constructs are important 
elements of affective information processing, but affective functioning is a much more 
broader domain. Including more diverse measures to investigate other aspects of affective 
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information processing would be desirable (e.g., perspective taking, auditory emotion 
perception, or real-life social interaction). However, in the present study design, neuro-
cognitive testing already lasted approximately eight hours (spread over two consecutive 
days); a more extensive examination would not have been feasible in this sample. 
 In conclusion, affective information processing was examined in two phenotypically 
comparable, but genetically different syndromes, showing different patterns of affective 
information processing. While women with TS showed higher levels of alexithymia, 
women with NS only showed specific impairments in anger recognition. Since alexithymia 
has not previously been described in TS, this is a novel and interesting finding. The presence of 
dissimilar patterns of affective information processing in NS and TS groups suggests that 
the difference in genetic aetiology contributes to the specific social cognitive profiles, 
rather than the social consequences of having a deviant physical appearance. Imaging 
studies in TS describe an increased volume of the amygdala, an area of the brain associated 
with affective information processing (Kesler et al., 2004), while in NS, mutations in the 
RAS/MAPK pathway are suggested to result in abnormal brain development and 
functioning without a specific neural structure known to be affected yet (Wingbermühle, 
Roelofs et al., 2012). Since affective information processing is required for adequate 
daily functioning and greatly influences quality of life (Beauchamp & Anderson, 2010), 
this  cognitive-affective domain should be an area of consideration within the treatment 
options of these syndromes. Both individuals with NS and TS could benefit from treatment 
focusing on the improvement of affective information processing, in which alexithymia or 
emotion perception should be accentuated depending on the specific impairments of 
the individual.
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Abstract
This is the first controlled study regarding personality and psychopathology in adults with 
Noonan syndrome (NS). Anxiety, depression, higher levels of alexithymia, and symptoms 
of Attention Deficit-Hyperactivity Disorder and Autism Spectrum Disorder have been 
previously described in NS. More information regarding personality and psychopathology 
in NS could improve mental health care for this population. Therefore, scores on the 
Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), a widely 
used self-report questionnaire of personality and psychopathology, were compared 
between patients with NS (n = 18) and matched, healthy controls (n = 18). Furthermore, 
correlations between MMPI-2-RF scores and alexithymia, measured by the Toronto 
Alexithymia Scale-20, were investigated. Patients with NS showed significantly higher 
scores on the MMPI-2-RF scales reflecting infrequent responses (F-r), somatic and cognitive 
complaints (FBS-r), internalising problems (EID), demoralisation (RCd), and introversion 
(INTR-r), although the overall profile in both groups was within the non-clinical range. 
Alexithymia correlated with internalising problems and negative emotionality in the 
patient group. In conclusion, patients with NS showed higher levels of introversion, which 
may predispose them to internalising problems. These problems were indeed more 
frequent in patients with NS, especially higher levels of demoralisation. Patients may 
benefit from psychological interventions aimed to decrease internalising problems, 
introversion, and alexithymia.
63
4
PERSONALITY AND PSYCHOPATHOLOGY IN ADULTS WITH NOONAN SYNDROME
Introduction
Noonan syndrome (NS) is a genetic condition with an estimated prevalence from 1 in 
1,000 to 2,500 live births (Noonan, 2005; Nora et al., 1974). NS is one of the ‘RASopathies’, 
referring to a group of neurodevelopmental disorders with clinical overlap that are caused 
by gene mutations resulting in dysregulation of the RAS/mitogen-activated protein kinase 
(RAS/MAPK) pathway. This signal transduction cascade is involved in several developmental 
processes in the cell and is crucial for normal development (Allanson & Roberts, 2016; 
Roberts et al., 2013; Tidyman & Rauen, 2008). To date, mutations in 17 different genes are 
associated with NS, of which mutations in PTPN11 (50%), SOS1 (10%), and RAF1 (10%) are 
most common (Tajan et al., 2018). The phenotype of patients with NS is characterised by 
distinctive facial features (e.g., ocular hypertelorism, ptosis, low-set posteriorly rotated 
ears), short stature, and congenital heart defects (Allanson & Roberts, 2016). Regarding 
cognitive functioning, NS is associated with varying degrees of developmental delay and 
intelligence scores tend to vary from intellectual disability to superior levels of functioning. 
However, most patients with NS show intellectual abilities within the (low)average range 
(Pierpont, 2016). In children and adolescents with NS, cognitive difficulties in language 
functioning, visual processing, motor abilities, attention and executive functioning, 
memory, and social functioning have been found (Pierpont, 2016). Studies regarding 
cognitive functioning in adults are scarce, but mainly report a lowered speed of 
information processing, subjective executive difficulties, and social cognitive problems 
(e.g., alexithymia) (Wingbermühle, Egger, et al., 2012; Wingbermühle, Roelofs, et al., 2012).
 Patients with NS may more likely develop interpersonal problems or psychopathology 
than healthy individuals due to the previously mentioned cognitive impairments, as well 
as psychological risk factors that frequently accompany the syndrome. For instance, most 
patients with NS report a history of being bullied, which may potentially be associated 
with having a deviant physical appearance and less social resilience or social competence 
than peers (Wingbermühle, Roelofs, et al., 2012). Bullying victimisation and coping with a 
chronic physical illness have been related to increased mental health problems, especially 
anxiety and depressive symptoms (Arseneault, 2018; Green, 2004; Karsdorp et al., 2006; 
Pinquart & Shen, 2011). Moreover, individuals with a developmental delay are known to 
be at a higher risk for developing psychopathology, although the issue of ‘diagnostic 
overshadowing’ (i.e., ascribing all features of an individuals’ presentation to developmental 
delay) frequently leads to the underdiagnosis of (treatable) mental disorders (Einfeld, Ellis, 
& Emerson, 2011; Siegel & Smith, 2010). 
 Regarding psychopathology in NS, internalising and externalising behavioural problems 
have been frequently reported by parents of children with NS (Alfieri et al., 2014; Garg et al., 
2017; Pierpont et al., 2015; Sarimski, 2000; Van der Burgt et al., 1999; Wood et al., 1995). 
Although anxiety and mood problems have been described rather frequently (Noonan, 
2005; Perrino et al., 2018; Pierpont et al., 2015; Smpokou et al., 2012; Wingbermühle, Egger, 
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et al., 2012) and the prevalence of symptoms of Attention Deficit Hyperactivity Disorder 
(ADHD) and Autism Spectrum Disorder (ASD) seems to be higher in children and 
adolescents with NS than in the general population (Adviento et al., 2014; Alfieri et al., 2014; 
Garg et al., 2017; Perrino et al., 2018; Pierpont et al., 2015; Smpokou et al., 2012), only few 
systematic studies regarding psychopathology in adults with NS are yet available. In a 
previous study of our research group, significantly higher levels of self-reported distress in 
social situations – but equal levels of social avoidant behaviour - were found in adults with 
NS in comparison with controls, as well as higher levels of anger-hostility and obsessive- 
compulsive complaints mostly reflecting subjective cognitive difficulties (Wingbermühle, 
Egger, et al., 2012). Furthermore, there are incidental reports of psychopathology in adult 
patients with NS (i.e., schizophrenia, bipolar disorder, panic disorder, obsessive compulsive 
disorder, alcoholism, oppositional disorder, and anorexia nervosa) (Arvaniti et al., 2014; 
Krishna et al., 1977; Mahendran & Aw, 1989; Noonan, 2005; Verhoeven et al., 2004; Verhoeven 
et al., 2008).
 Only a limited number of studies examined personality characteristics in patients 
with NS. Observations of confident, happy, talkative children, and a socially desirable 
attitude in adults (friendly, cooperative, willing to please) have been described at an 
anecdotal level (Collins & Turner, 1973; Verhoeven et al., 2008). Lee et al. (2005) found no 
differences regarding self-esteem in comparison with the general population. In a recent 
study of Bizaoui, Gage, Brar, Rauen, and Weiss (2018), Big Five personality traits of individuals 
with a RASopathy were compared to that of sibling controls. The patients with NS in this 
study (n = 17, age range 2-39) demonstrated lower levels of Extraversion and Openness 
to experience in comparison with controls. However, it should be noted that this study 
mostly consisted of children, only used parent-based reports, and no information 
regarding the level of intellectual functioning was available. In adults with NS, higher 
levels of alexithymia, reflecting problems in the identification and verbalisation of own 
emotions have been reported in a more systematic study, using matched controls as a 
reference (Wingbermühle, Egger, et al., 2012). Alexithymia has been described as a 
dimensional personality trait, reflecting weaknesses in the cognitive processing and 
regulation of one’s own emotions, which is thought to partly overlap with mentalisation 
(referring to the ability to be aware of and think about the feelings and mental states of 
oneself and others) (Taylor & Bagby, 2012). Alexithymia can be a risk factor for various 
medical and psychiatric conditions, and may lead to interpersonal problems (Taylor & 
Bagby, 2012; Vanheule, Desmet, Meganck, & Bogaerts, 2007). Higher levels of alexithymia 
in patients with NS may be understood as an inadequate coping strategy (reflecting a 
proneness to suppressive emotion regulation strategies instead of reappraisal strategies), 
in which an inability to express feelings may result in mood and anxiety problems 
(Wingbermühle, Egger, et al., 2012).
 Although internalising problems and alexithymia seem to be more prevalent in NS 
patients, psychopathology and personality characteristics have not yet been systematically 
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studied in adults with NS. Increased insight into the psychopathological issues and 
personality traits specific to patients with NS may contribute to the behavioural and 
psycho pathological phenotype of NS and could provide targets for counselling and 
treatment of mental disorders in this population. Therefore, in the current study the results 
of the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF) - 
a widely used self-report questionnaire of psychopathology and personality traits 
(Ben-Porath & Tellegen, 2008) - of adults with NS and controls, matched regarding age, 
sex, and intelligence, have been compared. Higher levels of interpersonal and internalising 
problems were expected in patients with NS in comparison with the control group. 
Furthermore, to increase the understanding of the typical alexithymic profile of NS 
patients, we investigated whether the MMPI-2-RF scores were related to alexithymia.
Methods
Participants
Eighteen patients with NS and 18 healthy controls (HC) were included in the study. 
The control participants were matched to the patient sample regarding age, sex, and 
intelligence (as measured by Wechsler Adult Intelligence Scales). The (social) cognitive 
abilities of a portion of the participants in the current study have been described in 
previous studies (Wingbermühle, Egger, et al., 2012; Wingbermühle, Roelofs, et al., 2012). 
Participation was voluntary and written informed consent was obtained from all 
participants. The study was approved by the local institutional review board of the Vincent 
van Gogh Institute for Psychiatry, in accordance with the declaration of Helsinki. Individuals 
with a clinical diagnosis of NS, based on the criteria of Van der Burgt (2007), were referred 
to the Centre of Excellence for Neuropsychiatry of the Vincent van Gogh Institute for (neuro)
psychological assessment. Patients were referred for research purposes or when cognitive 
or psychological complaints were present. The control group consisted of community- 
dwelling volunteers. Control participants with a diagnosis of a neurological disorder, 
language barriers, or medical problems that might interfere with (neuro)psychological 
functioning were excluded. 
 Due to the careful matching procedure, no significant differences between the 
groups were present with regard to age (MdnNS = 29.5; MdnHC = 28, U = 172.50, z =  0.33, 
p = 0.74, r = 0.06), sex (χ2(1)= 0.12, p = 0.73), and full-scale IQ (FSIQ) measured by the third or 
fourth edition of the Dutch version of the Wechsler Adult Intelligence Scale (Wechsler, 
2005, 2012) (MdnNS = 93; MdnHC = 93.5, U= 157.00, z = -0.16, p = 0.89, r = -0.03). FSIQ ranged 
from 73 to 124 for patients with NS and from 84 to 109 for control participants. Education 
level, according to the Dutch educational system and ranging from category 1 (less than 
six years of primary education) to 7 (academic degree) (Duits & Kessels, 2014), varied from 
3 to 7 in the patient group (mode = 5) and from 4 to 5 in the control group (mode = 5). 
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For individuals with FSIQ scores below 85 (NS n = 4; HC n = 2), verbal reasoning abilities 
and comprehension were judged to be sufficient to complete the MMPI-2(-RF) and the 
test administrator was available to answer questions concerning the items. Moreover, the 
MMPI-2-RF profiles of these individuals were valid, based on the scores on the Validity 
scales. There was no significant difference between the groups regarding the average 
level of alexithymia as measured by the total score of the Toronto Alexithymia Scale-20 
(TAS-20) (Bagby, Parker, & Taylor, 1994; Bagby, Taylor, & Parker, 1994) (MdnNS = 48.5; MdnHC 
= 49.0; U = 143.00, z = -0.60, p = 0.56, r = -0.10). However, four patients with NS (22.2%) 
showed total scores on the TAS-20 indicative of (high) alexithymia, whereas only one 
healthy control showed scores above the threshold of 61 (5.6%). In the patient group, 33% 
males were included (n = 6), compared to 39% in the control group (n = 7). In 55.6% of the 
patients, a mutation in the PTPN11 gene was found (n = 10), 22.2% had a mutation in SOS1 
(n = 4), 5.6% in CBL (n =1), 5.6% in A2ML1 (n =1), and in 11,1% the genetic mutation was 
unknown (n = 2). A history of bullying victimisation was present in 83.3% of the patients 
and in 38.9% of controls. 
Measures
The MMPI-2-RF is a well-known self-report instrument for measuring psychological symptoms 
and maladaptive personality traits. The questionnaire consists of 338 true-or-false items, 
from which eight Validity scales, three Higher-Order (H-O) scales, nine RC scales, 23 Specific 
Problem scales, two Interest scales, and five revised Personality Psychology Five (PSY-5) 
scales can be calculated (Ben Porath & Tellegen, 2008). The MMPI-2-RF was used in the 
current study because of its correspondence with contemporary models of personality 
and psychopathology (Kotov et al., 2017). The MMPI-2-RF scores were derived from the 
original 567-item MMPI-2 booklet (Tellegen & Ben-Porath, 2008; Van der Heijden, Egger, & 
Derksen, 2010). In the present study, the Validity scales, H-O scales, RC scales, Interpersonal 
Scales, and PSY-5 scales were used (see Table 1 for a description of the scales). 
 The TAS-20 is the most widely used self-report questionnaire for assessing alexithymia 
(Bagby, Parker, et al., 1994; Bagby, Taylor, et al., 1994). The TAS-20 consists of 20 items, rated on 
a five-point Likert scale, and it provides a total score and three factor scores: Difficulty 
Identifying Feelings (the ability to identify feelings and distinguish these from somatic 
sensations that accompany emotional arousal), Difficulty Describing Feelings (the ability 
to describe feelings to other people), and Externally Oriented Thinking (a cognitive style 
that shows a preference for external information rather than inner experiences, such as 
feelings or fantasies) (Parker, Taylor, & Bagby, 2003; Taylor, Bagby, & Parker, 2003). Total 
scores of 61 and higher are considered to be indicative of (high) alexithymia (Parker et al., 
2003). Numerous studies have supported the reliability and validity of the TAS-20 (Bagby, 
Parker, et al., 1994; Bagby, Taylor, et al., 1994; Parker et al., 2003; Taylor et al., 2003).
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Table 1  MMPI-2-RF Scales used in the Current Study.
Meaning of the scale 
Validity scales
VRIN-r Variable Response Inconsistency: Random responding
TRIN-r True Response Inconsistency: Fixed responding
F-r Infrequent Responses: Responses infrequent in the general population
Fp-r Infrequent Psychopathology Responses: Responses infrequent in psychiatric populations
Fs-r Infrequent Somatic Responses: Somatic complaints infrequent in medical patient 
populations
FBS-r Symptom Validity: Non-credible somatic and cognitive complaints
L-r Uncommon Virtues: Rarely claimed moral attributes or activities
K-r Adjustment Validity: Uncommonly high level of psychological adjustment
Higher-Order scales
EID Emotional/Internalising Dysfunction: Problems associated with mood and affect
THD Thought Dysfunction: Problems associated with disordered thinking
BXD Behavioural/Externalising Dysfunction: Problems associated with under-controlled 
behaviour
Restructured Clinical scales
RCd Demoralisation: General unhappiness and dissatisfaction
RC1 Somatic Complaints: Diffuse physical health complaints
RC2 Low Positive Emotions: A distinctive, core vulnerability factor in depression
RC3 Cynism: Non-self-referential beliefs that others are bad and not to be trusted
RC4 Antisocial Behaviour: Rule breaking and irresponsible behaviour
RC6 Ideas of Persecution: Self-referential beliefs that others pose a threat
RC7 Dysfunctional Negative Emotions: Maladaptive anxiety, anger, and irritability
RC8 Aberrant Experiences: Unusual perceptions or thoughts associated with psychosis
RC9 Hypomanic Activation: Over-activation, aggression, impulsivity, and grandiosity
Interpersonal scales
FML Family Problems: Conflictual family relationships
IPP Interpersonal Passivity: Being unassertive and submissive
SAV Social Avoidance: Avoiding or not enjoying social events
SHY Shyness: Bashful, prone to feel inhibited and anxious around others
DSF Disaffiliativeness: Disliking people and being around them
Personality Psychopathology Five scales
AGGR-r Aggressiveness-Revised: Instrumental, goal-directed aggression
PSYC-r Psychoticism-Revised: Disconnection from reality
DISC-r Disconstraint-Revised: Under-controlled behaviour
NEGE-r Negative Emotionality/Neuroticism-Revised: Anxiety, insecurity, worry, and fear
INTR-r Introversion/Low Positive Emotionality-Revised: Social disengagement and anhedonia
Note: From Ben-Porath and Tellegen (2008).
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Design and procedure
MMPI-2-RF profiles of 19 patients with NS were available. The validity of the individual 
MMPI-2-RF profiles was checked using the following criteria (Ben-Porath & Tellegen, 2008): 
Cannot Say raw score < 15, (U/L)T-scores VRIN-r and TRIN-r ≤ 80, F-r ≤ 120, Fp-r ≤ 100, Fs-r 
≤ 100, FBS-r ≤ 100, L-r ≤ 80, and K-r ≤ 70. This led to the exclusion of one patient with NS 
due to a high VRIN-r score. Another patient with NS had a Fs-r score higher than 100, but 
was not excluded, because this score could reflect the actual somatic complications 
accompanying NS and all other validity scores of this individual were below the cut-off 
scores, which implicated a valid profile. Two patients and two controls scored between 70 
and 75 on the K-r scale, which could indicate underreporting (Ben-Porath & Tellegen, 
2008), but since the other validity scales did not show deviant scores, these profiles were 
considered valid and were therefore not excluded from the study. This resulted in the 
inclusion of 18 patients with NS and 18 matched controls.
 In total, there were 18 missing answers in the patient group and five in the control 
group. The missing items in the patient group included 10 items that were part of the 
Validity scales (VRIN-r, F-r, FBS-r, Fp-r, Fs-r), three of the H-O scales (EID, BXD), 13 of the RC 
scales (RCd, RC1, RC2, RC3, RC4, RC7, RC9), two of the Interpersonal scales (FML), and four 
of the PSY-5 scales (AGGR-r, DISC-r, PSYC-r, INTR-r). The missing answers in the control 
group constituted of six items of the Validity scales (VRIN-r, TRIN-r, F-r), three of the H-O 
scales (EID, BXD), four of the RC scales (RCd, RC2, RC9), two of the interpersonal scales 
(SHY, SAV), and two of the PSY-5 scales (INTR-r, DISC-r). Because more items were missing 
in the patient group and could therefore not be included in the analyses, raw scores may 
be lower for patients with NS than controls. Raw scale scores were used in the analyses.
 The current study has a case-control design, studying differences in MMPI-2-RF scores 
between patients with NS and healthy controls. First, the raw scores on the eight Validity 
scales are compared to investigate whether differences in response tendencies are 
present between the groups. Second, the raw scores on the three H-O scales, nine RC 
scales, five Interpersonal scales, and five PSY-5 scales will be compared across the groups. 
Furthermore, mean (U/L)T-scores - calculated using a Dutch normative sample – of the 
two groups will be investigated qualitatively with regard to elevations (scores ≥ 65) or 
decreased scores (< 39) on the H-O, RC, Interpersonal, and PSY-5 scales. Finally, the 
correlation between the total score on the TAS-20 (i.e., alexithymia) and the raw scores on 
the H-O, RC, Interpersonal, and PSY-5 scales will be calculated. 
Data-analysis
Due to the violation of normality and the presence of outliers, non-parametric tests are 
used. Mann-Whitney U tests will be performed to investigate differences in raw scores 
between the groups on the Validity scales, H-O scales, RC scales, Interpersonal scales, and 
PSY-5 scales. Effect sizes are calculated manually, using the following equation: r = z / (√N) 
(Perdices, 2018; Rosenthal, 1991). Spearman’s correlation coefficients will be calculated to 
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investigate the relation between alexithymia and the scores on the H-O, RC, Interpersonal, 
and PSY-5 scales. All analyses are performed with SPSS Version 23.0.0.0.
Results
On the Validity Scales, patients with NS showed significantly higher scores on F-r and FBS-r 
than controls, reflecting a tendency to report more psychological, cognitive, and somatic 
complaints (see Table 2). Significantly higher scores were found on the H-O scale Emotional/ 
Internalising Dysfunction (EID) and the RC scale Demoralisation (RCd) in patients with NS 
compared with controls (see Table 3). No significant differences were found regarding 
the Interpersonal scales, although Family Problems (FML) almost reached significance. 
Patients with NS showed significantly higher scores than controls on the PSY-5 scale 
Introversion/Low Positive Emotionality (INTR-r). The scores on Negative Emotionality/
Neuroticism (NEGE-r) almost reached significance (see Table 4).
Table 2  Results of the MMPI-2-RF Validity Scales of Patients with Noonan Syndrome 
(NS) and Healthy Controls (HC).
Median raw scores 
(range)
MMPI-2-RF 
Validity scales
NS
(n = 18)
HC
(n = 18)
U z p r
VRIN-r 4
(0-7)
3.5
(0-6)
133.00 -0.93 0.37 -0.16
TRIN-r 12
(9-12)
11
(8-13)
131.50 -1.02 0.34 -0.17
F-r 4.5
(1-16)
2.5
(0-10)
96.00 -2.10 0.04 -0.35
Fp-r 2
(0-6)
1
(0-3)
137.00 -0.81 0.44 -0.14
Fs-r 2
(0-9)
1.5
(0-3)
130.50 -1.02 0.32 -0.17
FBS-r 14
(4-22)
10
(6-17)
84.50 -2.46 0.01 -0.41
L-r 4
(1-10)
4
(1-9)
147.00 -0.48 0.65 -0.08
K-r 6
(1-14)
7
(1-13)
190.5 0.91 0.37 0.15
Note: VRIN-r, Variable Response Inconsistency; TRIN-r, True Response Inconsistency; F-r, Infrequent Responses; 
Fp-r, Infrequent Psychopathology Responses; Fs-r, Infrequent Somatic Responses; FBS-r, Symptom Validity; L-r, 
Uncommon Virtues; K-r, Adjustment Validity; U, Mann-Whitney’s U statistic; z, z-score; r, effect size estimate.
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The presentation of the mean (U/L) T-scores in Figure 1 shows that the scores in both 
groups are within the normal, non-clinical, range. In general, the scores in the control 
group seem to be lower than in the patient group. While EID shows the highest T-score of 
the H-O scales in the patient group, Behavioural/Externalising Dysfunction is highest in 
the control group. Regarding the RC scales, it appears that T-scores for Somatic Complaints 
and Demoralisation almost reach the (clinical) threshold of 65 in the patient group, and that 
Table 3  Results of the MMPI-2-RF Higher-Order and Restructured Clinical Scales of 
Patients with Noonan Syndrome (NS) and Healthy Controls (HC).
Median raw score 
(range) 
MMPI-2-RF
H-O and RC scales
NS
(n = 18)
HC
(n = 18)
U z p r
EID 17.5
(2-36)
9
(4-34)
99.00 -2.00 0.05 -0.33
THD 3
(0-8)
1.5
(0-7)
154.50 -0.24 0.82 -0.04
BXD 3.5
(0-15)
3.5
(0-14)
184.00 0.70 0.50 0.12
RCd 10
(0-23)
2
(0-20)
83.50 -2.49 0.01 -0.42
RC1 8.5
(0-21)
6.5
(3-14)
123.00 -1.24 0.23 -0.21
RC2 8
(2-12)
6
(2-13)
120.00 -1.34 0.19 -0.22
RC3 4
(0-14)
6.5
(0-11)
206.00 1.40 0.17 0.23
RC4 4
(0-18)
2
(0-10)
129.00 -1.05 0.31 -0.18
RC6 3
(0-10)
2
(0-6)
134.50 -0.89 0.39 -0.15
RC7 7.5
(0-16)
5.5
(1-16)
144.00 -0.57 0.58 -0.10
RC8 2
(0-5)
2
(0-9)
168.00 0.19 0.86 0.03
RC9 7.5
(0-19)
10.5
(1-20)
198.00 1.14 0.27 0.19
Note: H-O, Higher-Order; RC, Restructured Clinical; EID, Emotional/Internalising Dysfunction; THD, Thought 
Dysfunction; BXD, Behavioural/Externalising Dysfunction; RCd, Demoralisation; RC1, Somatic Complaints; RC2, 
Low Positive Emotions; RC3, Cynism; RC4, Antisocial Behaviour; RC6, Ideas of Persecution; RC7, Dysfunctional 
Negative Emotions; RC8, Aberrant Experiences; RC9, Hypomanic Activation; U, Mann-Whitney’s U statistic; 
z, z-score; r, effect size estimate.
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the score for Antisocial behaviour is the next highest score within the profile. Inspection 
of the item scores of the scale Antisocial Behaviour revealed that patients especially reported 
family problems more frequently than controls. Cynism and Hypomanic Activation show 
the lowest T-scores in the patient group. In the control group the highest T-scores are 
found for Somatic Complaints, Ideas of Persecution, and Antisocial Behaviour. The lowest 
score is for Cynism. In patients with NS, Family Problems shows the highest T-score within 
the Interpersonal scales while Social Avoidance demonstrates the lowest score. In the 
control group, the highest T-score is found for Shyness, and the lowest for Disaffiliativeness. 
Regarding the PSY-5 scales, patients with NS show the highest T-score for Negative 
Emotionality/Neuroticism, and the lowest for Aggressiveness. For the control participants, 
Table 4  Results of the MMPI-2-RF Interpersonal Scales and Personality Psychopathology 
Five Scales of Patients with Noonan Syndrome (NS) and Healthy Controls (HC).
Median raw score 
(range) 
MMPI-2-RF
Interpersonal and  
PSY-5 scales
NS
(n = 18)
HC
(n = 18)
U z p r
FML 2
(0-9)
0
(0-4)
106.00 -1.88 0.08 -0.31
IPP 4
(1-9)
4
(0-8)
155.50 -0.21 0.84 -0.04
SAV 4
(0-8)
3.5
(0-7)
149.50 -0.40 0.70 -0.07
SHY 3
(0-7)
4
(0-7)
167.50 0.18 0.86 0.03
DSF 0
(0-3)
0
(0-1)
130.00 -1.47 0.32 -0.25
AGGR-r 7.5
(0-15)
7.5
(3-14)
170.50 0.27 0.79 0.05
PSYC-r 3
(0-8)
3
(0-8)
167.50 0.18 0.86 0.03
DISC-r 3.5
(0-14)
4
(0-13)
197.50 1.14 0.27 0.19
NEGE-r 8.5
(1-17)
5.5 
(2-13)
105.50 -1.79 0.07 -0.30
INTR-r 9
(1-14)
7
(2-14)
96.50 -2.08 0.04 -0.35
Note: FML, Family Problems; IPP, Interpersonal Passivity; SAV, Social Avoidance; SHY, Shyness; DSF, Disaffiliativeness; 
AGGR-r, Aggressiveness; PSYC-r, Psychoticism; DISC-r, Disconstraint; NEGE-r, Negative Emotionality/Neuroticism; 
INTR-r, Introversion/Low Positive Emotionality; U, Mann-Whitney’s U statistic; z, z-score; r, effect size estimate.
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Psychoticism shows the highest T-score, while Introversion/Low Positive Emotionality 
demonstrates the lowest score. 
 After calculating Spearman’s correlation coefficients between the total score on the 
TAS-20 and the H-O, RC, Interpersonal, and PSY-5 scales of the MMPI-2-RF for patients with 
NS and controls separately, significant positive relations were found between alexithymia 
and EID and Negative Emotionality/Neuroticism in the patient group. In the control group, 
the correlation between the TAS-20 and EID almost reached significance. The correlations 
between alexithymia and Somatic Complaints (RC1) and Low Positive Emotions (RC2) 
almost reached significance in the patient group (see Table 5).
Figure 1  Mean MMPI-2-RF (U/L)T-scores of patients with NS and healthy controls.
Note: EID, Emotional/Internalising Dysfunction; THD, Thought Dysfunction; BXD, Behavioural/Externalising 
Dysfunction; RCd, Demoralisation; RC1, Somatic Complaints; RC2, Low Positive Emotions; RC3, Cynism; RC4, 
Antisocial Behaviour; RC6, Ideas of Persecution; RC7, Dysfunctional Negative Emotions; RC8, Aberrant Experiences; 
RC9, Hypomanic Activation; FML, Family Problems; IPP, Interpersonal Passivity; SAV, Social Avoidance; SHY, 
Shyness; DSF, Disaffiliativeness; AGGR-r, Aggressiveness; PSYC-r, Psychoticism; DISC-r, Disconstraint; NEGE-r, 
Negative Emotionality/Neuroticism; INTR-r, Introversion/Low Positive Emotionality.
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Table 5  Spearman’s Correlation Coefficients between the Total Score of the TAS-20 
and Raw Scores on the MMPI-2-RF Higher-Order Scales, Restructured Clinical Scales, 
Interpersonal Scales, and PSY-5 Scales for Patients with Noonan Syndrome (NS) and 
Healthy Controls (HC).
MMPI-2-RF-scales NS
(n = 18)
HC
(n = 18)
r p r p
EID 0.52 0.03 0.43 0.07
THD 0.30 0.23 0.11 0.65
BXD 0.27 0.28 0.35 0.16
RCd 0.40 0.10 0.40 0.10
RC1 0.44 0.07 0.32 0.20
RC2 0.44 0.07 0.28 0.26
RC3 0.22 0.37 0.18 0.47
RC4 0.40 0.10 0.27 0.28
RC6 0.18 0.47 0.25 0.31
RC7 0.33 0.19 0.12 0.65
RC8 0.31 0.22 0.35 0.16
RC9 0.20 0.43 0.29 0.24
FML 0.41 0.09 0.26 0.30
IPP -0.26 0.30 0.19 0.45
SAV 0.33 0.18 0.21 0.42
SHY 0.24 0.34 0.36 0.15
DSF 0.36 0.15 0.24 0.34
AGGR-r 0.30 0.23 -0.10 0.70
PSYC-r 0.16 0.52 0.30 0.22
DISC-r 0.00 > .99 0.27 0.29
NEGE-r 0.50 0.03 0.23 0.37
INTR-r 0.19 0.45 0.13 0.60
Note: EID, Emotional/Internalising Dysfunction; THD, Thought Dysfunction; BXD, Behavioural/Externalising 
Dysfunction; RCd, Demoralisation; RC1, Somatic Complaints; RC2, Low Positive Emotions; RC3, Cynism; RC4, 
Antisocial Behaviour; RC6, Ideas of Persecution; RC7, Dysfunctional Negative Emotions; RC8, Aberrant Experiences; 
RC9, Hypomanic Activation; FML, Family Problems; IPP, Interpersonal Passivity; SAV, Social Avoidance; SHY, 
Shyness; DSF, Disaffiliativeness; AGGR-r, Aggressiveness; PSYC-r, Psychoticism; DISC-r, Disconstraint; NEGE-r, 
Negative Emotionality/Neuroticism; INTR-r, Introversion/Low Positive Emotionality.
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Discussion
This is the first controlled study investigating personality characteristics and psycho-
pathology in adult patients with NS, using the MMPI-2-RF, a well-known and widely used 
comprehensive instrument for this purpose. Patients with NS showed higher scores on 
two validity scales, reflecting a higher amount of psychological, cognitive, and somatic 
complaints. The H-O scales showed higher levels of internalising problems in patients 
with NS. Regarding the RC scales, only a higher score on Demoralisation was found in the 
patient group. There were no significant differences regarding the Interpersonal scales, 
while on the PSY-5 scales patients with NS showed significantly higher scores on introversion 
than controls. Alexithymia was significantly correlated with negative emotionality and 
internalising problems in patients with NS, while the correlation with internalising problems 
was almost significant in controls. 
 Our finding of more subjectively reported psychological, cognitive, and somatic 
problems in patients with NS, as reflected by the Validity scales of the MMPI-2-RF, can be 
understood given the fact that NS is a complex system disorder, affecting somatic, cognitive, 
and psychological functioning. Higher scores on these scales may also suggest a tendency 
to over-report symptoms, although other Validity scales (Fp-r, Fs-r) reflecting complaints 
that are rarely endorsed by individuals with severe psychopathology or medical complaints 
were not higher in patients with NS than in controls. This suggests that the elevated scores 
in this study reflect genuinely experienced difficulties in NS. Another explanation for 
finding higher levels of reported somatic problems in patients with NS may be related to 
alexithymia, as difficulties in identifying and verbalising feelings have been associated 
repeatedly with somatisation (Mattila et al., 2008). However, there were no differences in 
the mean level of alexithymia between the two groups in this study. 
 The higher levels of emotional and internalising dysfunction in patients with NS are 
consistent with previous reports of anxiety and mood problems in NS and in accordance 
with our hypotheses (Noonan, 2005; Perrino et al., 2018; Smpokou et al., 2012; Wingbermühle, 
Egger, et al., 2012). The results of the current study showed that especially higher levels of 
demoralisation were characteristic for the difference between patients with NS and 
controls. According to Ben-Porath & Tellegen (2008), demoralisation reflects a pervasive 
and affect-laden dimension of unhappiness and life dissatisfaction. The higher levels of 
demoralisation in NS could reflect the experienced burden of living with this chronic 
condition, while no specific psychopathology is present, as reflected by the lack of 
significant differences on the other RC scales. This finding is in contrast with previous 
reports of an unimpaired quality of life in patients with NS (Binder et al., 2012; Shaw et al., 
2007). Finding lower levels of life satisfaction in the current study may be explained by the 
higher face validity of the items of quality of life questionnaires compared to the items of 
the MMPI-2-RF, which could have triggered a social desirable response tendency in 
previous studies. Also, the inclusion of patients that were referred for neuropsychological 
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assessment due to psychological or cognitive complaints could explain the higher levels 
of demoralisation in this study. Inspection of the standardised T-scores showed results 
within the normal range in both groups and hence did not reflect clinical levels of psycho-
pathology. In general, the scores of patients seemed to be higher than controls.
 No significant differences were found regarding the Interpersonal scales, although 
the higher score for family problems in the patient group almost reached significance. 
With regard to the PSY-5 scales, patients with NS reported higher levels of introversion, 
reflecting a lack of positive emotional experiences and avoidance of social situations and 
interactions (Ben-Porath & Tellegen, 2008). The scores on Negative Emotionality/
Neuroticism almost reached significance. Bizaoui et al. (2018) also found lower levels of 
extraversion in their sample of (mostly) children and adolescents with NS. However, in a 
previous study of our research group, higher levels of social distress were found in patients 
with NS, but no social avoidance (Wingbermühle, Egger, et al., 2012). A qualitative 
investigation of the item scores of the Introversion scale in the current study showed that 
patients with NS especially answered the items regarding the experience of positive 
emotions more negatively than controls, and not the items reflecting social interactions. 
Although this could reflect an alexithymic characteristic, no significant correlation was 
found between alexithymia and introversion and the groups did not differ significantly 
regarding the level of alexithymia. An introverted personality style has been associated 
with social introversion, anhedonia, restricted interests, and a pessimistic outlook 
(Ben-Porath & Tellegen, 2008). Hence, introversion is known to be related to mood and 
(social) anxiety problems (Kotov, Gamez, Schmidt, & Watson, 2010). Possibly, an introverted 
personality style may predispose patients with NS to internalising problems. 
 Because higher levels of alexithymia in adults with NS have been found in previous 
studies (Wingbermühle, Egger, et al., 2012) and alexithymia has been related to psycho-
pathology (Taylor & Bagby, 2012), the correlation between MMPI-2-RF scales and alexithymia, 
as measured by the TAS-20, was investigated. Higher levels of alexithymia appeared to 
be related to higher levels of internalising problems in patients with NS. This correlation 
almost reached significance in the control group. The positive correlation between 
alexithymia and Negative Emotionality/Neuroticism was only significant in the patient 
group, while the correlation with Somatic Complaints (RC1) as well as Low Positive 
Emotions (RC2) almost reached significance. In patients with NS, higher levels of alexithymia 
are related to higher levels of negative emotionality. Finding a positive relation between 
internalising problems and alexithymia was expected, however, it is surprising that the 
positive relation with Negative Emotionality/Neuroticism is only present in the patient 
group, despite finding similar levels of alexithymia in both groups. Bagby, Taylor, et al. 
(1994) found alexithymia to correlate positively with neuroticism and negatively with 
extraversion in a student sample, suggesting a tendency of alexithymic individuals to be 
anhedonic and to experience emotions with less differentiation, due to weaknesses in the 
cognitive representation and modulation of emotions.  
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Potential limitations of this study should be considered. Because only patients were 
included who could complete the MMPI-2-RF, the sample consisted of relatively more 
patients with higher IQ scores - hence more patients with a mutation in SOS1. Other 
studies also found patients with a mutation in SOS1 to have more favourable outcomes 
regarding intellectual functioning than patients with PTPN11 (Pierpont, 2016). Furthermore, 
patients with psychological or cognitive problems may be overrepresented in this study, 
because they could be more inclined to participate or were more likely to be referred for 
neuropsychological assessment, which might have consequences for the generalisation 
of the findings of this study to the general NS population. Also, there were more missing 
items in the patient group than in the control group, which could have led to an under-
estimation of problems in the patient group. Moreover, although the TAS-20 is a valid and 
frequently used instrument for measuring alexithymia, the use of a self-report measure to 
assess alexithymia could be viewed as paradoxical, because alexithymic individuals may 
be less able to reflect on their emotional difficulties due to a limited affective insight (Lane, 
Ahern, Schwartz, & Kaszniak, 1997; Waller & Scheidt, 2004). This could have led to an under-
estimation of alexithymic problems in the patient group. 
 The results of this study nonetheless point out the fact that patients with NS show 
a more introvert personality style and experience more internalising difficulties in 
comparison with controls. Moreover, higher levels of alexithymia appeared to be related 
to higher levels of internalising problems and negative emotionality in the patient group. 
Clinicians (general practitioners, clinical (neuro)psychologists, medical specialists) should 
be aware of the psychological vulnerability of patients with NS, especially when patients 
have an alexithymic tendency. If these problems interfere with daily functioning, patients 
with NS can benefit from psychological interventions, aimed to decrease internalising 
problems, introversion, and alexithymia.
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Abstract
Social cognitive deficits are common in neuropsychiatric disorders. Given the proximity 
of social cognition (SC) to everyday functioning, many intervention studies (including 
targeted, comprehensive, and broad-based approaches) have focused on SC. The aim of 
this paper was to quantitatively meta-analyse the efficacy of SC interventions in adult 
neuropsychiatric patients. Databases Pubmed, PsycINFO, Web of Knowledge, and Embase 
were searched for controlled SC intervention studies published between 01-01-2003 and 
01-01-2016. Forty-one studies, comprising 1,508 patients with schizophrenia, autism 
spectrum disorders, or acquired brain injury were included. Outcome measures evaluated 
emotion perception (EP), social perception (SP), Theory of Mind (ToM), and social functioning 
(SF). The meta-analyses showed that interventions were effective in improving SC (Cohen’s 
d = 0.71). Interventions targeting one specific SC function were found to be most effective 
(d = 0.89), followed by broad-based interventions, targeting non-SC domains in addition 
to SC (d = 0.65), and comprehensive interventions, that target multiple SC processes 
(d = 0.61). Targeted interventions were especially effective in improving EP and ToM. 
Comprehensive interventions were able to ameliorate EP, ToM, and SF. Broad-based 
interventions were especially effective in improving SF, but also showed effects on EP 
and ToM.
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Introduction
Social cognitive deficits are common in a variety of psychiatric and neurological disorders. 
Given the proximity of social cognition (SC) to everyday functioning, many intervention 
studies have focused on improving SC in these populations. The aim of this paper is to 
quantitatively meta-analyse the efficacy of these interventions in adult neuropsychiatric 
patients.
Defining social cognition
SC is considered to be a cognitive domain that includes the mental processes underlying 
social interactions. In other words, SC represents how people make sense of other people 
and themselves (Fiske & Taylor, 2013). SC is commonly conceptualised as three components 
of information processing (Adolphs, 2001; Beer & Ochsner, 2006): (1) perception of socially 
relevant information (of the self, other people, or the interaction between the two), (2) 
interpretation of this information and the integration with contextual information, and (3) 
execution and regulation of social behaviour. 
 In accordance with this definition, three cognitive processes are commonly distinguished 
in SC intervention studies and also used as outcome measures. These include emotion 
perception, social perception, and Theory of Mind (ToM) (Green, Olivier, Crawley, Penn, & 
Silverstein, 2005; Horan, Kern, & Green, 2008). Emotion perception refers to the ability to 
perceive emotional information from the self (inner feelings) or others (in facial expressions 
or voices for instance). Social perception is conceptualised as the ability to identify social 
cues from contextual information and communicative gestures, such as awareness of 
social roles, rules, and social relationships. ToM is defined as mental state attribution or 
mentalising, and it refers to the ability to infer the intentions, beliefs, feelings, and opinions 
of the self and others. Fourth, social functioning encompasses social behaviours that are 
the result of the aforementioned cognitive processes, for instance, interpersonal contact 
or social skills. Alexithymia is a personality concept that is strongly related to SC, which is 
characterised by an emotion regulation deficit, difficulties in identifying and describing 
own emotional feelings, a limited imaginal capacity, and an externally oriented cognitive 
style (Taylor & Bagby, 2012). A considerable body of evidence suggests that alexithymia is 
often associated with SC impairments, such as deficits in emotion recognition (Bird & 
Cook, 2013; Grynberg et al., 2012; Lane et al., 1997; Lane, Sechrest, Riedel, Shapiro, & 
Kaszniak, 2000; Mann, Wise, Trinidad, & Kohanski, 1995; Parker, Taylor, & Bagby, 1993) and 
mentalising (Moriguchi et al., 2006; Subic-Wrana, Beutel, Knebel, & Lane, 2010; Swart, 
Kortekaas, & Aleman, 2009).
Social cognition in neuropsychiatric patients
SC deficits have been demonstrated in a variety of neuropsychiatric disorders (e.g., 
schizophrenia: Penn, Corrigan, Bentall, Racenstein, & Newman, 1997; autism spectrum 
82
CHAPTER 5
disorders (ASD): Couture et al., 2010; mood disorders: Samamé, 2013; anxiety disorders: 
Plana et al., 2014; traumatic brain injury: Muller et al., 2010; Alzheimer’s dementia: Bediou et 
al., 2009; frontotemporal dementia: Gregory et al., 2002; Lough et al., 2006; Huntington’s 
disease: Snowden et al., 2003). Furthermore, impaired SC has also been reported in 
individuals with intellectual disabilities (Baurain & Nader-Grosbois, 2013; Leffert, Siperstein, 
& Widaman, 2010) and genetic syndromes (e.g., Williams syndrome: Meyer-Lindenberg et 
al., 2005; Prader–Willi syndrome: Whittington & Holland, 2011; Noonan syndrome: 
Wingbermühle, Egger, et al., 2012; Turner syndrome: Burnett et al., 2010; Phelan–McDermid 
syndrome: Egger, Zwanenburg, van Ravenswaaij-Arts, Kleefstra, & Verhoeven, 2016). 
 Poor SC is associated with psychological distress, social isolation, and reduced 
self-esteem (Beauchamp & Anderson, 2010). Alexithymia has been shown to diminish 
quality of life and is associated with difficulty in interpersonal relationships (Kennedy & 
Franklin, 2002). It is also thought to be a risk factor for various (psycho)somatic and 
psychiatric disorders (for instance, mood and anxiety disorders), although only correlational 
data are available to date, making causal inferences not possible (Taylor & Bagby, 2012).
 In patients with schizophrenia, associations have been found between SC (emotion 
perception, social perception, and ToM) and functional outcome measures such as 
community functioning, social behaviour, social problem solving, and social skills (Couture, 
2006). Fett et al. (2011) even found SC to be more strongly related to community functioning 
than ‘cold’ neurocognitive processes (i.e., cognitive functions involved in non-affective 
information processing, such as processing speed, attention, [working] memory, and 
problem solving). Penn et al. (1997) stated that SC differs from neurocognition in the type 
of stimuli processed (social, personally relevant, mutable vs. non-social, neutral, stable), 
the relationship of the observer to the stimulus (multidirectional vs. unidirectional), and 
the evaluation of the performance. Given the proximity of SC to community functioning 
(i.e., interpersonal relations, work functioning), SC is also an important treatment target in 
addition to neurocognitive (dys)function in isolation.
Treatments for social cognition
Regarding the influence of SC on the functional status of patients with schizophrenia and 
its established responsiveness to treatment, research concerning SC interventions in other 
psychiatric disorders has increased rapidly over the past decade. Most studies categorise 
SC treatments into three groups: targeted, comprehensive, or broad-based interventions 
(Fiszdon & Reddy, 2012). Targeted interventions focus on a single SC subdomain, like emotion 
perception (e.g., Treatment of Affect Recognition (TAR): Wölwer et al., 2005). Comprehensive 
interventions also solely focus on SC, but address a broader range of SC subdomains and 
impairments. For instance, the Social Cognition Interaction Training (SCIT) (Roberts, Penn, 
& Combs, 2016) encompasses treatment of emotion perception, ToM, and attributional 
bias. Broad-based interventions embed training of SC aspects within the context of other 
interventions, such as social skills training or neurocognitive remediation. The Cognitive 
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Enhancement Therapy (CET) is a well-known example of a broad-based intervention, 
which combines a SC intervention with neurocognitive training (Hogarty & Flesher, 1999).
 By far, the majority of SC interventions have focused on reducing impairments in 
patients with schizophrenia spectrum disorders (SSD). Several reviews and one meta- 
analysis have been published in the field of schizophrenia research (e.g., Fiszdon & Reddy, 
2012; Horan et al., 2008; Kurtz & Richardson, 2012). These reviews concluded that targeted, 
comprehensive, and broad-based interventions are all able to enhance relatively ‘simple’ 
SC processes (e.g., emotion perception), whereas more complex, higher order functions 
such as ToM and social perception have proven to be less amenable for treatment (Fiszdon 
& Reddy, 2012; Kurtz & Richardson, 2012). Especially targeted interventions improve specific 
SC functions in SSD, whilst improvement in multiple domains has been reported for 
comprehensive and broad-based interventions (Choi et al., 2009; Horan et al., 2008; Kurtz 
& Richardson, 2012; Mueller, Schmidt, & Roder, 2013; Statucka & Walder, 2013). The common 
multi-component design of the broad-based and comprehensive interventions complicates 
the assignment of specific intervention effects and the indication of key ingredients (Choi 
et al., 2009; Horan et al., 2008; Roberts et al., 2014; Roberts & Velligan, 2012). The high 
degree of similarity between the training stimuli and test stimuli in targeted interventions 
has raised concern about ‘training to the task’ and the (lack of) transfer to real-life social 
functioning has appeared to be problematic (Horan et al., 2008; Paquin, Wilson, Cellard, 
Lecomte, & Potvin, 2014; Wolfgang Wölwer & Frommann, 2011). In addition, Peyroux and 
Franck (2014) stated that SC interventions rely too heavily on hierarchical, step-by-step 
models, which train one component at a time, lacking the complex demands of real-life 
social interactions.
 Interventions addressing SC in ASD or in patients with acquired brain injury (ABI) have 
been studied less frequently than those in SSD. In patients with ABI, SC interventions 
mainly focused on retraining social cue perception, social communication, and social skills or 
functioning. Although the number of studies so far is limited, there are positive indications 
from previous literature reviews that emotion perception, social communication skills, and 
social functioning can be improved after brain injury (Braden, 2014; Driscoll, Dal Monte, & 
Grafman, 2011; Manly & Murphy, 2012). A systematic review on psychosocial interventions 
(including SC interventions) in adults with ASD reported that these treatments are 
generally effective, although the quantity and quality of the studies are again limited 
(Bishop-Fitzpatrick, Minshew, & Eack, 2013). A meta-analysis on targeted interventions of 
ToM and precursor skills (such as emotion perception) in children and adults with ASD 
showed modest evidence of treatment success, but studies lacked generalisation to novel 
contexts and the long-term maintenance of learnt skills was unclear (Fletcher-Watson, 
McConnell, Manola, & McConachie, 2014). 
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Several studies focused on alexithymia in psychotherapeutic treatments, but only a few 
interventions have been described that were specifically designed to remediate 
alexithymic problems. Alexithymia is considered to be a difficult construct to treat, 
because most interventions require some awareness of and access to the patient’s own 
emotions, skills that are commonly impaired in alexithymic individuals (Byrne, Bogue, Egan, 
& Lonergan, 2016; Ogrodniczuk, Sochting, Piper, & Joyce, 2012). Cameron, Ogrodniczuk, 
and Hadjipavlou (2014) reviewed 23 studies that examined changes in alexithymia levels, 
following a psychological intervention. Patient populations included eating disorders 
(k = 4), anxiety disorders (k = 4), mood disorders (k = 1), substance use disorders (k = 2), 
mixed in- and outpatient populations (k = 5), non-psychiatric medical conditions (k = 5), 
and non-patient populations (k = 2). The authors concluded that especially the studies 
that targeted alexithymia directly tended to report significant reductions in alexithymia 
levels, whilst psychological interventions that were not primarily intended to treat 
alexithymia showed more inconsistent results.
Aims of this meta-analysis
Since SC impairments are common in a variety of neuropsychiatric disorders (Bediou et al., 
2009; Couture et al., 2010; Gregory et al., 2002; Lough et al., 2006; Muller et al., 2010; Penn 
et al., 1997; Plana et al., 2014; Samamé, 2013; Snowden et al., 2003) and are known to affect 
psychological wellbeing, it is of clinical importance to investigate how SC deficits can be 
effectively treated in these patient groups. Therefore, the aim of the present paper is to 
conduct a meta-analysis on all published evidence regarding the effects of SC interventions 
on SC and alexithymia in adult neuropsychiatric patients, that is, patients with psychiatric 
diseases and/or neurological conditions, for which evident neuropsychological disorders 
have been described. 
 Furthermore, we investigated the effects of the three different treatment types 
(targeted, comprehensive, and broad-based) on SC and alexithymia, both in the general 
population of neuropsychiatric patients as well as for specific patient groups. To our 
knowledge, no systematic reviews are available that investigate SC interventions across 
different patient groups and treatment types. This meta-analysis will be of relevance to 
clinical and academic professionals, since it provides information about required methods 
and intensity of SC interventions, and the applicability to different patient groups. The 
findings of this systematic review can subsequently be used to develop new, 
evidence-based interventions for the enhancement of SC in other adult neuropsychiatric 
patient populations.
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Methods
Inclusion criteria
In the current study, SC interventions were defined as psychological, skill-based treatments, 
designed to ameliorate one of the five SC aspects, described in more detail in the 
introduction (i.e., emotion perception, social perception, ToM, social functioning, and 
alexithymia). At least one SC outcome measure needed to be included at post-treatment 
assessment. Medical interventions (e.g., oxytocin nasal spray, Guastella, Graustella, 
& MacLeod, 2012) and alternative, non-psychological treatments, such as yoga therapy 
(Bangalore & Varambally, 2012), and drama therapy (Corbett et al., 2011; Lerner, Mikami, 
 & Levine, 2011) did not meet this definition.
 Neuropsychiatric disorders were defined as psychiatric diseases and/or neurological 
conditions, for which evident neuropsychological problems have been described. Based 
on this definition, patients with SSD, ASD, dementia, brain injury, or mood and anxiety 
disorders could be included, whilst for example patients with eating disorders, personality 
disorders, or etiologically unspecified intellectual disability were excluded. Furthermore, 
given the influence of cultural differences on (social) cognition (Varnum, Grossmann, 
Kitayama, & Nisbett, 2010), this study only focused on patients in Western societies 
(i.e., Europe – including Turkey, United States, Canada, Australia, and New Zealand). Lastly, 
studies including patients younger than 18 years or patients with a comorbid diagnosis 
of substance dependency or abuse were also excluded.
 In sum, to be included in this systematic review, studies must have (1) investigated a 
SC intervention or alexithymia treatment, (2) used at least one behavioural measure of 
SC as a primary outcome measure at post-treatment assessment, (3) included a sample of 
adult (> 18 years) neuropsychiatric patients, (4) contained a patient control group, (5) used 
a sample-size of more than one patient per group, (6) investigated patients in Western 
societies, (7) presented original data (no abstracts, reviews, conference proceedings, 
research protocols), (8) been published in peer-reviewed journals, and (9) been written in 
the English language. 
Search methods
All available published literature from January 1, 2003 up to January 1, 2016 was 
systematically searched using the electronic databases of PubMed, PsycINFO,Web of 
Knowledge, and Embase. The following search terms (or combinations/truncated versions) 
were used: ‘social cognition’, ‘affective information processing’, ‘training’, ‘intervention’, 
‘rehabilitation’, and ‘treatment’. Additional searches were performed, using the more 
focused search terms: ‘autism’, ‘theory of mind’, ‘alexithymia’, ‘brain injury’, or ‘brain damage’. 
Subsequently, the reference lists of the included studies and relevant review articles were 
scanned for additional eligible studies.
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Selection procedure
Articles were selected and scrutinised according to the PRISMA guidelines (Preferred 
Reporting Items of Systematic reviews and Meta-Analyse; Moher, Liberati, Tetzlaff, Altman, 
& PRISMA Group, 2009). In Figure 1, the selection procedure is depicted in a flow diagram. 
All hits were screened on title or abstract by the first author. All citations obviously 
irrelevant to the topic were directly excluded and duplicates were removed. Subsequently, 
two of the authors (RLR and EW) independently assessed and selected the remaining 
studies. Any discrepancies were resolved by discussion between these authors, resulting 
in consensus. 
 To avoid bias due to duplicate results, studies that used data or patient samples 
identical to other included studies were excluded. In such cases, RLR and EW discussed 
the overlapping studies and came to an agreement about which study should be 
excluded. Here, more recent studies and those with larger sample sizes were preferred 
over older studies or those reporting preliminary data. Furthermore, one study had to be 
excluded because the requested information for the meta-analysis was not available in 
a timely fashion.
Data extraction
The following data were extracted from the selected studies: population, sample size, 
design, name and type of intervention, intervention target(s), control group, age of 
participants, duration and dose of intervention, group size, SC outcome measures, 
availability of follow-up data, and main findings. 
 The included intervention studies were divided into three categories: targeted, 
comprehensive, or broad-based interventions. For the purpose of this review, the following 
classification was used: Targeted interventions should focus on one SC impairment; 
comprehensive interventions should focus on two or more SC impairments; and broad- 
based interventions should focus on one or more SC impairments within other (non-SC) 
treatment programmes, which themselves could not be classified as targeted or 
comprehensive.
 If studies used more than one control group (e.g., both a wait-list control group and a 
treatment-as-usual condition), the most frequently used control group was included in 
the meta-analysis. For studies including more than one SC intervention group, the authors 
discussed which intervention was included in the meta-analysis. Here, criteria for selection 
were the focus of the article, the sample size of the two treatment groups, and the 
additional informative value of the intervention (preference for new interventions over 
already included interventions).
 SC outcome measures were grouped into four domains: emotion perception, social 
perception, ToM, and social functioning. Measures of social functioning were very diverse, 
encompassing social behaviour but also non-social activities of daily living. To reduce 
heterogeneity, in this systematic review only (subscale) scores were included that primarily 
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assessed social behaviour in social interactions. For studies that presented a composite 
score to reflect SC, only relevant subscores were included. Outcome measures that were 
specific for the patient group under study (for instance, attributional bias or jumping to 
conclusions in schizophrenia studies) were not included in the review. For an overview of 
the included outcome measures, see Table 1. All selected outcome measures had to 
generate continuous data. Means and standard deviations of post-treatment assessment 
were selected for the meta-analyses.
Table 1  Included Social Cognitive Outcome measures for Emotion Perception,  
Social Perception, Theory of Mind, and Social Functioning.
Social 
cognitive 
domain
Social cognitive outcome measures at post-treatment
Emotion 
perception
Pictures of Facial Affect (POFA; Ekman & Friesen, 1976)
Face Emotion Identification Test (FEIT; Kerr & Neale, 1993)
Face Emotion Discrimination Test (FEDT; Kerr & Neale, 1993)
Cambridge Mindreading Face-Voice Battery (Golan, Baron-Cohen, & Hill, 2006)
Reading the mind in the Voice Task Revised (Golan, Baron-Cohen, Hill, & Rutherford, 2007)
Reading the Mind in Film Task (Golan, Baron-Cohen, Hill, & Golan, 2006)
Emotion Recognition-40 (Lahera et al., 2013)
The Awareness of Social Inference Test-Part 1 (TASIT; McDonald, Flanagar, Rollins, & Kinch, 2003; 
McDonald et al., 2006) 
Emotion Attribution Task (Blair & Cipolotti, 2000; Mazza et al., 2007)
Bell-Lysaker Emotion Recognition Task (BLERT; Bell, Bryson, & Lysaker, 1997)
Emotion Recognition Task (Hoschel & Irle, 2001)
Japanese and Caucasian Facial Expressions of Emotion (Matsumoto & Ekman, 1988)
Vienna Emotion Recognition Task (VERT-K; Pawelak, 2004)
Geneva Vocal Emotion Expression Stimulus (GVEESS; Banse & Scherer, 1996)
Emotion Recognition Test-40 faces edition (Kohler et al., 2005)
Computerized test of facial emotion recognition (CFER, based on Tottenham, John, & 
MacArthur, 1998)
Levels of Emotional Awareness Scale (LEAS, Lane, Quinlan, Schwartz, Walker, & Zeitlin, 1990)
Facial Expression Same/Different Task (Green, Turner, & Thompson, 2004)
Facial Expression Naming Task (Hornak, Rolls, & Wade, 1996)
Facial Expression Matching Task (Croker & McDonald, 2005)
Prosodic Emotion Labelling Task (Dimoska, McDonald, Pell, Tate, & James, 2010)
Diagnostic Analysis of Nonverbal Accuracy scale, facial and vocal affect (DANVA, Nowicki & 
Duke, 1994)
Frankfurt Test and Training of Facial Affect Recognition (FEFA, Bölte et al., 2002)
NimStim Face Stimulus Set (Tottenham et al., 2009)
Emotion Recognition Questionnaire (Emorec; Bähler, 2012)
Emotional Inference from Stories Test (EIST, Neumann et al., 2012; Zupan, 2009)
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Table 1  Continued.
Social 
cognitive 
domain
Social cognitive outcome measures at post-treatment
Social 
perception
Social Perception Scale (Garcia, Fuentes, Ruiz, Gallach, & Roder, 2003)
Half-Profile of Nonverbal Sensitivity (PONS; Ambady, Hallahan, & Rosenthal, 1995; Rosenthal, 
Hall, DiMatteo, Rogers, & Archer, 1979)
Schema Component Sequencing Task-Revised (Vauth, Rusch, Wirtz, & Corrigan, 2004)
Social Situation Task (Blair & Cipolotti, 2000)
Theory  
of Mind
Reading the Mind in the Eyes Task Revised (Baron-Cohen, Wheelwright, Hill, Raste, & Plumb, 2001)
Theory of Mind Picture Sequencing Task and Questionnaire (PST; Brüne, 2003b, 2003a, 2005)
Hinting Task (Corcoran, Mercer, & Frith, 1995)
TASIT-Part 2 & 3 (McDonald et al., 2003; McDonald et al., 2006)
Advanced Theory of Mind Scale (Blair & Cipolotti, 2000; Happe, 1994)
False belief stories (Washing Machine Story and Wallpaper Story; Mazza et al., 2007; Rowe, 
Bullock, Polkey, & Morris, 2001)
Empathy Questionnaire (EQ, (Baron-Cohen & Wheelwright, 2004)
Unexpected Outcomes Test (UOT; Bora, Goekcen, & Veznedaroglu, 2008; Dyck, Ferguson, & 
Shochet, 2001)
Nonverbal ToM-task (Kayser, Sarfati, Besche, & Hardy-Baylé, 2007)
False belief/deception stories (‘The Cigarettes, Happe, 1994; ‘The Piggy Bank’, ‘The Train Station’, 
and ‘The Coke’, (Frith & Corcoran, 1996)
Interpersonal Reactivity Index (IRI, (Davis, 1983)
Social 
functioning
Social Functioning Scale (social engagement & interaction subscales, Birchwood, Smith, 
Cochrane, Wetton, & Copestake, 1990)
Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT, subtest managing emotions, 
(Mayer, Salovey, & Caruso, 2002; Mayer, Salovey, Caruso, & Sitarenios, 2003))
Social Cognition Profile (Hogarty & Greenwald, 2006)
Behavioural Referenced Rating System of Intermediate Social Skills—Revised (BRISS-R) Partner 
Directed Behaviour Scale (Farrel, Rabinowitz, Wallander, & Curran, 1985; Wallander, Conger, 
& Conger, 1985)
BRISS-R Personal Conversational Style Scale (Farrel et al., 1985; Wallander et al., 1985)
Life Skills Profile, subscale social contact (LSP, Rosen, Hadzipavlovic, & Parker, 1989)
Personal and Social Performance Scale (PSP, Hsieh et al., 2011; Morosini, Magliano, Brambilla, 
Ugolini, & Pioli, 2000)
Social Performance Survey Schedule (SPSS; Lowe & Cautela, 1978)
Social Skills Performance Assessment (SSPA; Patterson, Moscona, McKibbin, Davidson, & Jeste, 2001)
Assertion Inventory, subscale behaviour (Gambrill & Richey, 1975; Martin et al., 2012)
Simulated Social Interaction Test (SSIT; Curran, 1982)
Social Role-play Task (Penn, Mueser, Doonan, & Nishith, 1995)
Observable Social Cognition, A Rating Scale (OSCARS; Healey, Roberts, Combs, & Penn, 2012)
Global Social Functioning Scale (GSFS; Cornblatt et al., 2007)
Social Communication Skills Questionnaire (SCSQ; McGann, Werven, & Douglas, 1997)
Brock Adaptive Functioning Questionnaire, socio-emotional scale (Dywan, Roden, & Murphy, 1995)
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Data-analysis
MetaWin version 2.1 (www.metawinsoft.com) was used to calculate Hedges’ g based on 
post-treatment means (or adjusted means) and standard deviations. If lower scores 
represented a better performance, scores were multiplied by −1 before being entered into 
MetaWin. Subsequently, pooled standardised mean differences and variances were 
calculated per study for a total SC score and for the four SC domains. Positive values 
indicated improvement. When studies included more than one outcome measure per 
domain, the standardised mean differences and their variances were averaged to avoid 
studies with multiple outcome measures having more influence in the analyses. The 
pooled standardised mean differences and sample sizes were entered into RevMan 
version 5.3 (www.tech.cochrane.org/revman). The inverse-variance random-effects 
method was used, since it was assumed that the studies were estimating different, yet 
related, intervention effects (Deeks, Higgins, & Altman, 2008).
 First, the overall effect of the three treatment types (targeted, comprehensive, 
broad-based) on SC was studied. Subgroup analyses were performed for the effects of 
treatment type on SC for the different patient populations. 
 Heterogeneity of intervention effects was assessed by the χ2 test. The I2 statistic 
was used to quantify the inconsistency, reflecting the percentage of the variability in 
effect estimates that is due to heterogeneity rather than chance (Deeks et al., 2008). 
A heterogeneity over 50% was considered substantial. As an estimate of the between- 
study variance in random-effects meta-analyses, τ2 was presented. The square root of 
τ2 represents the estimated standard deviation of underlying effects across studies (Deeks 
et al., 2008).
 In order to address a potential publication bias, fail-safe N were calculated using the 
method of Rosenthal (1979). The PEDro-P scale (available on the website of PsycBITE, 
www.psycbite.com) was used as a measure of internal validity and methodological quality 
of the included studies (total score ranging from 0 to 10). Studies were scored by two of 
the authors (RLR and EW) in order to generate consensus ratings. Maher, Sherrington, 
Herbert, Moseley, and Elkins (2003) indicated that the reliability of the total PEDro score, 
based on consensus judgements, is acceptable. They concluded that the scale has 
sufficient reliability for use in systematic reviews.
Results
Results of the search
The initial systematic searches of the databases in 2013 yielded 3,676 hits. After a first 
screening based on titles and the removal of duplicates 341 records remained. Reasons for 
exclusion were, for example, the use of animal subjects or the evaluation of a pharmaco-
logical intervention. After independent screening of the 341 abstracts by authors RLR and 
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EW, 75 full-text articles were selected for closer reading. Subsequently, additional searches 
for the years 2014 and 2015 were performed, resulting in 45 full-text articles that were 
assessed for eligibility. Last, the reference lists of the selected studies and relevant review 
articles were searched. This resulted in another 46 full-text articles that were assessed for 
eligibility. Of the 166 articles that were potentially eligible for inclusion, 41 studies were 
finally included. The majority of the studies was excluded because one or more of the 
inclusion criteria was not met (k= 120) and four studies were excluded due to overlap with 
other included studies.
 In 13 studies, additional information for the meta-analysis was required and the 
corresponding authors were contacted by e-mail (Bechi et al., 2015; Bechi et al., 2013; 
Combs et al., 2007; Eack et al., 2009; Fuentes, Garcia, Ruiz, Soler, & Roder, 2007; Gil Sanz et 
al., 2009; Hogarty et al., 2004; Horan et al., 2011; Lindenmayer et al., 2013; Mazza et al., 2010; 
Rocha & Queiros, 2013; Roncone et al., 2004; Veltro et al., 2011). The requested information 
was received from the majority of the authors, with exception of three studies. One study 
had to be excluded due to missing information.
Description of included studies
Table 2 shows a detailed description of the study characteristics. Forty-one studies were 
included in the review and meta-analyses. The dates of publication ranged from 2003 to 
2015. In the article of Golan & Baron-Cohen (2006), two studies were reported that had 
been performed in different patient samples. Therefore, both experiments were included 
as separate studies in the meta-analysis.
 The majority of studies (k = 33) used a randomised controlled trial design. In eight 
studies, a quasi-experimental design was used (Bechi et al., 2015; Combs et al., 2007; Golan 
& Baron-Cohen, 2006; Lahera et al., 2013; McDonald et al., 2008; Roberts & Penn, 2009; 
Rocha & Queiros, 2013; Turner-Brown, Perry, Dichter, Bodfish, & Penn, 2008).
 The studies included in total 1,508 participants (794 patients in intervention groups 
and 714 in control groups), involving patients with SSD (schizophrenia, schizoaffective 
disorder, schizoaffective psychosis, schizophreniform disorder, delusional disorder, 
psychosis not otherwise specified, k = 30), ABI (mainly including patients with traumatic 
brain injury, k = 6), and ASD (Autism, Asperger syndrome, high-functioning autism, k = 4). 
One study included a population of patients with bipolar or schizoaffective disorder. The 
mean age of patients in the included studies ranged from 24.4 (Mazza et al., 2010) to 51.0 
(Horan et al., 2011). In almost all studies, the number of men was higher than women. 
Sample sizes varied widely from 10 patients (Bölte et al., 2006; Bornhofen & McDonald, 
2008b) to 140 (Mueller, Schmidt, & Roder, 2015).
 Table 2 shows the consensus ratings on the PEDro-P scale. Most studies (k = 16) 
received a score of 5 out of 10 points, which was also the average score over all 41 studies. 
The study with the lowest score (a PEDro-P total score of 2 points) concerned a pilot study 
(Turner-Brown et al., 2008), explaining why its methodological quality was considered to 
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be lower than that of other studies. Four studies received the highest score of 7 out of 
10 points (McDonald et al., 2013; Mueller et al., 2015; Neumann et al., 2015; Veltro et al., 2011). 
It should be noted that these studies could never receive the maximum number of 
10 points, because blinding of the therapists who administer the treatment is not possible 
in most psychological intervention studies (item 6 of the PEDro-P scale). Therefore, 
the studies could only receive a maximum score of 9 points. Moreover, only two studies 
met the criterion of blinding all participants (Golan & Baron-Cohen, 2006, experiment 1; 
Golan & Baron-Cohen, 2006, experiment 2).
 All interventions could be classified as broad-based (k = 10), comprehensive (k = 16), 
or targeted interventions (k = 15). Some interventions were evaluated by multiple studies: 
SCIT (Combs et al., 2007; Lahera et al., 2013; Roberts et al., 2014; Roberts & Penn, 2009; 
Tas et al., 2012; Taylor et al., 2016; Turner-Brown et al., 2008), CET (Eack et al., 2009; Hogarty 
et al., 2004), Mind Reading (Golan & Baron-Cohen, 2006; Lindenmayer et al., 2013), TAR 
(Sachs et al., 2012; Wölwer et al., 2005; Wölwer & Frommann, 2011), Social Cognitive Skills 
Training (SCST, Horan et al., 2009, 2011), SST (McDonald et al., 2008; Rus-Calafell et al., 2013), 
Emotion and ToM Imitation Training (ETIT, Mazza et al., 2010; Pino et al., 2015), Theory of 
Mind Intervention (ToMI, Bechi et al., 2015; Bechi et al., 2013), and the Social Cognition 
Training Program (SCTP, Gil-Sanz et al., 2009; Gil-Sanz et al., 2014). 
 Overall, emotion perception, specifically or amongst other SC subdomains, was the 
most frequently investigated treatment target (k = 34). Twenty-five studies aimed to 
ameliorate ToM, 13 focused on social perception, and six studies aimed to improve social 
functioning. No intervention studies for remediating alexithymic problems could be 
included, because the studies focused on non-neuropsychiatric participants (for instance, 
somatic patients), used alexithymia as a moderator of treatment success rather than as 
an outcome measure, or did not meet the other inclusion criteria (see e.g., Cameron et al., 
2014; Samur et al., 2013; Vanheule, Verhaeghe, & Desmet, 2011 for reviews on alexithymia 
interventions). Targeted interventions predominantly focused on training emotion 
perception (k = 13), comprehensive interventions mostly trained emotion perception 
(k = 16) combined with ToM (k = 15), and broad-based interventions almost exclusively 
combined neurocognitive training (k = 8) or social skills training (k = 2) with ToM treatment 
(k = 9). 
 Intervention duration varied widely from a single session in one week (Combs et al., 
2008) to a combination of 56 sessions SC training with 75 sessions neurocognitive training 
for 104 weeks (Hogarty et al., 2004). The intensity of treatments, expressed in treatment 
hours, ranged from 2 hours (Kayser et al., 2007) to 159 hours (Hogarty et al., 2004). Session 
duration was also variable and commonly ranged between 45 (Wölwer et al., 2005) and 
180 minutes (Garcia et al., 2003; McDonald et al., 2008; Russell et al., 2008) per session. 
Group size ranged between an individual setting (Combs et al., 2008; Golan & Baron-Cohen, 
2006; Radice-Neumann et al., 2009; Russell et al., 2008) and groups of up to 12 participants 
(Lahera et al., 2013; Veltro et al., 2011). Intervention and session duration, intensity, and 
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group size were not specified in some studies (Bölte et al., 2006; Eack et al., 2009; Gil-Sanz 
et al., 2009; Lindenmayer et al., 2013; Mazza et al., 2010; Roberts & Penn, 2009; Rocha & 
Queiros, 2013; Sachs et al., 2012; Taylor et al., 2016). In general, targeted interventions were 
the least intensive training type, in terms of treatment duration and intensity. Broad-based 
interventions were most intensive. 
 The activities of the patients in the control groups were diverse. Sixteen studies 
included a treatment as usual condition (e.g., illness management, pharmacotherapy), 
11 studies included no intervention (e.g., waiting list, deferred treatment) as control group, 
11 studies used an intervention that was not SC in nature (e.g., neurocognitive intervention, 
problem solving skills training), two studies used another SC intervention, and for one 
study the nature of the control group was not specified.
 A variety of SC outcome measures was used in the selected studies (see Table 1 for an 
overview). For measuring emotion perception, the following tests were administered 
most frequently: the Face Emotion Identification Test (FEIT, Kerr & Neale, 1993, k = 12), the 
Face Emotion Discrimination Test (FEDT, Kerr & Neale, 1993, k = 5), the Reading the Mind in 
the Eyes Task Revised (Baron-Cohen et al., 2001, k = 5), and The Awareness of Social 
Inference Test-Part 1 (TASIT-1, (McDonald et al., 2003; McDonald et al., 2006, k = 5). To assess 
social perception, the Social Perception Scale (SPS, Garcia et al., 2003, k = 4) and Half-Profile 
of Non-verbal Sensitivity (PONS, Ambady et al., 1995; Rosenthal et al., 1979, k = 2) were used 
most frequently. Most commonly used measures of ToM included the Hinting Task 
(Corcoran et al., 1995, k = 10), TASIT-Parts 2 and 3 (McDonald et al., 2003; McDonald et al., 
2006, k = 6), and the Reading the Mind in the Eyes Task Revised (Baron-Cohen et al., 2001, 
k = 5). Regarding social functioning, the subtest managing emotions of the Mayer–
Salovey–Caruso Emotional Intelligence Test (MSCEIT, Mayer et al., 2002; Mayer et al., 2003, 
k = 4) was used most commonly, but also the Social Functioning Scale (SFS, Birchwood 
et al., 1990, k = 4), the Personal and Social Performance Scale (PSP, Hsieh et al., 2011; Morosini 
et al., 2000, k = 3), and the Social Skills Performance Assessment (SSPA, Patterson et al., 
2001, k = 3) were administered frequently.
 Ten studies performed a follow-up assessment after a non-treatment period 
(Bornhofen & McDonald, 2008a, 2008b; Combs et al., 2008; Hogarty et al., 2004; Hogarty & 
Greenwald, 2006; McDonald et al., 2013; Mueller et al., 2015; Neumann et al., 2015; 
Radice-Neumann et al., 2009; Roberts et al., 2014; Russell et al., 2008). Follow-up test 
intervals were highly variable and ranged from one week post-treatment (Combs et al., 
2008; Russell et al., 2008) to three years post-treatment (Hogarty et al., 2004, data were 
published in Hogarty, Greenwald, & Eack, 2006). It is notable that seven of the ten follow-up 
studies concerned targeted interventions, one comprehensive intervention, and two 
broad-based interventions. Overall, eight studies found maintenance effects at follow-up 
(mostly compared with baseline) at one or more outcome measures. 
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Table 2  Characteristics of the 41 Included Studies.
Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Bechi  
et al., 2012
SSD Social Cognitive 
Training (SCT) 
combined 
with cognitive 
rehabilitation 
training (CRT)
B 4 EP, ToM, and 
neurocognition
Time-matched control 
group (NI)
49
(27/22)
68/67 Quasi-
experiment
SCT: 37.14 (10.02)
NI: 40.20 (8.99)
12 sess./12 h./12 wks. 
SCT combined with
24 sess./24h./12 wks. 
CRT
5 - POFA (EP)
- PST Sequencing 
(ToM)
- PST Questionnaire 
(ToM)
- Improvement 
on ToM 
Questionnaire.
Bechi  
et al., 2013
SSD ToM-Intervention 
(ToMI) combined 
with CRT
B 5 ToM, SP, and 
neurocognition
Active control group 
with cognitive 
remediation therapy 
(NSCI)
30
(19/11)
42/54 RCT ToMI: 37.68 (8.42)
NSCI: 37.73 (15.45)
18 sess./18 h/9 wks.
SCT combined with
36 sess./36h./12 wks. 
CRT
5 - PST Total (ToM) - Improvement 
on PST.
Bechi  
et al., 2015
SSD ToMI 
combined with 
CRT
B 6 ToM, SP, and 
neurocognition
Active control group 
with cognitive 
remediation therapy 
(NSCI)
51
(32/19)
53.13/52.63 RCT ToMI: 40.34 (10.33)
NSCI: 37.21 (12.45)
18 sess./18h./9 wks. 
ToMI combined with 24 
sess./24 h/12 wks. CRT
5 - PST Total (ToM) - Improvement 
on PST.
Bölte  
et al., 2006
ASD Frankfurt Test and 
Training of Facial 
Affect Recognition 
(FEFA)
T 4 EP Ongoing inpatient 
treatment (TAU)
10
(5/5)
91 RCT FEFA: 29.4 (5.9)
TAU: 25.8 (8.0)
5 sess./10 h/5 wks. Unknown - FEFA Face (EP)
- FEFA Eyes (EP)
- Improvement 
on FEFA Face 
and Eyes.
Bornhofen & 
McDonald, 
2008a
ABI Emotion 
Perception 
Treatment-Self-
Instruction 
Training (SIT)
T 6 EP Waitlist control group 
(NI)
10
(5/5)
- RCT SIT: 35.40 (14.01) 
NI: 31.20 (16.83)
10 sess./25 h./10 wks. 2-3 - FES/DT (EP)
- FENT (EP)
-FEMT (EP)
-TASIT-1 (EP)
-TASIT-2 & 3 (ToM)
6 mos. Improvement 
on FEMT and 
TASIT-2. 
Bornhofen & 
McDonald, 
2008b
ABI Emotion 
Perception 
Programme (EPP)
T 6 EP Waitlist control group 
(NI)
11
(5/6)
- RCT EPP: 29.2 (4.49)
NI: 43.5 (14.43)
16 sess./24 h./8 wks. 2-3 - FENT (EP)
- FEMT (EP)
-TASIT-1 (EP)
-TASIT-2 & 3 (ToM)
1 mo. Improvement 
on TASIT-1 and 
TASIT-3.
Combs  
et al., 2007
SSD Social Cognition 
and Interaction 
Training (SCIT)
C 5 EP and ToM Coping skills group 
(NSCI)
28
(18/10)
67/90 Quasi-
experiment
SCIT: 41.3 (11.2)
NSCI: 44.0 (10.6)
18 sess./18 h./18 wks. 8-10 - FEIT (EP)
- FEDT (EP)
- SPS, stimulus 
identification (SP)
- HT (ToM)
- SFS, social 
withdrawal & 
interpersonal 
behaviour (SF) 
- Improvement 
on all outcome 
measures.
Combs  
et al., 2008
SSD Attentional 
Shaping (AS)
T 5 EP Repeated practice (NI) 40
(20/20)
65 RCT AS/NI: 38.7 (13.7) 1 sess. 1 - FEIT (EP) 1 week Improvement 
on FEIT.
Eack  
et al., 2009
SSD Cognitive 
Enhancement 
Therapy (CET)
B 6 ToM, SP, SF, and 
neurocognition
Enriched Supportive 
Therapy (NSCI)
58
(31/27)
69 RCT CET/NSCI: 25.92 
(6.31)
60 sess./60 h./104 wks. 
neurocognitive training 
combined with 
45 sess./67.5h./104 wks. 
social cognitive training
Unknown - SC Profile (SF)
- MSCEIT, subtest 
managing 
emotions (SF)
- Improvement 
on both 
outcome 
measures.
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intervention
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(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Bechi  
et al., 2012
SSD Social Cognitive 
Training (SCT) 
combined 
with cognitive 
rehabilitation 
training (CRT)
B 4 EP, ToM, and 
neurocognition
Time-matched control 
group (NI)
49
(27/22)
68/67 Quasi-
experiment
SCT: 37.14 (10.02)
NI: 40.20 (8.99)
12 sess./12 h./12 wks. 
SCT combined with
24 sess./24h./12 wks. 
CRT
5 - POFA (EP)
- PST Sequencing 
(ToM)
- PST Questionnaire 
(ToM)
- Improvement 
on ToM 
Questionnaire.
Bechi  
et al., 2013
SSD ToM-Intervention 
(ToMI) combined 
with CRT
B 5 ToM, SP, and 
neurocognition
Active control group 
with cognitive 
remediation therapy 
(NSCI)
30
(19/11)
42/54 RCT ToMI: 37.68 (8.42)
NSCI: 37.73 (15.45)
18 sess./18 h/9 wks.
SCT combined with
36 sess./36h./12 wks. 
CRT
5 - PST Total (ToM) - Improvement 
on PST.
Bechi  
et al., 2015
SSD ToMI 
combined with 
CRT
B 6 ToM, SP, and 
neurocognition
Active control group 
with cognitive 
remediation therapy 
(NSCI)
51
(32/19)
53.13/52.63 RCT ToMI: 40.34 (10.33)
NSCI: 37.21 (12.45)
18 sess./18h./9 wks. 
ToMI combined with 24 
sess./24 h/12 wks. CRT
5 - PST Total (ToM) - Improvement 
on PST.
Bölte  
et al., 2006
ASD Frankfurt Test and 
Training of Facial 
Affect Recognition 
(FEFA)
T 4 EP Ongoing inpatient 
treatment (TAU)
10
(5/5)
91 RCT FEFA: 29.4 (5.9)
TAU: 25.8 (8.0)
5 sess./10 h/5 wks. Unknown - FEFA Face (EP)
- FEFA Eyes (EP)
- Improvement 
on FEFA Face 
and Eyes.
Bornhofen & 
McDonald, 
2008a
ABI Emotion 
Perception 
Treatment-Self-
Instruction 
Training (SIT)
T 6 EP Waitlist control group 
(NI)
10
(5/5)
- RCT SIT: 35.40 (14.01) 
NI: 31.20 (16.83)
10 sess./25 h./10 wks. 2-3 - FES/DT (EP)
- FENT (EP)
-FEMT (EP)
-TASIT-1 (EP)
-TASIT-2 & 3 (ToM)
6 mos. Improvement 
on FEMT and 
TASIT-2. 
Bornhofen & 
McDonald, 
2008b
ABI Emotion 
Perception 
Programme (EPP)
T 6 EP Waitlist control group 
(NI)
11
(5/6)
- RCT EPP: 29.2 (4.49)
NI: 43.5 (14.43)
16 sess./24 h./8 wks. 2-3 - FENT (EP)
- FEMT (EP)
-TASIT-1 (EP)
-TASIT-2 & 3 (ToM)
1 mo. Improvement 
on TASIT-1 and 
TASIT-3.
Combs  
et al., 2007
SSD Social Cognition 
and Interaction 
Training (SCIT)
C 5 EP and ToM Coping skills group 
(NSCI)
28
(18/10)
67/90 Quasi-
experiment
SCIT: 41.3 (11.2)
NSCI: 44.0 (10.6)
18 sess./18 h./18 wks. 8-10 - FEIT (EP)
- FEDT (EP)
- SPS, stimulus 
identification (SP)
- HT (ToM)
- SFS, social 
withdrawal & 
interpersonal 
behaviour (SF) 
- Improvement 
on all outcome 
measures.
Combs  
et al., 2008
SSD Attentional 
Shaping (AS)
T 5 EP Repeated practice (NI) 40
(20/20)
65 RCT AS/NI: 38.7 (13.7) 1 sess. 1 - FEIT (EP) 1 week Improvement 
on FEIT.
Eack  
et al., 2009
SSD Cognitive 
Enhancement 
Therapy (CET)
B 6 ToM, SP, SF, and 
neurocognition
Enriched Supportive 
Therapy (NSCI)
58
(31/27)
69 RCT CET/NSCI: 25.92 
(6.31)
60 sess./60 h./104 wks. 
neurocognitive training 
combined with 
45 sess./67.5h./104 wks. 
social cognitive training
Unknown - SC Profile (SF)
- MSCEIT, subtest 
managing 
emotions (SF)
- Improvement 
on both 
outcome 
measures.
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Table 2  Continued.
Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Fernandez-
Gonzalo  
et al., 2015
SSD Neuro Personal 
Training-Mental 
Health (NPT-MH)
B 5 EP, ToM, and 
neurocognition
Non-specific computer 
training (NI)
40
(21/19)
60.7/68 RCT NPT-MH: 30.9 (5.9)
Control: 30.02 (7.4)
+/- 36 sess./36 h./18 
wks.
6 - POFA (EP)
- False-belief/
deception stories 
(ToM)
- HT (ToM)
- RMET (EP)
- Improvement 
on POFA.
Garcia  
et al., 2003
SSD Social Perception 
subprogram 
of Integrated 
Psychological 
Therapy (IPT)
T 4 SP Not specified 20
(11/9)
82/56 RCT IPT: 40.45 (7.10)
Control:  36.88 
(8.10)
21 sess./18.5h./ 12 wks. 5-6 - SPS (SP) - Improvement 
on SPS.
Gil-Sanz  
et al., 2009
SSD Social Cognition 
Training Program 
(SCTP)
C 4 EP and SP TAU 14
(7/7)
57/43 RCT SCTP: 33.29 (8.36)
TAU: 41.43 (9.03)
20 sess./15h./10 wks. Unknown - CFER (EP)
- SPS stimulus 
identification (SP)
- SPS interpretation 
(SP)
- SPS allocation of 
title (SP)
- Improvement 
on SPS 
interpretation 
and allocation 
of title.
Gil-Sanz, 
et al., 2014
SSD SCTP C 5 EP, ToM, and SP Attention and memory 
exercises (NSCI)
44
(20/24)
40/66.67 RCT SCTP: 37.05 (6.43)
Control: 43.83 (9.77)
28 sess./ 21 h./28 wks. 10 - HT (ToM)
- NimStimFace 
Stimulus Set Total 
Score (EP)
- Improvement 
on HT and 
NimStimFace 
Stiumulus Set.
Golan & Baron-
Cohen, 2006, 
exp. 1
ASD Mind Reading (MR) T 6 EP No intervention (NI) 41
(19/22)
74/77 RCT MR: 30.5 (10.3)
NI: 30.9 (11.2)
20 h./10 wks. 1 - CAM Face (EP)
- CAM Voice (EP)
- CAM Emotion (EP)
- RMET (EP)
- RMVT (EP)
- RMFT (EP)
- Improvement 
on all CAM 
measures.
Golan & Baron-
Cohen, 2006, 
exp. 2
ASD MR T 4 EP Social skills training (SCI) 26
(13/13)
92/77 Quasi-
experiment
MR: 25.5 (9.3)
SCI: 24.4 (6.4)
20 h./10 wks. individual 
training combined with 
10 sess./10 wks. group 
training
1/6 - CAM Face (EP)
- CAM Voice (EP)
- CAM Emotion (EP)
- RMET (EP)
- RMVT (EP)
- RMFT (EP)
- Improvement 
on CAM Voice, 
CAM Emotion, 
and RMET.
Hogarty  
et al., 2004
SSD CET B 5 ToM, SP, SF, and 
neurocognition
Enriched Supportive 
Therapy (NSCI)
113 (63/50) 59 RCT 37.3 (8.9) 75 h./104 wks. 
neurocognitive training 
combined with
56 sess./84 h./104 wks. 
social cognitive training
6 - SC Profile (SF) 3-yr 
(published 
in Hogarty 
et al. 
2006)
Improvement 
on SC Profile 
subscales 
Tolerant, 
Perceptive, and 
Self-confident.
 Horan  
et al., 2009
SSD Social Cognitive 
Skills Training 
(SCST)
C 5 EP, ToM, and SP Illness self-management 
and relapse prevention 
skills training (TAU)
31 (15/16) 87/100 RCT SCST: 50.7 (5.8)
NSCI: 45.9 (7.5)
12 sess./12 h./6 wks. 6 - FEIT (EP)
- PONS (SP)
-TASIT-3 (ToM)
- Improvement 
on FEIT.
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(ToM)
- HT (ToM)
- RMET (EP)
- Improvement 
on POFA.
Garcia  
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SSD Social Perception 
subprogram 
of Integrated 
Psychological 
Therapy (IPT)
T 4 SP Not specified 20
(11/9)
82/56 RCT IPT: 40.45 (7.10)
Control:  36.88 
(8.10)
21 sess./18.5h./ 12 wks. 5-6 - SPS (SP) - Improvement 
on SPS.
Gil-Sanz  
et al., 2009
SSD Social Cognition 
Training Program 
(SCTP)
C 4 EP and SP TAU 14
(7/7)
57/43 RCT SCTP: 33.29 (8.36)
TAU: 41.43 (9.03)
20 sess./15h./10 wks. Unknown - CFER (EP)
- SPS stimulus 
identification (SP)
- SPS interpretation 
(SP)
- SPS allocation of 
title (SP)
- Improvement 
on SPS 
interpretation 
and allocation 
of title.
Gil-Sanz, 
et al., 2014
SSD SCTP C 5 EP, ToM, and SP Attention and memory 
exercises (NSCI)
44
(20/24)
40/66.67 RCT SCTP: 37.05 (6.43)
Control: 43.83 (9.77)
28 sess./ 21 h./28 wks. 10 - HT (ToM)
- NimStimFace 
Stimulus Set Total 
Score (EP)
- Improvement 
on HT and 
NimStimFace 
Stiumulus Set.
Golan & Baron-
Cohen, 2006, 
exp. 1
ASD Mind Reading (MR) T 6 EP No intervention (NI) 41
(19/22)
74/77 RCT MR: 30.5 (10.3)
NI: 30.9 (11.2)
20 h./10 wks. 1 - CAM Face (EP)
- CAM Voice (EP)
- CAM Emotion (EP)
- RMET (EP)
- RMVT (EP)
- RMFT (EP)
- Improvement 
on all CAM 
measures.
Golan & Baron-
Cohen, 2006, 
exp. 2
ASD MR T 4 EP Social skills training (SCI) 26
(13/13)
92/77 Quasi-
experiment
MR: 25.5 (9.3)
SCI: 24.4 (6.4)
20 h./10 wks. individual 
training combined with 
10 sess./10 wks. group 
training
1/6 - CAM Face (EP)
- CAM Voice (EP)
- CAM Emotion (EP)
- RMET (EP)
- RMVT (EP)
- RMFT (EP)
- Improvement 
on CAM Voice, 
CAM Emotion, 
and RMET.
Hogarty  
et al., 2004
SSD CET B 5 ToM, SP, SF, and 
neurocognition
Enriched Supportive 
Therapy (NSCI)
113 (63/50) 59 RCT 37.3 (8.9) 75 h./104 wks. 
neurocognitive training 
combined with
56 sess./84 h./104 wks. 
social cognitive training
6 - SC Profile (SF) 3-yr 
(published 
in Hogarty 
et al. 
2006)
Improvement 
on SC Profile 
subscales 
Tolerant, 
Perceptive, and 
Self-confident.
 Horan  
et al., 2009
SSD Social Cognitive 
Skills Training 
(SCST)
C 5 EP, ToM, and SP Illness self-management 
and relapse prevention 
skills training (TAU)
31 (15/16) 87/100 RCT SCST: 50.7 (5.8)
NSCI: 45.9 (7.5)
12 sess./12 h./6 wks. 6 - FEIT (EP)
- PONS (SP)
-TASIT-3 (ToM)
- Improvement 
on FEIT.
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Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Horan  
et al., 2011
SSD SCST C 5 EP, ToM, and SP Standard Illness 
Management Training 
(TAU)
33 (15/18) 94/79 RCT SCST: 51.0 (7.1)
TAU: 45.1 (11.2)
24 sess./24 h./12 wks. 6-8 - FEIT (EP)
- MSCEIT, man. em. 
(SF)
- PONS (SP)
- TASIT-3 (ToM)
- Improvement 
on FEIT.
Kayser  
et al, 2007
SSD ToM Video Training 
(ToM-VT)
T 5 ToM TAU 14 (8/6) 75/83 RCT ToM-VT: 32.4 (9.4)
TAU: 38.2 (9.3)
2 sess./2h./2 wks. 6-8 - Nonverbal ToM task 
(ToM)
- Improvement 
on Nonverbal 
ToM.
Lahera  
et al., 2013
Bipolar & 
schizoaffective 
disorder
SCIT C 3 EP and ToM TAU 37 (21/16) 24/50 Quasi-
experiment
SCIT: 40.6 (8.2)
TAU:  37.4 (12.7)
18 sess./18 h./18-24 wks. Max. 12 - FEIT (EP)
- FEDT (EP)
- ER-40 (EP)
-HT (ToM)
- Improvement 
on all measures.
Lindenmayer 
et al., 2013
SSD Cognitive 
remediation (CR) 
combined with 
Mind Reading: 
Interactive Guide 
to Emotions 
(MRIGE)
B 6 EP and 
neurocognition
Cognitive remediation 
(NSCI)
59 (32/27) 81 RCT MRIGE: 43.95 (11.12)
NSCI: 42.48 (9.09)
24h./12wks. CR
combined with
12h./12 wks. MRIGE
Unknown - FEIT (EP)
- FEDT (EP)
- MSCEIT, managing 
emotions (SF)
- Improvement 
on all measures.
Mazza  
et al., 2010
SSD Emotion and ToM 
Imitation Training 
(ETIT)
C 6 EP and ToM Problem Solving Skill 
Training (NSCI)
23 (16/17) 59 RCT ETIT: 24.37 (2.12)
NSCI: 24.71 (2.17)
24 sess./20 h./12 wks. Unknown - PSP, personal and 
social relationships 
(SF)
- Advanced ToM-
scale (ToM)
- EAT (EP)
-EQ (ToM)
- Improvement 
on all measures.
McDonald  
et al., 2008
ABI Social Skills 
Treatment (SST)
B 5 EP, ToM, SF and 
social skills
Waitlist control group 
(NI)
26 (13/13) 77 Quasi-
experiment
SST: 35.5 (11.3)
NI: 35.3 (11.6)
12 sess./36 h./12 wks. 
(group) combined with
12 sess./12 h./12wks. 
(individual)
3-5 - BRISS-R PDBS (SF)
- BRISS-R PCSS (SF)
- TASIT-1 (EP)
- TASIT-2 & 3 (ToM)
- SPSS (SF)
- Improvement 
on BRISS-R PDBS.
McDonald  
et al., 2013
ABI Remediation 
Programme for 
Perception of 
Affective Prosody 
(RPPAP)
T 7 EP Waitlist control group 
(NI)
20 (10/10) 60/90 RCT RPPAP/NI: 45.62 
(11.26)
RPPAP: 44.54
NI: 46.64
3 sess./6 h./2 wks. 2 -TASIT-1 (EP)
-Prosodic Emotion 
Labelling Task (EP)
1 mo. No 
improvement 
on the outcome 
measures.
Mueller  
et al., 2015
SSD Integrated 
Neurocognitive 
Therapy (INT)
B 7 EP, ToM, SP, SF, and 
neurocognition
TAU 140 (73/67) 64.2/74.7 RCT INT: 34.6 (8.5)
TAU: 33.8 (8.7)
30 sess./45 h./15 wks. 6-8 - POFA (EP)
- Emotion 
Recogniton 
Questionnaire 
(Emorec) (EP)
- Schema 
Component 
Sequencing Task-
Revised (SCST-R) 
(SP)
9 mos. Improvement 
on all outcome 
measures.
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Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Horan  
et al., 2011
SSD SCST C 5 EP, ToM, and SP Standard Illness 
Management Training 
(TAU)
33 (15/18) 94/79 RCT SCST: 51.0 (7.1)
TAU: 45.1 (11.2)
24 sess./24 h./12 wks. 6-8 - FEIT (EP)
- MSCEIT, man. em. 
(SF)
- PONS (SP)
- TASIT-3 (ToM)
- Improvement 
on FEIT.
Kayser  
et al, 2007
SSD ToM Video Training 
(ToM-VT)
T 5 ToM TAU 14 (8/6) 75/83 RCT ToM-VT: 32.4 (9.4)
TAU: 38.2 (9.3)
2 sess./2h./2 wks. 6-8 - Nonverbal ToM task 
(ToM)
- Improvement 
on Nonverbal 
ToM.
Lahera  
et al., 2013
Bipolar & 
schizoaffective 
disorder
SCIT C 3 EP and ToM TAU 37 (21/16) 24/50 Quasi-
experiment
SCIT: 40.6 (8.2)
TAU:  37.4 (12.7)
18 sess./18 h./18-24 wks. Max. 12 - FEIT (EP)
- FEDT (EP)
- ER-40 (EP)
-HT (ToM)
- Improvement 
on all measures.
Lindenmayer 
et al., 2013
SSD Cognitive 
remediation (CR) 
combined with 
Mind Reading: 
Interactive Guide 
to Emotions 
(MRIGE)
B 6 EP and 
neurocognition
Cognitive remediation 
(NSCI)
59 (32/27) 81 RCT MRIGE: 43.95 (11.12)
NSCI: 42.48 (9.09)
24h./12wks. CR
combined with
12h./12 wks. MRIGE
Unknown - FEIT (EP)
- FEDT (EP)
- MSCEIT, managing 
emotions (SF)
- Improvement 
on all measures.
Mazza  
et al., 2010
SSD Emotion and ToM 
Imitation Training 
(ETIT)
C 6 EP and ToM Problem Solving Skill 
Training (NSCI)
23 (16/17) 59 RCT ETIT: 24.37 (2.12)
NSCI: 24.71 (2.17)
24 sess./20 h./12 wks. Unknown - PSP, personal and 
social relationships 
(SF)
- Advanced ToM-
scale (ToM)
- EAT (EP)
-EQ (ToM)
- Improvement 
on all measures.
McDonald  
et al., 2008
ABI Social Skills 
Treatment (SST)
B 5 EP, ToM, SF and 
social skills
Waitlist control group 
(NI)
26 (13/13) 77 Quasi-
experiment
SST: 35.5 (11.3)
NI: 35.3 (11.6)
12 sess./36 h./12 wks. 
(group) combined with
12 sess./12 h./12wks. 
(individual)
3-5 - BRISS-R PDBS (SF)
- BRISS-R PCSS (SF)
- TASIT-1 (EP)
- TASIT-2 & 3 (ToM)
- SPSS (SF)
- Improvement 
on BRISS-R PDBS.
McDonald  
et al., 2013
ABI Remediation 
Programme for 
Perception of 
Affective Prosody 
(RPPAP)
T 7 EP Waitlist control group 
(NI)
20 (10/10) 60/90 RCT RPPAP/NI: 45.62 
(11.26)
RPPAP: 44.54
NI: 46.64
3 sess./6 h./2 wks. 2 -TASIT-1 (EP)
-Prosodic Emotion 
Labelling Task (EP)
1 mo. No 
improvement 
on the outcome 
measures.
Mueller  
et al., 2015
SSD Integrated 
Neurocognitive 
Therapy (INT)
B 7 EP, ToM, SP, SF, and 
neurocognition
TAU 140 (73/67) 64.2/74.7 RCT INT: 34.6 (8.5)
TAU: 33.8 (8.7)
30 sess./45 h./15 wks. 6-8 - POFA (EP)
- Emotion 
Recogniton 
Questionnaire 
(Emorec) (EP)
- Schema 
Component 
Sequencing Task-
Revised (SCST-R) 
(SP)
9 mos. Improvement 
on all outcome 
measures.
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Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Neumann  
et al., 2015
ABI Stories Intervention T 7 EP Computer games (NI) 47 (23/24) 78/67 RCT Stories: 41.5 (11.6)
Control: 39.5 (10.3)
9 sess./ 9 h./3 wks. 1 - DANVA 2-AF (EP)
- EIST (EP)
- IRI (ToM)
3 & 6 
mos. 
No 
improvement 
on the outcome 
measures.
Pino  
et al., 2015
SSD ETIT C 6 EP and ToM PST (NSCI) 14 (7/7) 57.14/42.86 RCT ETIT: 45. (16.91)
Control: 42.25 
(8.20)
24 sess./ 20 h./ 12 wks. 7 - PSP, personal and 
social relationships 
(SF)
- Advanced ToM Task 
(ToM)
- Social Situation 
Task (SP)
- EAT (EP)
- RMET (EP)
- EQ (ToM)
- Improvement 
on Advanced 
ToM Task, EAT, 
and PSP. 
Radice-
Neumann  
et al., 2009
ABI Facial Affect 
Recognition 
Training (FAR) 
T 4 EP Stories of Emotional 
Inference Training (SCI)
19 (10/9) 82/33 RCT FAR:  47 (6.31)
SCI: 38 (14.37)
6-9 sess./6-9h./2-3 wks. 1 - LEAS (EP)
- DANVA2-AF (EP)
- DANVA2-AP (EP)
- TASIT-1 (EP)
- BAFQ (SF)
2 wks. Improvement 
on DANVA2-AF, 
LEAS, and BAFQ.
Roberts & 
Penn, 2009
SSD SCIT C 3 EP and ToM E.g., medication 
management, 
psychotherapy, 
casemanagement, 
family education and 
support (TAU)
25 (14/11) 55/64 Quasi-
experiment
SCIT: 36.8 (12.3)
TAU: 41.4 (12.3)
20 wks. 4-11 - FEIT (EP)
- BLERT (EP)
- HT (ToM)
- TASIT-abbreviated 
(ToM)
- SSPA (SF)
- Improvement 
on FEIT and 
SSPA.
Roberts  
et al., 2014
SSD SCIT C 5 EP and ToM E.g., pharmaco-therapy, 
case-management, 
psychotherapy (TAU)
63 (32/31) 67/67 RCT SCIT: 40.0 (12.2)
TAU: 39.4 (10.8)
20-24 sess./20-
24h./20-24 wks.
4-8 - FEIT (EP)
- FEDT (EP)
- ERT-40 (EP)
- HT (ToM)
- TASIT (ToM)
- OSCARS (SF)
- SSPA (SF)
- GSFS (SF)
3 mos. Improvement 
on SSPA.
Rocha & 
Queiros, 2013
SSD Metacognitive and 
Social Cognitive 
Training (MCST)
C 4 EP, ToM, and SP E.g., medication, 
psychosocial 
services, life and 
social skills training, 
psycho-education, 
stress-management, 
psychotherapy, family-
education (TAU)
35 (19/16) 84/94 Quasi-
experiment
MCST: 38.63 (8.88)
TAU: 35.94 (8.69)
18 sess./10 wks. Unknown - FEIT (EP)
- MSCEIT, managing 
emotions (EP)
- HT (ToM)
- SPS (SP)
-LSP, social contact 
(SF)
- Improvement 
on LSP. 
Roncone  
et al., 2004
SSD Instrumental 
Enrichment 
Programme (IEP)
C 5 EP, ToM, and SF E.g., medication, 
support, psychotherapy 
(TAU)
20 (10/10) 60/70 RCT IEP: 33.9
TAU: 33.5
22 sess./22 h./22 wks. 10 - False belief stories 
(ToM)
- ERT (EP)
- Improvement 
on ToM and ERT 
Sadness and 
Fear.
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Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Neumann  
et al., 2015
ABI Stories Intervention T 7 EP Computer games (NI) 47 (23/24) 78/67 RCT Stories: 41.5 (11.6)
Control: 39.5 (10.3)
9 sess./ 9 h./3 wks. 1 - DANVA 2-AF (EP)
- EIST (EP)
- IRI (ToM)
3 & 6 
mos. 
No 
improvement 
on the outcome 
measures.
Pino  
et al., 2015
SSD ETIT C 6 EP and ToM PST (NSCI) 14 (7/7) 57.14/42.86 RCT ETIT: 45. (16.91)
Control: 42.25 
(8.20)
24 sess./ 20 h./ 12 wks. 7 - PSP, personal and 
social relationships 
(SF)
- Advanced ToM Task 
(ToM)
- Social Situation 
Task (SP)
- EAT (EP)
- RMET (EP)
- EQ (ToM)
- Improvement 
on Advanced 
ToM Task, EAT, 
and PSP. 
Radice-
Neumann  
et al., 2009
ABI Facial Affect 
Recognition 
Training (FAR) 
T 4 EP Stories of Emotional 
Inference Training (SCI)
19 (10/9) 82/33 RCT FAR:  47 (6.31)
SCI: 38 (14.37)
6-9 sess./6-9h./2-3 wks. 1 - LEAS (EP)
- DANVA2-AF (EP)
- DANVA2-AP (EP)
- TASIT-1 (EP)
- BAFQ (SF)
2 wks. Improvement 
on DANVA2-AF, 
LEAS, and BAFQ.
Roberts & 
Penn, 2009
SSD SCIT C 3 EP and ToM E.g., medication 
management, 
psychotherapy, 
casemanagement, 
family education and 
support (TAU)
25 (14/11) 55/64 Quasi-
experiment
SCIT: 36.8 (12.3)
TAU: 41.4 (12.3)
20 wks. 4-11 - FEIT (EP)
- BLERT (EP)
- HT (ToM)
- TASIT-abbreviated 
(ToM)
- SSPA (SF)
- Improvement 
on FEIT and 
SSPA.
Roberts  
et al., 2014
SSD SCIT C 5 EP and ToM E.g., pharmaco-therapy, 
case-management, 
psychotherapy (TAU)
63 (32/31) 67/67 RCT SCIT: 40.0 (12.2)
TAU: 39.4 (10.8)
20-24 sess./20-
24h./20-24 wks.
4-8 - FEIT (EP)
- FEDT (EP)
- ERT-40 (EP)
- HT (ToM)
- TASIT (ToM)
- OSCARS (SF)
- SSPA (SF)
- GSFS (SF)
3 mos. Improvement 
on SSPA.
Rocha & 
Queiros, 2013
SSD Metacognitive and 
Social Cognitive 
Training (MCST)
C 4 EP, ToM, and SP E.g., medication, 
psychosocial 
services, life and 
social skills training, 
psycho-education, 
stress-management, 
psychotherapy, family-
education (TAU)
35 (19/16) 84/94 Quasi-
experiment
MCST: 38.63 (8.88)
TAU: 35.94 (8.69)
18 sess./10 wks. Unknown - FEIT (EP)
- MSCEIT, managing 
emotions (EP)
- HT (ToM)
- SPS (SP)
-LSP, social contact 
(SF)
- Improvement 
on LSP. 
Roncone  
et al., 2004
SSD Instrumental 
Enrichment 
Programme (IEP)
C 5 EP, ToM, and SF E.g., medication, 
support, psychotherapy 
(TAU)
20 (10/10) 60/70 RCT IEP: 33.9
TAU: 33.5
22 sess./22 h./22 wks. 10 - False belief stories 
(ToM)
- ERT (EP)
- Improvement 
on ToM and ERT 
Sadness and 
Fear.
102
CHAPTER 5
Table 2  Continued.
Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
Group
size
Outcome 
measures
Follow-
up
Main Findings
Rus-Calafell,  
et al., 2013
SSD SST B 5 ToM, SP, SF, and 
social skills
E.g., case-management, 
psychotherapy, 
medication adherence, 
family support, leisure 
engagement (TAU)
31 (13/18) 77/83 RCT SST 37.54 (8.05)
TAU 42.39 (8.1)
16 sess. 9 - AI behaviour (SF)
- SSIT (SF)
- SFS, withdrawal 
& interpersonal 
behaviour (SF)
- Improvement 
on SFS.
Russell  
et al., 2008
SSD Micro Expression 
Training Tool 
(METT)
T 5 EP Repeated exposure (NI) 40 (26/14) 65/71 RCT METT: 40 (10)
NI: 44 (9)
1 sess./3 h. 1 - JCFEE (EP) 1 wk. Improvement 
on JCFEE.  
Sachs 
et al., 2012
SSD TAR T 5 EP TAU 38 (20/18) 60/40 RCT TAR: 27.20 (7.17)
TAU: 31.72 (9.35)
12 sess./6 wks. Unknown - VERT-K (EP) - Improvement 
on VERT-K.
Tas  
et al., 2012
SSD Family-Assisted 
SCIT (F-SCIT)
C 6 EP and ToM Social stimulation (NI) 45 (19/26) 58/46 RCT F-SCIT: 33.32 (11.57)
NI: 34.62 (10.06
14 sess./19 h./20 wks. 
(group) combined with 
one individual sess.
9-10 - FEIT (EP)
- FEDT (EP)
- HT (ToM)
- RMET (EP)
- UOT (ToM)
-SFS, social 
withdrawal & 
interpersonal 
communication (SF)
- Improvement 
on HT, FEIT, 
FEDT, UOT, 
and SFS social 
withdrawal.
Taylor  
et al., 2016
SSD SCIT-adapted (a) C 5 EP and ToM TAU 27 (16/11) - RCT SCIT-a: 40.7 (10.3)
Control: 39.2 (10.6)
16 sess./12 h./8 wks. ? - FEIT (EP)
- HT (ToM)
- Improvement 
on FEIT.
Turner-Brown 
et al., 2008
ASD SCIT-Autism 
(SCIT-A)
C 2 EP, ToM, and SP TAU 11 (6/5) 83/100 Quasi-
experiment
SCIT-A: 42.5 (12.3)
TAU:  28.8 (1.0)
18 sess./15 h./18 wks. 5-6 - FEIT (EP)
- HT (ToM)
- SCSQ (SF)
- SSPA (SF)
- Improvement 
on HT.
Veltro  
et al., 2011
SSD Cognitive-
Emotional 
Rehabilitation 
(REC)
C 7 EP and ToM Problem solving 
training (NSCI)
24 (12/12) - RCT REC: 38.8 (6.3)
NSCI: 37.7 (11.16)
+/- 24 sess./33 h./24 
wks.
8-12 - PSP, personal and 
social relationships 
(SF)
- Advanced ToM 
Scale (ToM)
- EAT (EP)
- Improvement 
on Advanced 
ToM Scale and 
EAT.
Wölwer  
et al., 2005
SSD TAR T 4 EP E.g., medication, 
psycho-educational 
therapy (TAU)
53 (28/25) 89/84 RCT TAR 31.5 (6.9)
TAU 35.2 (11.1)
12 sess./9 h./6 wks. 2 - POFA (EP) - Improvement 
on POFA.
Wölwer & 
Frommann, 
2011
SSD TAR T 6 EP Cognitive Remediation 
Therapy (NSCI)
38 (20/18) 68 (n = 38) RCT TAR/NSCI: 36.7 
(13.1)
12 sess./+/- 10.5 h./6 
wks.
2 - GVEESS (EP)
- PST (ToM)
- RPT (SF)
- Improvement 
on all measures.
Note: SSD, schizophrenia spectrum disorders; ASD, autism spectrum disorders; ABI, acquired brain injury; B, broad-based intervention; C, 
comprehensive intervention; T, targeted intervention; TAU, treatment as usual; NI, no intervention; NSCI, no social cognitive intervention; SCI, 
other social cognitive intervention; Nt, N treatment group; Nc, N control group; EP, emotion perception; ToM, Theory of Mind; SP, social 
perception, SF, social functioning; POFA, Pictures of Facial Affect; PST, ToM Picture Sequencing Task; FENT, Facial Expression Naming Task; 
FEMT, Facial Expression Matching Task; TASIT, The Awareness of Social Inference Test; FES/DT, Facial Expression Same/Different Task; FEIT, 
Face Emotion Identification Test; FEDT, Face Emotion Discrimination Test; SPS, Social Perception Scale; HT, Hinting Task; SFS, Social 
Functioning Scale, subscales social withdrawal & interpersonal behaviour (SFS, SW&IB); MSCEIT, Mayer-Salovey-Caruso Emotional Intelligence 
Test; CFER, Computerised test of Facial Emotion Recognition; CAM, Cambridge Mindreading Face-Voice Battery; RMET, Reading the Mind in 
the Eyes Task; RMVT, Reading the Mind in the Voice Task; RMFT, Reading the Mind in the Film Task; PONS, Half-Profile  of Nonverbal
Sensitivity; ER-40, Emotion Recognition 40; PSP, Personal and Social Performance Scale; EAT, Emotion Attribution Task; EQ, Empathy 
Questionnaire; SPSS, Social Performance Survey Schedule; BRISS-R PDBS/PCSS, Behavioural Referenced Rating System of Intermediate Social 
Skills—Revised Partner Directed Behaviour Scale/Personal Conversational Style Scale; LEAS, Levels of Emotional Awareness Scale; DANVA2 
AF/AP, Diagnostic Assessment of Nonverbal Affect 2- Adult Faces/Adult Paralanguage; BAFQ, Brock Adaptive Functioning Questionnaire; 
SSPA, Social Skills Performance Assessment; ERT-40, Emotion Recognition Test-40 faces edition; OSCARS, Observable Social Cognition: A 
Rating Scale; GSFS, Global Social Functioning Scale; LSP, Life Skills Profile; ERT, Emotion Recognition Task; AI, Assertion Inventory; SSIT, 
Simulated Social Interaction Test; JCFEE, Japanese and Caucasian Facial Expression Emotion; VERT-K, Vienna Emotion Recognition Task; UOT, 
Unexpected Outcomes Test; SCSQ, Social Communication Skills Questionnaire; GVEESS, Geneva Vocal Emotion Expression Stimulus; RPT, 
Role Play Task; EIST, Emotional Inference from Stories Test; IRI, Interpersonal Reactivity Index, perspective taking and empathic concern.
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Study Population Name of 
intervention
Type of
intervention
PEDro-P
score
(0-10)
Intervention
target(s)
Control
group
Sample
size
(Nt/Nc)
%
Male
Design Age of patients Duration / dose
of intervention
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size
Outcome 
measures
Follow-
up
Main Findings
Rus-Calafell,  
et al., 2013
SSD SST B 5 ToM, SP, SF, and 
social skills
E.g., case-management, 
psychotherapy, 
medication adherence, 
family support, leisure 
engagement (TAU)
31 (13/18) 77/83 RCT SST 37.54 (8.05)
TAU 42.39 (8.1)
16 sess. 9 - AI behaviour (SF)
- SSIT (SF)
- SFS, withdrawal 
& interpersonal 
behaviour (SF)
- Improvement 
on SFS.
Russell  
et al., 2008
SSD Micro Expression 
Training Tool 
(METT)
T 5 EP Repeated exposure (NI) 40 (26/14) 65/71 RCT METT: 40 (10)
NI: 44 (9)
1 sess./3 h. 1 - JCFEE (EP) 1 wk. Improvement 
on JCFEE.  
Sachs 
et al., 2012
SSD TAR T 5 EP TAU 38 (20/18) 60/40 RCT TAR: 27.20 (7.17)
TAU: 31.72 (9.35)
12 sess./6 wks. Unknown - VERT-K (EP) - Improvement 
on VERT-K.
Tas  
et al., 2012
SSD Family-Assisted 
SCIT (F-SCIT)
C 6 EP and ToM Social stimulation (NI) 45 (19/26) 58/46 RCT F-SCIT: 33.32 (11.57)
NI: 34.62 (10.06
14 sess./19 h./20 wks. 
(group) combined with 
one individual sess.
9-10 - FEIT (EP)
- FEDT (EP)
- HT (ToM)
- RMET (EP)
- UOT (ToM)
-SFS, social 
withdrawal & 
interpersonal 
communication (SF)
- Improvement 
on HT, FEIT, 
FEDT, UOT, 
and SFS social 
withdrawal.
Taylor  
et al., 2016
SSD SCIT-adapted (a) C 5 EP and ToM TAU 27 (16/11) - RCT SCIT-a: 40.7 (10.3)
Control: 39.2 (10.6)
16 sess./12 h./8 wks. ? - FEIT (EP)
- HT (ToM)
- Improvement 
on FEIT.
Turner-Brown 
et al., 2008
ASD SCIT-Autism 
(SCIT-A)
C 2 EP, ToM, and SP TAU 11 (6/5) 83/100 Quasi-
experiment
SCIT-A: 42.5 (12.3)
TAU:  28.8 (1.0)
18 sess./15 h./18 wks. 5-6 - FEIT (EP)
- HT (ToM)
- SCSQ (SF)
- SSPA (SF)
- Improvement 
on HT.
Veltro  
et al., 2011
SSD Cognitive-
Emotional 
Rehabilitation 
(REC)
C 7 EP and ToM Problem solving 
training (NSCI)
24 (12/12) - RCT REC: 38.8 (6.3)
NSCI: 37.7 (11.16)
+/- 24 sess./33 h./24 
wks.
8-12 - PSP, personal and 
social relationships 
(SF)
- Advanced ToM 
Scale (ToM)
- EAT (EP)
- Improvement 
on Advanced 
ToM Scale and 
EAT.
Wölwer  
et al., 2005
SSD TAR T 4 EP E.g., medication, 
psycho-educational 
therapy (TAU)
53 (28/25) 89/84 RCT TAR 31.5 (6.9)
TAU 35.2 (11.1)
12 sess./9 h./6 wks. 2 - POFA (EP) - Improvement 
on POFA.
Wölwer & 
Frommann, 
2011
SSD TAR T 6 EP Cognitive Remediation 
Therapy (NSCI)
38 (20/18) 68 (n = 38) RCT TAR/NSCI: 36.7 
(13.1)
12 sess./+/- 10.5 h./6 
wks.
2 - GVEESS (EP)
- PST (ToM)
- RPT (SF)
- Improvement 
on all measures.
Note: SSD, schizophrenia spectrum disorders; ASD, autism spectrum disorders; ABI, acquired brain injury; B, broad-based intervention; C, 
comprehensive intervention; T, targeted intervention; TAU, treatment as usual; NI, no intervention; NSCI, no social cognitive intervention; SCI, 
other social cognitive intervention; Nt, N treatment group; Nc, N control group; EP, emotion perception; ToM, Theory of Mind; SP, social 
perception, SF, social functioning; POFA, Pictures of Facial Affect; PST, ToM Picture Sequencing Task; FENT, Facial Expression Naming Task; 
FEMT, Facial Expression Matching Task; TASIT, The Awareness of Social Inference Test; FES/DT, Facial Expression Same/Different Task; FEIT, 
Face Emotion Identification Test; FEDT, Face Emotion Discrimination Test; SPS, Social Perception Scale; HT, Hinting Task; SFS, Social 
Functioning Scale, subscales social withdrawal & interpersonal behaviour (SFS, SW&IB); MSCEIT, Mayer-Salovey-Caruso Emotional Intelligence 
Test; CFER, Computerised test of Facial Emotion Recognition; CAM, Cambridge Mindreading Face-Voice Battery; RMET, Reading the Mind in 
the Eyes Task; RMVT, Reading the Mind in the Voice Task; RMFT, Reading the Mind in the Film Task; PONS, Half-Profile  of Nonverbal
Sensitivity; ER-40, Emotion Recognition 40; PSP, Personal and Social Performance Scale; EAT, Emotion Attribution Task; EQ, Empathy 
Questionnaire; SPSS, Social Performance Survey Schedule; BRISS-R PDBS/PCSS, Behavioural Referenced Rating System of Intermediate Social 
Skills—Revised Partner Directed Behaviour Scale/Personal Conversational Style Scale; LEAS, Levels of Emotional Awareness Scale; DANVA2 
AF/AP, Diagnostic Assessment of Nonverbal Affect 2- Adult Faces/Adult Paralanguage; BAFQ, Brock Adaptive Functioning Questionnaire; 
SSPA, Social Skills Performance Assessment; ERT-40, Emotion Recognition Test-40 faces edition; OSCARS, Observable Social Cognition: A 
Rating Scale; GSFS, Global Social Functioning Scale; LSP, Life Skills Profile; ERT, Emotion Recognition Task; AI, Assertion Inventory; SSIT, 
Simulated Social Interaction Test; JCFEE, Japanese and Caucasian Facial Expression Emotion; VERT-K, Vienna Emotion Recognition Task; UOT, 
Unexpected Outcomes Test; SCSQ, Social Communication Skills Questionnaire; GVEESS, Geneva Vocal Emotion Expression Stimulus; RPT, 
Role Play Task; EIST, Emotional Inference from Stories Test; IRI, Interpersonal Reactivity Index, perspective taking and empathic concern.
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Overall effects of the SC interventions
First, we present the overall results of the meta-analyses, investigating the effects of SC 
interventions on SC, followed by the specific effects on the four SC subdomains. Next, we 
describe the effects of the three different treatment types on SC. Finally, the intervention 
effects for the three patient groups are reported. Tables 3 and 4 provide an overview of all 
the effects and test statistics of the meta-analyses.
Table 3  Sample Sizes, Standardised Mean Differences, Test Statistics, and Fail-safe N of 
the Included Social Cognitive Intervention Studies Organised by Intervention Type and 
Outcome Domain.
k N (Nt/Nc) SMD (CI) Z χ2 Nfs
All interventions
Social cognition 41 1508 (794/714) 0.71 (0.56-0.86) 9.15*** 74.20*** 2336
Emotion perception 34 1191 (617/574) 0.79 (0.60-0.98) 8.07*** 75.72*** 1783
Social perception 8 315 (165/150) 0.52 (-0.01-1.06) 1.92* 29.13*** 34
Theory of Mind 27 853 (445/408) 0.64 (0.40-0.89) 5.18*** 71.56*** 667
Social functioning 17 646 (335/311) 0.61 (0.42-0.80) 6.30*** 21.01 312
Targeted interventions
Social cognition 15 427 (223/204) 0.89 (0.58-1.20) 5.67*** 28.83* 360
Emotion perception 13 393 (204/189) 0.83 (0.50-1.16) 4.92*** 26.76** 257
Social perception 1 20 (11/9) 1.33 (0.34-2.33) 2.63** - 2
Theory of Mind 7 187 (93/94) 0.86 (0.29-1.43) 2.94** 18.06** 38
Social functioning 2 57 (30/27) 0.52 (-0.01-1.05) 1.93* 0.70 0
Comprehensive interventions
Social cognition 16 484 (247/237) 0.61 (0.35-0.87) 4.65*** 26.84* 217
Emotion perception 16 484 (247/237) 0.83 (0.52-1.15) 5.17*** 38.51*** 367
Social perception 6 155 (81/74) 0.46 (-0.31-1.24) 1.17 25.44*** 8
Theory of Mind 15 470 (240/230) 0.58 (0.21-0.94) 3.10** 47.74*** 182
Social functioning 10 302 (153/149) 0.56 (0.27-0.84) 3.86*** 12.26 72
Broad-based interventions
Social cognition 10 597 (324/273) 0.65 (0.43-0.87) 5.81*** 14.01 191
Emotion perception 5 314 (166/148) 0.63 (0.28-0.98) 3.50*** 8.18 39
Social perception 1 140 (73/67) 0.33 (-0.01-0.66) 1.91 - 1
Theory of Mind 5 196 (112/84) 0.64 (0.34-0.93) 4.26*** 3.63 28
Social functioning 5 287 (152/135) 0.74 (0.40-1.08) 4.25*** 7.04 56
Note: k, number of studies; N, number of patients; Nt, number of patients in treatment group; Nc, 
number of patients in control group; Z, significance test; χ 2, heterogeneity statistic; Nfs, number of null findings 
needed for a non-significant combined effect size calculated by the method of Rosenthal (1979).
*p ≤ 0.05, **p < 0.01, *** p < 0.001.
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The main meta-analysis investigated the effect of the interventions on SC in general. 
The meta-analysis showed evidence of a moderate-to-large intervention effect (SMD = 
0.71, 95% CI = 0.56–0.86, Z = 9.15, p < 0.001) (Figure 2). Regarding the SC subdomains, the 
meta-analysis showed moderate-to-large intervention effects on emotion perception 
(SMD = 0.79, 95% CI = 0.60– .98, Z = 8.07, p < 0.001). Moderate effects were found on ToM, 
social perception, and social functioning (SMDToM = 0.64, 95% CI = 0.40–0.89, Z = 5.18, 
p < 0.001; SMDsocial perception = 0.52, 95% CI= −0.01–1.06, Z = 1.93, p = 0.05; SMDsocial functioning = 
0.61, 95% CI = 0.42–0.81, Z = 6.30, p < 0.001).
Effects of targeted interventions
The meta-analysis resulted in a large effect on SC (SMD = 0.89, 95% CI = 0.58–1.20, Z = 5.67, 
p < 0.001) (Figure 3). Regarding the SC subdomains, targeted interventions had large 
effects on emotion perception, social perception, and ToM (SMDemotion perception = 0.83, 
95% CI = 0.50–1.16, Z = 4.92, p < 0.001; SMDsocial perception = 1.33, 95% CI = 0.34–2.33, Z = 2.63, 
p < 0.01; SMDToM = 0.86, 95% CI = 0.29–1.43, Z = 2.94, p < 0.01). A borderline significant, 
moderate effect was found on social functioning (SMD = 0.52, 95% CI = −0.01–1.05, Z = 
1.93, p = 0.05).
Table 4  Sample Sizes, Standardised Mean Differences, Test Statistics, and Fail-safe N of 
the Included Social Cognitive Intervention Studies Organised by Patient Group.
k N (Nt/Nc) SMD (CI) Z χ2 Nfs
Schizophrenia spectrum disorders
Targeted, social cognition 7 243 (133/110) 1.20 (0.87-1.54) 7.05*** 8.20 182
Comprehensive, social cognition 14 438 (220/216) 0.63 (0.34-0.92) 4.22*** 26.83* 177
Broad-based, social cognition 9 571 (311/260) 0.67 (0.43-0.90) 5.52*** 13.89 172
Autism spectrum disorders
Targeted, social cognition 3 77 (37/40) 0.41 (-0.18-1.00) 1.36 2.90 2
Comprehensive, social cognition 1 11 (6/5) 0.53 (-0.69-1.74) 0.85 - 0
Broad-based, social cognition 0 - - - - -
Acquired brain injury
Targeted, social cognition 5 107 (53/54) 0.56 (0.11-1.01) 2.42* 4.76 13
Comprehensive, social cognition 0 - - - - -
Broad-based, social cognition 1 26 (13/13) 0.47 (-0.32-1.25) 1.17 - 0
Note: k, number of studies; N, number of patients; Nt, number of patients in treatment group; Nc, number of 
patients in control group; Z, significance test; χ 2, heterogeneity statistic; Nfs, number of null findings needed for 
a non-significant combined effect size calculated by the method of Rosenthal (1979).
*p < 0.05, **p < 0.01, *** p < 0.001.
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Effects of comprehensive interventions
The meta-analysis resulted in a moderate effect size on SC (SMD = 0.61, 95% CI = 0.35–0.87, 
Z = 4.65, p < 0.001) (Figure 4). Regarding the SC subdomains, comprehensive interventions 
had a large effect on emotion perception (SMD = 0.81, 95% CI = 0.52–1.15, Z = 5.17, p < 
0.001). For ToM and social functioning, moderate effects were found (SMDToM =.058, 95% 
CI = 0.21–0.94, Z = 3.10, p < 0.01; SMDsocial functioning = 0.56, 95% CI = 0.27–0.84, Z = 3.86, p 
< 0.001). The small effect on social perception was not significant (SMD = 0.46, 95% CI = 
−0.31–1.24, Z = 1.17, p = 0.24).
Effects of broad-based interventions
An overall moderate effect size on SC was found for the broad-based interventions (SMD 
= 0.65, 95% CI = 0.43–0.87, Z = 5.81, p < 0.001) (Figure 5). Regarding the four SC subdomains, 
broad-based interventions resulted in a moderate-to-large effect on social functioning 
(SMD = 0.74, 95% CI = 0.40–1.08, Z = 4.25, p < 0.001). Moderate effects were found on 
emotion perception and ToM (SMDemotion perception = 0.63, 95% CI = 0.28–0.98, Z = 3.50, p 
< 0.001; SMDToM = 0.64, 95% = 0.34–0.93, Z = 4.26, p < 0.001). Only a small, but non-signifi-
cant effect was found for social perception, based on only one broad-based intervention 
(SMD = 0.33, 95% CI = −0.01–0.66, Z = 1.91, p = 0.06).
Effects of the SC interventions per patient group
Table 4 shows all effects sizes and test statistics for the three patient groups. In patients 
with SSD, targeted interventions had a large effect on SC (SMD = 1.20, 95% CI = 0.87–1.54, 
Z = 7.05, p < 0.001), whilst both comprehensive and broad-based interventions had a 
moderate effect on SC (SMDcomprehensive = 0.63, 95% CI = 0.34–0.92, Z = 4.22, p < 0.001; 
(SMDbroad-based = 0.67, 95% CI = 0.43–0.90, Z = 5.52, p < 0.001).
 Regarding patients with ASD, no significant effects on SC were found for both 
targeted and comprehensive interventions (SMDtargeted = 0.41, 95% CI = −0.18–1.00, Z = 
1.36, p = 0.17; SMDcomprehensive = 0.53, 95% CI = −0.69–1.74, Z = 0.85, p = .40). No broad-based 
interventions for patients with ASD met the criteria for inclusion.
 In patients with ABI, a moderate effect of targeted interventions was found on SC 
(SMD = 0.56, 95% CI = 0.11–1.01, Z = 2.42, p = 0.02). No significant effect on SC was found 
for broad-based interventions (SMD = 0.47, 95% CI = −0.32–1.25, Z = 1.17, p = 0.24). No 
comprehensive interventions for patients with ABI met the inclusion criteria.
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Discussion
To our knowledge, this is the first systematic review that meta-analysed controlled 
intervention studies in neuropsychiatric patients targeting SC. The overall results showed 
that the selected SC interventions had a moderate-to-large effect on improving SC in 
general. The interventions were most effective in improving emotion perception, whilst 
ToM, social perception, and social functioning could be effectively improved by these 
treatments as well, with moderate effect sizes. The moderate-to-large effect size for 
emotion perception is in accordance with the findings from previous systematic reviews 
in patients with SSD (Fiszdon & Reddy, 2012; Kurtz & Richardson, 2012). The effects for ToM 
and social perception found in the current meta-analyses, being larger than in the 
aforementioned reviews, could be explained both by the inclusion of more recent studies 
as well as the inclusion of intervention studies for other neuropsychiatric patient 
populations. Overall, the meta-analyses showed that targeted interventions were most 
effective, with a large effect size, in improving SC, followed by broad-based and 
comprehensive interventions, both with moderate effect sizes. Social perception and ToM 
were trained most effectively by targeted interventions, emotion perception was trained 
equally effective by both targeted as well as comprehensive treatments, and social 
functioning by broad-based interventions. 
 Targeted interventions were most effective in improving SC and showed a large 
effect on emotion perception. However, these interventions almost exclusively trained 
emotion perception, often evaluated by outcome measures typically covering this 
particular process. The large, positive effects on emotion perception may thus result from 
‘training to the task’ rather than being the result of transfer to untrained tasks. The same 
phenomenon could be identified in the only targeted intervention study focusing on 
social perception (Garcia et al., 2003). The large effect for ameliorating social perception 
that was found in this study again raises concerns regarding ‘training to the task’. 
Surprisingly, targeted interventions also had a large effect on ToM. Here, only one of the 
seven targeted interventions measuring ToM was a ToM-intervention (Kayser et al., 2007), 
the other six focused on improving emotion perception (Bornhofen & McDonald, 2008a, 
2008b; O. Golan & Baron-Cohen, 2006; Neumann et al., 2015; Wölwer & Frommann, 2011). 
Whilst this finding suggests that training emotion perception may improve ToM abilities 
as well, generally, targeted interventions were not able to effectively improve social 
functioning. However, although only two targeted interventions included a measure of 
social functioning at post-treatment assessment, a marginally significant, moderate 
treatment effect was found in the current study.
 Comprehensive interventions had a moderate effect on improving SC. The effect size 
on emotion perception was large, and the effects on ToM and social functioning were 
moderate. As to the latter, it should be noted that comprehensive interventions, as compared 
to targeted interventions, are generally performed using longer treatment duration and 
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higher treatment frequency. This relatively higher intensity of the comprehensive 
interventions may have caused this effect on daily social functioning. In contrast, the 
comprehensive interventions in the meta-analysis were not able to effectively improve 
social perception. This is a striking finding, because 6 out of the 16 comprehensive 
interventions focused on social perception. After further inspection of these studies, 
it appeared that only four interventions measured social perception after treatment. 
Hence, the effects of the social perception modules in comprehensive interventions could 
be underestimated.
 Broad-based interventions had a moderate effect on improving SC in general. These 
interventions showed a moderate-to-large effect size in improving social functioning. 
Broad-based interventions were more effective in improving social functioning than 
targeted and comprehensive interventions. One explanation for this effect may be found 
in the content of the broad-based interventions. Combining SC treatment with training of 
neurocognition or social skills may have resulted in more robust effects and a better 
generalisation to daily life. A second explanation for the transfer effects of broad-based 
interventions to daily social functioning concerns the intensity of the training. In general, 
treatment duration of broad-based interventions is considerably longer than that of 
targeted and comprehensive interventions, and broad-based interventions include more 
sessions. Roberts et al. (2014) suggested that more frequent sessions may be more 
effective for maximizing treatment benefits. It could be hypothesised that patients 
participating in more intensive intervention programmes have had more opportunities to 
practise and incorporate new knowledge and skills in their daily life. The importance of 
practise opportunities was also discussed by Fiszdon and Reddy (2012). They suggested 
that higher-order SC functions might be more impacted by intensive treatment. Apart 
from their impact on social functioning, broad-based interventions were moderately 
effective in improving ToM and emotion perception. Notably, of the broad-based intervention 
studies that included social perception as a target of treatment, only one actually 
measured social perception. Here, the effect was small and not statistically significant.
 Most studies have been performed in patients with SSD. The small number of studies 
on adult patients with ASD was somewhat surprising. That is, during the literature search, 
many SC intervention studies for patients with ASD were identified, but almost all of the 
interventions focused on children and were therefore not eligible (see e.g., Fletcher- 
Watson et al., 2014). Furthermore, only in the group of patients with SSD, all three intervention 
types were studied. For patients with ASD and ABI, mainly targeted interventions have 
been employed. In these latter patient groups, more research is needed on the effects of 
(other) SC interventions. Targeted interventions appeared to be most effective for training 
SC in patients with SSD, with large effect sizes. This finding is in accordance with the results 
from previous reviews (Choi et al., 2009; Horan et al., 2008; Kurtz & Richardson, 2012; 
Mueller et al., 2013; Statucka & Walder, 2013). Broadbased interventions were slightly more 
effective than comprehensive interventions, both with moderate effect sizes.
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In patients with ASD, small to moderate effects on SC were found for targeted and 
comprehensive interventions, but these effects were not statistically significant. No 
broad-based interventions for SC in ASD could be included in the meta-analyses. The 
non-significant results could reflect a power problem in the original studies. This idea is 
strengthened by the fact that the present lack of significant treatment effects contrasts 
with the results of the systematic review of Bishop-Fitzpatrick et al. (2013), in which 
psychosocial and SC interventions were shown to be effective in an adult ASD population. 
Their systematic review included more studies (k = 13 with N = 291 patients), hence had 
more statistical power. However, also non-controlled studies and case-studies were 
included, which could in turn have led to an over- estimation of the actual effects. The 
meta-analysis of Fletcher-Watson et al. (2014) also showed larger effect sizes in a mixed 
population of children and adults with ASD.
 Regarding patients with ABI, only targeted interventions had a moderate, significant 
effect on SC. In one study that investigated the effects of a broad-based intervention, 
effects were small-moderate, but statistically insignificant. Previous review articles regarding 
patients with ABI also found positive indications for the effectiveness of SC interventions 
on SC (Braden, 2014; Driscoll et al., 2011; Manly & Murphy, 2012). 
 Only 10 of the 41 studies in the meta-analyses included a follow-up assessment after 
treatment had ended. Although the interval durations were highly variable, it appeared 
that most interventions were able to maintain at least one of the effects at follow-up. 
The majority of the follow-up assessments were performed as an evaluation of a targeted 
intervention, suggesting that focused and relatively brief interventions are not only 
effective in improving the performance on several SC tasks directly post-treatment, 
but that this improvement remains after a period without treatment. 
 Interestingly, no controlled intervention studies have focused on the reduction of 
alexthymia in adult neuro psychiatric patients yet. Most alexithymia intervention studies 
published so far focused on healthy participants or individuals with somatic disorders. 
Moreover, alexithymia was frequently studied as a moderator for treatment success, rather 
than a primary outcome variable. Since alexithymia has been related to lower levels of 
quality of life, more problems in social relations, somatic complaints, and psychiatric 
disorders (Kennedy & Franklin, 2002; Taylor & Bagby, 2012), it seems to be a very relevant 
treatment target for future studies. 
 The results of this meta-analysis have implications for future research. More studies 
should focus on SC interventions in other neuropsychiatric disorders than SSD, such as in 
adults with ASD and ABI. Patients with other neuropsychiatric disorders that comprise SC 
problems may also benefit from SC interventions, such as those with mood or anxiety 
disorders, neurodegenerative conditions, as well as patients with SC deficits caused by a 
genetic syndrome. Principally, the large treatment effects of the available interventions 
show that these are appropriate treatments for enhancing SC, that may also be suitable for 
adjustment and implementation in new patient groups. Future interventions should also 
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pay attention to alexithymia, given the high correlations with other psychological and 
somatic problems. Lastly, it is advised to also include measures of social perception to 
evaluate the effects of an SC intervention.
 The results of this study should be interpreted in light of its strengths and weaknesses. 
Strengths of this meta-analysis include the large sample size of controlled intervention 
studies (k = 41 studies with a total of N = 1,508 patients). Also, the failsafe N for the main 
meta-analyses showed that a large number of unpublished studies with null findings 
should exist to result in insignificant effect sizes, which is unlikely. Furthermore, this is the 
first study that meta-analysed the effects of three different SC treatment types on a 
population of neuropsychiatric patients instead of one specific patient group. At the same 
time, this explains the high degree of heterogeneity. A recurrent issue in many 
meta-analyses is the notable amount of differences found in patient population, 
intervention type, control group, and intervention content. In the present study, we partly 
succeeded in reducing this heterogeneity by performing different meta-analyses for the 
various treatment types and patient populations. Although the three categories of 
interventions (targeted, comprehensive, and broad-based) are well defined, there is some 
overlap between the three subtypes and other categorisations can be made. As to the 
patient groups, only three could be included in the meta-analysis. Although other 
psychiatric and neurological conditions met the definition of a neuropsychiatric disorder 
(e.g., mood and anxiety disorders, dementia, or Huntington’s disease), the literature search 
did not return eligible SC intervention studies for these populations, despite the fact that 
SC disorders have been described in these conditions (Bediou et al., 2009; Gregory et al., 
2002; Lough et al., 2006; Plana et al., 2014; Samamé, 2013; Snowden et al., 2003). Patients 
with SSD were overrepresented in this meta-analysis. This may have implications for the 
generalisation to the overall population of patients with neuropsychiatric disorders. 
Furthermore, it is conceivable that there are differences in the specific SC problems 
between the three patient groups, which could have influenced treatment effectiveness.
 In conclusion, the current meta-analysis showed that SC interventions are effective in 
improving SC in neuropsychiatric patients. Targeted interventions are effective in 
improving task performance of the trained SC domains (mainly emotion perception), but 
they are also able to positively affect ToM. Follow-up assessments in a small group of 
mainly targeted interventions suggested that some treatment effects remained after the 
intervention had ended. Comprehensive interventions were able to improve emotion 
perception, ToM, and social functioning. The broad-based interventions were especially 
effective in improving social functioning, probably due to more extensive treatment 
content and a more intensive design. Although our meta-analytic approach could not 
isolate effective elements specifically, training of emotion perception appears an 
important ingredient of effective SC interventions. Treatments should also incorporate 
social functioning and provide sufficient practise opportunities in daily life in order to 
optimise generalisation and maintenance of effects.
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Social cognitive training for adults with 
Noonan syndrome: A feasibility study
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training for adults with Noonan syndrome: a feasibility study. Neuropsychiatric Disease 
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Abstract
Purpose: Noonan syndrome (NS) is a genetic disorder that is associated with social cognitive 
problems. While treatment aimed at the improvement of social cognition is available for 
other neuropsychiatric disorders, no such interventions yet exist for NS patients. In this 
study, the development of the first social cognitive training for NS patients is described 
and its applicability and feasibility evaluated.
Methods: Eleven adult patients with NS participated in this controlled proof-of-principle 
study. Six patients were included in the treatment group and five in the control group. 
Neuropsychological testing was performed in both groups at baseline and posttreatment. 
Social cognition was a primary outcome measure and non-social cognition and psycho-
pathology secondary outcome measures. Differences between pre- and posttest were 
investigated with Wilcoxon-Signed Rank Tests, and a process evaluation was performed to 
aid interpretation of the results. 
Results: Both groups were comparable with regard to age, estimated intelligence, and 
baseline performance. Although no significant differences were found between pre- and 
posttest scores on primary and secondary outcome measures in either group, a medium- large 
effect size was found on emotion recognition in the treatment group. Also, the process 
evaluation demonstrated the feasibility of the training.
Conclusions: This first social cognitive training for adult patients with NS has proven to be 
feasible for this population and showed some encouraging results regarding emotion 
recognition, although the training protocol could be optimised. Further investigation is 
required using a randomised controlled design in a larger sample, in order to substantiate 
the overall effectiveness of the training. 
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Introduction
Noonan syndrome (NS) is an autosomal-dominant genetic disorder characterised by 
distinctive facial features, congenital heart disease, short stature, and varying degrees of 
developmental delay. Other features include chest deformities, a broad or webbed neck, 
cryptorchidism, coagulation defects, and lymphatic dysplasia (Allanson & Roberts, 2016; 
Roberts et al., 2013). The estimated prevalence is 1 in 1,000-2,500 live births (Noonan, 
2005). NS is caused by germ-line mutations encoding components of the RAS/mitogen- 
activated protein kinase (RAS/MAPK) pathway, a signal transduction cascade involved in 
several developmental processes, such as cell cycle regulation, differentiation, growth, 
apoptosis, and cell senescence (Roberts et al., 2013; Tidyman & Rauen, 2016b). NS is one of 
the ‘RASopathies’, referring to a class of related developmental disorders that are caused 
by gene mutations, resulting in dysregulation of the RAS/MAPK pathway (Rauen, 2013). 
To date, mutations in 17 different genes have been associated with NS, of which mutations 
in PTPN11 (50%), SOS1 (10%), and RAF1 (10%) are most frequently identified (Tajan et al., 
2018). In approximately 75% of the patients with NS a genetic mutation can be identified, 
although the diagnosis is still primarily based on clinical criteria (Tartaglia et al., 2011; 
Turner, 2014; Van der Burgt, 2007).
 In children with NS, difficulties have been found in several cognitive domains, among 
which language, motor function, attention, executive function, and social cognition 
(Pierpont, 2016). Regarding the cognitive profile of adults with NS, a (low-)average 
intelligence and lowered speed of information processing were found in comparison to 
matched controls (Wingbermühle, Roelofs, et al., 2012). Performance on other cognitive 
domains such as memory, executive functioning, and visuoconstruction seems to be 
relatively intact in adulthood, although patients report subjective executive problems 
(Wingbermühle, Roelofs, et al., 2012). With regard to social cognition – the mental 
processes underlying social functioning (Beauchamp & Anderson, 2010) - in adults with 
NS, difficulty in identifying and describing one’s own emotional feelings (i.e., higher levels 
of alexithymia), slight overall problems in facial emotion recognition, and social discomfort 
have been described (Wingbermühle, Egger, et al., 2012). Alexithymia (from Greek for ‘no 
words for emotions’) is a dimensional personality trait, reflecting weaknesses in cognitive 
processing and regulation of one’s own emotions. Alexithymia is characterised by 
difficulties in identifying and describing feelings, limited imaginal capacity, and an 
externally oriented cognitive style (Taylor & Bagby, 2012). In a variety of clinical and healthy 
populations, alexithymia has been related to social cognitive impairments, such as 
problems in the automatic processing of emotional stimuli, affect recognition, empathy, 
and mentalising (Bird & Cook, 2013; Grynberg et al., 2012; Lane et al., 2000; Parker, Taylor & 
Bagby, 1993; Moriguchi et al., 2006; Swart, Kortekaas & Aleman, 2009; Donges & Suslow, 
2017; Neumann et al., 2014; Milosavljevic et al., 2016; Poquérusse et al., 2018; Wearne et al., 
2019; Williams & Wood, 2010). Studies on a behavioural level in patients with NS showed a 
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higher prevalence of autism traits and weaker social skills, although it should be noted 
that these studies focused predominantly on children and only two included a (normally 
developing) control group (Adviento et al., 2014; Alfieri et al., 2014; Garg et al., 2017; Pierpont 
et al., 2018). Even though only a few studies have investigated the presence of psychiatric 
disorders in adults with NS, mood and anxiety problems are suggested to be rather 
frequent (Noonan, 2005; Smpokou et al., 2012; Verhoeven et al., 2008). Despite the mental 
health risks associated with social cognitive impairments and alexithymia (Beauchamp & 
Anderson, 2010; Taylor & Bagby, 2012), no social cognitive intervention, incorporating 
alexithymia training, is yet available for patients with NS. 
 Various social cognitive interventions have demonstrated improvements in social 
cognition in adult neuropsychiatric patients (i.e., patients with schizophrenia spectrum 
disorders, autism spectrum disorders, and acquired brain injury) (Roelofs, Wingbermühle, 
Egger, & Kessels, 2017). These treatments included targeted interventions, focusing on one 
social cognitive subdomain (e.g., emotion recognition or Theory of Mind (ToM)), 
comprehensive interventions that addressed more than one social cognitive subdomain 
(for instance, emotion recognition and ToM training), and broad-based interventions in 
which social cognition training was embedded in the context of other interventions, such 
as neurocognitive remediation or social skill training. In general, these social cognitive 
interventions were most effective in improving emotion perception, but ToM, social 
perception, and social functioning could also be trained effectively. Training of emotion 
perception appears to be an important component of effective social cognitive 
interventions, while addressing social functioning and providing sufficient practice 
opportunities in daily life are beneficial for generalisation (Roelofs et al., 2017). Some 
well-described social cognitive interventions for various neuropsychiatric disorders 
include Social Cognition and Interaction Training (Roberts et al., 2016), Treatment of Affect 
Recognition (Wölwer et al., 2005), Cognitive Enhancement Therapy (Hogarty & Greenwald, 
2006), and Treatment for Impairments in Social Cognition and Emotion Regulation 
(Westerhof-Evers et al., 2017). Several social cognitive interventions exist for children with 
ASD, but well-studied treatments for adults are scarce, although the results seem 
promising (Bishop-Fitzpatrick et al., 2013; Roelofs et al., 2017). Given the fact that alexithymia 
is related to social cognitive difficulties, it is remarkable that social cognitive interventions 
for neuropsychiatric disorders do not address alexithymia.  
 Almost four decades ago, Krystal (1979) recommended the use of specific therapeutic 
techniques in alexithymic patients, such as making patients aware of their alexithymic 
problems and emotional feelings, developing affect tolerance, and providing psycho-ed-
ucation regarding emotions (i.e., their signal function, duration, and intensity), and helping 
patients to recognise and verbalise their emotions. A more recent narrative review, 
regarding psychological interventions aimed at reducing alexithymia in psychiatric, 
medical, and healthy populations suggests that alexithymia is partly modifiable and that 
reductions in alexithymia scores can be obtained when alexithymia is directly trained 
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(Cameron et al., 2014). Some studies have used relaxation techniques and mindfulness to 
diminish stress levels and increase awareness of inner experiences and physical sensations 
(Beresnevaite, 2000; Byrne et al., 2016; Neumann, Malec, & Hammond, 2017). Psycho-edu-
cation regarding emotions and their function, as well as the identification of antecedents 
of alexithymia (e.g., emotional expression in family of origin) have also been described 
(Byrne et al., 2016; Kennedy & Franklin, 2002; Neumann et al., 2017). Since alexithymia is 
correlated with decrements in emotion recognition, many alexithymia interventions 
incorporate training of emotion perception, identification, and differentiation (Beresnevaite, 
2000; Byrne et al., 2016; Kennedy & Franklin, 2002; Levant, Halter, Hayden, & Williams, 2009; 
Neumann et al., 2017). Mentalising and differentiating bodily feelings, thoughts, emotions, 
and behaviour have also been addressed (Kennedy & Franklin, 2002; Neumann et al., 2017). 
In order to improve verbalisation of emotions, training of affect labelling, extension of the 
‘emotional vocabulary’, and training of self-expressing skills are used (Kennedy & Franklin, 
2002; Levant, Halter, et al., 2009; Neumann et al., 2017). Listening to music, creating fantasy 
stories, creative writing, noting dreams, reading literary fiction or creating poetry can 
stimulate fantasising (Beresnevaite, 2000; Samur et al., 2013). Lastly, Taylor & Bagby (2012) 
suggested that alexithymia interventions are preferably provided in a group-therapy 
setting, because a group offers relevant interpersonal practice situations. However, they 
suggest that the groups should be small and consist of no more than three patients.
 Because the existing social cognitive treatments do not incorporate alexithymia 
training, they are not completely suitable for NS patients, in whom specific difficulties in 
the identification and verbalisation of their own emotions have been demonstrated. For 
this reason, a social cognitive training was developed, based on the promising results of 
previous social cognitive and alexithymia interventions and tailored to the specific (social) 
cognitive profile of adult patients with NS. The training consists of 10 weekly group 
sessions comprising the three phases of social cognition: 1) the perception of one’s own 
emotions and the emotions of others, 2) the interpretation and integration of socially 
relevant information, and 3) the execution and regulation of social behaviour (Adolphs, 
2001). In this proof-of-principle study, the development, applicability, and feasibility of the 
new training protocol will be described in a group of patients with NS in comparison to an 
NS control group. Social cognition, operationalised by the three aforementioned phases 
of affective information processing, was a primary outcome measure. Given the cognitive 
profile of patients with NS and the relation with social cognition, non-social cognition 
(speed of information processing, inhibition, planning abilities), psychopathology ((social) 
anxiety, depression), quality of life and self-efficacy, were included as secondary outcome 
measures.
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Methods
Design and procedure
Pilot sessions of the training were held at meetings of the Dutch Noonan Syndrome 
Foundation to investigate both interest and support for a social cognitive training as well 
as to obtain input from patients and their relatives regarding important aspects of 
everyday functioning (for instance the inclusion of training partners). Subsequently, a 
training protocol was designed by authors RR and EW, including important elements of 
evidence-based social cognitive interventions (e.g., training of emotion recognition, ToM, 
social behaviour) and exercises from alexithymia treatments. This resulted in a structured, 
10-week group intervention of 90-minute sessions, in which the three phases of social 
cognition were addressed (perception, interpretation, and reaction). The training protocol 
included psycho-education and in-session exercises, incorporating emotion recognition 
training, ToM and mentalising strategies, and exercises to improve the identification, 
labelling, and expression of (own) emotional feelings (see Table 1 for topics and content 
per session). Participants also performed homework exercises aimed at increasing 
awareness of one’s own emotional feelings and social behaviour and allowed them to 
practice with the training topics. Each training session was structured similarly, starting 
with the evaluation of homework exercises, psycho-education concerning a social 
cognitive phase and/or subdomain, practice in the group, and introducing new 
homework. The group size was intentionally limited, with a maximum of five patients per 
group. Participants were asked to select a training partner, who was invited for two 
training sessions, and performed homework exercises with the patients in order to provide 
practice opportunities in daily life. 
 The current study has a controlled pre- vs. posttest within-subject design with a 
treatment group and a control group. Patients in the control group received treatment- 
 as-usual (e.g., psycho-education, psychological counselling, consultation with general 
practitioner and/or medical specialist). Before and after the training a neuropsychological 
test battery, including several (social) cognitive tasks and self-report questionnaires, was 
administered in both groups. The primary outcome measures reflect all three phased of 
affective information processing, thus including emotion recognition, ToM, social perception, 
alexithymia, and social behavioural problems. As secondary outcome measures, subjective 
and objective measures of non-social cognition, psychopathology, quality of life, and 
self-efficacy were included. Proxies of patients in the treatment group were asked to 
complete two questionnaires as well. Training sessions were held at a central location in 
The Netherlands within an acceptable travel distance for all participants. For patients in 
the treatment group, the pre- and posttests were planned at the same location and 
combined with the first and the last training session, if possible. Participants of the control 
group were tested at a location of their preference. However, most testing took place at 
the same location as for the treatment group, and at about the same time. Control 
123
6
SOCIAL COGNITIVE TRAINING FOR ADULTS WITH NOONAN SYNDROME: A FEASIBILITY STUDY
Table 1  Overview of Topic and Content of each Training Session.
Session Topic Content
1 Introduction • Identification of treatment aims
• Psychoeducation on social cognition (perception, 
interpretation, and reaction) in Noonan syndrome
• Relaxation exercise
Perception
2 Emotion perception in 
other people
• Psychoeducation on emotions and emotion perception in 
others
• Exercises aimed at emotion perception via different 
modalities
3 Perception of own 
emotions
• Introduction of emotion word of the day (repeated exercise)
• Psychoeducation on (affective) alexithymia
• Exercises regarding the identification of emotional feelings 
and mindfulness
4 Training partner session 
(with patients)
• Psychoeducation on social cognition (in Noonan syndrome)
• Providing information regarding the training and the role of 
training partners
Interpretation
5 Theory of Mind/
perspective taking
• Psychoeducation on analysing emotions, mentalising, 
Theory of Mind, and perception of social information
• Exercises aimed at the perception of social faux pas, 
perspective taking, and social context
6 Theory of Mind/
perspective taking
• Psychoeducation on perspective taking and attributional 
biases
• Exercises concerning perspective taking, Theory of Mind, 
attributional biases, and social faux pas
Reaction
7 Alexithymia • Psychoeducation on (cognitive) alexithymia, emotion 
regulation, and inhibition
• Exchanging emotion regulation strategies (coping with 
emotions) in family of origin
• Exercises aimed at extending the emotional vocabulary and 
alternative ways of expressing emotions
8 Alexithymia • Psychoeducation on coping strategies (reappraisal, 
acceptance, and action)
• Exercises regarding emotional expression
9 Recapitulation • Summary of training information
• Evaluation of individual treatment aims
• Exercises concerning emotional expression and repeating 
exercises from previous phases
10 Evaluation with training 
partners and patients
• Summary of training information
• Evaluation of individual mood boards (personal, non-verbal 
expression of the six basic emotions) 
• Evaluating the role of training partners and treatment aims
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participants received a gift voucher as compensation for their travel expenses. Further 
information regarding the procedure is provided in the process analysis in Table 2. 
Participants
Eleven patients with NS participated in this study. Four more patients were eligible for 
inclusion, but did not participate, due to current work or study obligations, or non-response. 
Due to the small number of patients who volunteered to participate in the training study, 
it was not possible to allocate the patients randomly to the treatment and control 
conditions. The treatment group consisted of six patients, who followed the training in 
two consecutive groups. The control group comprised five patients. Participants were 
recruited by the Centre of Excellence for Neuropsychiatry of the Vincent van Gogh Institute 
for Psychiatry, the department of Medical Genetics of Radboud university medical centre 
Nijmegen, and the Dutch Noonan Syndrome Foundation. Written informed consent was 
obtained and the study was approved by the Institutional Review Board of Vincent van 
Gogh Institute for Psychiatry, in accordance with the Declaration of Helsinki. 
 Inclusion criteria were a confirmed clinical diagnosis of NS or other RASopathy, a 
minimum age of 16, and sufficient verbal capacities, estimated during the intake procedure 
by two neuropsychologists (RR and EW). The presence of subjective or objective social 
cognitive impairments was required for participation in the treatment group. More 
information regarding the recruitment and inclusion procedures is presented in Table 2.
 The mean age in the treatment group was 47.7 years (SD = 12.8, range = 29-60) and 
35.8 years in the control group (SD = 9.8, range = 23-46). Mean IQ, estimated by the Dutch 
version of the National Adult Reading Test (NART, Schmand, Lindeboom, & van Harskamp, 
1992), was 85.33 in the treatment group (SD = 17.86, range = 69-113) and 83.40 (SD = 17.59, 
range = 55-103) in the control group. Education level, according to the Dutch educational 
system and ranging from category 1 (less than six years of primary education) to 7 
(academic degree) (Duits & Kessels, 2014), varied from 3 to 7 in the treatment group (mode 
= 4) and from 2 to 5 in the control group (mode = 5). In the treatment group, 17% of the 
participants were men, while in the control group 60% men were included. Half the 
participants in the treatment group had a mutation in the PTPN11 gene, compared to 40% 
in the control group. One patient in the treatment group was diagnosed with NS with 
multiple lentigines and one patient in the control group with NS with loose anagen hair. 
After a Mann-Whitney U test, there appeared to be no significant differences between the 
treatment group and the control group with regard to NART IQ (treatment median = 78, 
control median = 85, U = 13, z = -0.37, p = 0.76, r = -0.11), and age (treatment median = 50 
years, control median = 40 years, U = 7.50, z = -1.38, p = 0.19, r = -0.42), although the effect 
size for age was medium to large. 
 Five patients in the treatment group reported previous psychological problems 
(mood problems, anxiety, stress related psychological complaints, alcohol abuse) and 
three had current psychological complaints (mainly mood problems). Two patients still 
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Table 2  Results from the Process Analysis Organised per Process-Evaluation 
Components, Related Process Measures, and Process Variables.
Process 
components
Findings 
Study 
population
1. Recruitment and selection rate
1a. Number of eligible persons in screened population
Fifty-five patients from the department of clinical genetics of Radboudumc and 
all contributors to the Dutch Noonan Syndrome Foundation were contacted 
by letter or e-mail with information regarding the training. This information was 
also displayed on the websites of the Centre of Excellence for Neuropsychiatry 
of Vincent van Gogh Institute for Psychiatry and the Dutch Noonan Syndrome 
Foundation, and presented in newsletters and at meetings of the Dutch Noonan 
Syndrome Foundation. In total, approximately 150 patients were approached, 
of which a maximum of 25% was thought to be eligible, because children and 
adolescents aged < 16 years, adult patients without social cognitive complaints, 
or patients who were not interested in this intervention were not eligible for 
participation. 
1b. Number of participants from the sample of eligible persons
Initially, 15 patients were interested in participating in the training. Five patients 
were excluded due to age (<16 years) or low verbal intelligence. Four other 
patients were eligible for inclusion, but did not (yet) participate, because 
they could not combine the training with current work or study obligations, 
or because they did not respond to invitations. Given the small number of 
patients who volunteered, it was not possible to allocate patients randomly to 
a treatment group and a wait-list control group. Therefore, control participants 
were actively recruited at meetings of the Dutch Noonan Syndrome Foundation 
and five patients were included in the control group. The control group did 
not follow the training at a later point in time. One patient of the control group 
subsequently participated in the training. No pre- or posttest information was 
obtained from this participant after the training, because they had already been 
included in the control group and repeated neuropsychological assessment 
after participation in the training would have affected the results. The training 
was provided in two treatment groups (n = 4 and n = 3) which started 
consecutively. In sum, 11 patients were included in this study: six patients in the 
treatment group and five in the control group.
1c. Number of participants versus aimed-at number
The aim was to include 20 patients (10 patients in the treatment group and 10 in 
the control group). The recruitment objective was not reached. 
2. Barriers and facilitators in recruitment and selection
2a. Difference in baseline characteristics between nonparticipating and participating 
eligible persons
No information was available regarding the differences between participating 
and nonparticipating eligible patients. There were no significant differences in 
demographics and baseline variables between the control group and treatment 
group, although this could reflect a power problem due to the small study 
sample size. Because the groups could not be allocated randomly, a selection 
bias might be present as patients with more severe social cognitive deficits may 
be more inclined to participate in the treatment group.
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Table 2  Continued.
Process 
components
Findings 
2b. Motivation of nonparticipating and participating eligible persons
Some patients who were initially interested in the training could not make the 
required time investment in combination with current work or study activities. 
There also seemed to be some hesitation for participation in group training. 
Possibly, the nature of the (social) cognitive problems of patients with NS, could 
provide an explanation for these findings.
2c. Experience with recruitment and selection
Although there appeared to be much interest for the social cognitive training, 
the number of patients that volunteered in the feasibility study was lower than 
expected. 
3. Number of participants completing follow-up versus number started 
3. Number of participants completing follow-up versus number started
All participants completed the neuropsychological measures at pre- and 
posttest. However, not all self-report and proxy questionnaires were returned.
4. Barriers and facilitators for follow-up
4. Reasons for drop-out and motivation for continued participation
There were no dropouts. All participants in the treatment group completed 
the training and wanted to improve their social cognitive functioning. Patients 
in both groups valued the importance of this study to increase the treatment 
options for patients with NS and were driven to contribute.
Complex 
intervention
1. Quality of delivery of the interventional components
1a. Part of each component and the complete intervention delivered by instructors
All three phases of the intervention (perception, interpretation, reaction) were 
delivered successfully. The number and difficulty of exercises could be adjusted 
flexibly to the level of social cognitive functioning of the group or to individual 
participants.
1b. Satisfaction with delivery
All phases appeared to be feasible. It was observed that participants were 
inclined to spend a lot of time on sharing their experiences at the expense of 
practicing social cognitive exercises. A possible explanation for this observation 
could be that patients with NS seldom meet other patients and enjoyed 
exchanging experiences. However, it could also reflect avoidance of (possibly 
distressing) exercises or be the result of verbosity, due to executive difficulties. 
The time spent on psycho-education could be shortened in favour of more 
(group) exercises. The training initially incorporated one proxy session without 
participants and one evaluation session with proxies and participants together. 
After the evaluation of the first training group, both proxy sessions were 
provided in the presence of the participants. 
2. Barriers and facilitators for delivery of interventional components
2. Reasons for diverging from, or applying (planned) components
The three phases of the training were all delivered, although the exercises were 
slightly adjusted to the level of social cognitive functioning of the group. Despite 
differences in intellectual capacities and education level, participants had 
comparable training aims and found many similarities between one another’s 
social cognitive difficulties.
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Table 2  Continued.
Process 
components
Findings 
3. Adherence to interventional components
3a. Number of sessions followed
Three participants (50%) followed all sessions. One participant missed one-and-
a-half session due to problems with public transport. Two participants missed 
two sessions, because of work-related activities or health issues. When sessions 
were missed, participants received the information and exercises of that week by 
e-mail, studied them independently and had the opportunity to ask questions 
via e-mail or telephone. On average, less than one session was missed (mean= 
9.08 ±, 1.02 sessions). Not all training partners attended both proxy sessions due 
to the required time investment, work obligations, or cognitive difficulties.
3b. Intervention components (partly) followed
The participants received all three training phases. 
3c. Compliance to individual recommendations
Individual recommendations were followed up.
3d. Homework adherence
All participants did homework exercises, although some of them needed 
additional guidance or support. The number and nature of the homework 
exercises slightly differed per week. Some patients viewed the number of 
exercises as too many. Also, there seemed to be a tendency to avoid the 
exercises with the training partners. Some proxies were thus less involved in the 
training than intended. Adequate involvement of a training partner seemed to 
be supportive and beneficial for the participant.
4. Barriers and facilitators for adherence to interventional components
4. Motivation for (lack of ) attendance and compliance
Patients appeared motivated to attend the training. They valued the importance 
of the training and seemed to enjoy the sessions.
5. Experience of participants and instructors with interventional components
5a. Perceived benefit
All participants reported that they benefited from the training. They mentioned, 
for instance, an increased awareness of social cognitive difficulties (related to NS) 
and the acquisition of useful strategies to improve social cognitive functioning 
in daily life. In addition to the content of the training, the participants seemed 
to benefit from the recognition in one another’s experiences and the support 
from their group members. For some participants, this training was the first time 
they had come in contact with other patients with NS. Patients also mentioned 
that the training was intensive and demanding with regard to emotional load 
and time investment. required Two participants suggested more time and 
elaboration, for instance on social rules and social interaction. Furthermore, 
it was suggested by one participant that it be stated more clearly that the 
homework exercises could be time-consuming and to provide a contact 
person, whom patients could reach when they felt worse or relapsed. Three 
of the training partners, who evaluated the training at posttest, experienced 
that the participants benefited from the training. The training partners judged 
the proxy sessions as sufficient in frequency, although one partner mentioned 
that more proxy sessions were preferred. For the three other patients, no 
evaluative information was provided by their training partners. On average, 
the general satisfaction with the training, evaluated by five participants in the 
treatment group, was judged as 8.9 (ranging from 0 to 10). Satisfaction with the 
therapeutic relationship 7.8, satisfaction with aims and topics of training 7.6, and 
satisfaction with approach and methods with 8.4. 
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Table 2  Continued.
Process 
components
Findings 
5b. Strong and weak aspects of the interventional components (structure and 
content), and the total intervention
Strong aspects of the training concerned its (small) group based format, in 
which patients learned from each other’s experiences, increased their awareness 
of social cognitive difficulties, and were able to practice learned strategies. 
The training stimulated three participants for additional psychotherapy to 
continue practicing with the training topics. For two patients, information 
and elements from the training were incorporated into already existing 
coaching or counselling trajectories. In addition, patients used the psycho-
education, provided during the training, to inform other people (e.g., health 
care professionals or family members) or in case of relapse. Every six months, 
participants were invited to follow-up evaluation group sessions at meetings of 
the Dutch Noonan syndrome foundation. If patients were not able to participate 
in this session, individual (telephone) contact was offered. Besides the small 
sample size, a weak aspect of the training may be the slight imbalance between 
time spend on psycho-education and discussion of social cognitive complaints 
and the amount of practice time. More concise and practical psycho-education 
in combination with additional exercises may be helpful. Also, some training 
partners were less involved in the training than intended.
Evaluation 
data
1. Outcome measures: Coverage of interventional components
1. Average number of outcomes per component
The primary outcome measure covered all three phases of social cognition, 
that were addressed in the training: perception (emotion recognition task and 
alexithymia questionnaire), interpretation (social perception task, Theory of 
Mind task, and alexithymia questionnaire), and reaction (questionnaire of social 
behavioural problems and alexithymia). The five secondary outcome measures 
concerned non-social cognition (speed of information processing, inhibition, 
and planning), psychopathology ((social) anxiety and mood problems), quality 
of life, and self-efficacy.
2. Completeness of data collection
2. Number and characteristics of missing data
The neuropsychological test data was all complete. With regard to the 
questionnaires, for one patient in the treatment group the BVAQ and DEX-SC 
were missing at posttest, while the SIB was missing both at pre- and posttest 
in this individual. For one control participant the BVAQ, DEX-SC and SIB were 
missing. One individual in the treatment group missed one page of the 
questionnaire book, which was replaced with the pretest scores. In addition, 
there were nine incidental missing data points (five in the treatment group 
and four in the control group); six at pretest and three at posttest. Most missing 
data were on the BVAQ, SIB, and DEX-SC. If it was not able to re-contact the 
participants, incidental missing data points were replaced with the score at pre- 
or posttest (depending on which score was missing), or with the average score 
on the other items of that questionnaire. When two answers were given, the 
average score was calculated. 
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received psychosocial counselling, which did not focus on improving social cognition. 
All participants in the control group had received psychological treatment once in their 
lives for anxiety and compulsions, posttraumatic stress disorder, suicidal ideation, attention 
deficit/hyperactivity disorder, or a history of being bullied. Two participants in the control 
group reported current psychological problems, and one was still receiving psychological 
and psychiatric treatment, not aimed at reducing social cognitive problems, at another 
mental healthcare facility. 
Baseline measures
The Dutch Version of the National Adult Reading Test (NART) was administered at baseline 
as an estimate of intellectual functioning (Schmand et al., 1992).
Table 2  Continued.
Process 
components
Findings 
3. Barriers and facilitators for data collection
3a. Feasibility of outcome measures. 
The test battery lasted approximately two hours, but it was not considered to be 
too long by the participants. The questionnaires were mostly filled out at home, 
which possibly led to a lower response rate. Three participants in the treatment 
group reported trouble with some of the questionnaires and one received help 
from a friend. One proxy had difficulty with filling out the questionnaires and 
thus did not complete the posttest.
3b. Reasons why data were missing. 
Reasons for attrition in returning the questionnaires at posttest were: difficulty 
with completing the questionnaires, lack of supervision while filling out the 
questionnaires, psychosocial problems, and unfortunate practical complications 
with mail order services. 
3c. Reasons why participants were excluded from analysis. 
There were no participants excluded from the analyses for other reasons than 
missing data. With regard to heterogeneity in patient characteristics in this 
sample, outliers could be present. However, for the purpose of this feasibility 
study, all data was included. 
4. Comparison of qualitative and quantitative effectiveness data. 
The perceived benefit by patients and training partners was not reflected by 
the quantitative data. Finding no significant improvement on the primary and 
secondary outcome measures may be the result of a power problem, due to 
the small sample size. Furthermore, it is possible that some tests in the current 
battery were not able to adequately detect differences between pre- and 
posttest.
Note: BVAQ, Bermond–Vorst Alexithymia Questionnaire; DEX-SC, Dysexecutive Questionnaire – social conventions; 
NS, Noonan syndrome; SIB, Scale for Interpersonal Behaviour.
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Primary outcome measures
Emotion recognition. The Emotion Recognition Task (ERT) was used as a measure of facial 
emotion recognition (Kessels et al., 2014). The ERT is a computer task in which participants 
are presented with dynamic images of the faces of four actors, expressing the six basic 
emotional expressions: anger, disgust, fear, happiness, sadness, and surprise. A computer 
program enables real-time interactive morphing between a neutral expression and the 
emotional expression in four intensities (40%, 60%, 80%, and 100%) (Kessels et al., 2014). 
After each video clip, the participant is asked to choose among the six emotions, displayed 
as buttons on the test computer. Performance is defined by the total number of correctly 
identified emotional expressions. Scores range from 0 to 96 and higher scores represent 
better facial emotion recognition. The ERT has been validated in a wide range of clinical 
groups and normative data of healthy participants are available (Kessels et al., 2014).
 Theory of Mind. Two subtests of the short Dutch version of The Awareness of Social 
Inference Test (TASIT-NL) were used as measures of ToM (McDonald et al., 2003; Wester-
hof-Evers, Visser-Keizer, McDonald, & Spikman, 2014). A combined score of the subtests 
Social Inference- Minimal (SI-M) and Social Inference- Enriched (SI-E) was used, because 
these subtests measure aspects of ToM, while the first subtest - the Emotion Evaluation 
Test - addresses emotion recognition (Westerhof-Evers et al., 2014). The TASIT-NL is the 
only ToM test that uses videos of actual persons in familiar social situations. Subtest SI-M 
includes nine videos with three sincere, three sarcastic, and three paradoxical sarcastic 
scenes. After each video, the participant has to answer four questions about what the 
actor was doing, saying, thinking, and feeling. Subtest SI-E consists of eight other videos 
(four lies, four sarcastic scenes) with additional contextual cues to assist the understanding 
of the situation. After each video, the participant has to answer the same four questions 
(do, say, think, feel). The combined score for the two subtests ranges from 0 to 68, with 
higher scores reflecting better ToM abilities. The TASIT-NL has two parallel forms: Form A 
was used at pretest and Form B at posttest. Although some differences were found 
between the two forms regarding the difficulty at item level and the presence of a 
sequence effect for subtest SI-M (lower performance on Form B when participants first 
completed Form A), no differences were found between Form A and B on subtest total 
scores and overall score, indicating that both forms are comparable. Overall performance 
on the alternate forms was correlated moderately (r = 0.45) (Westerhof-Evers et al., 2014).
 Social perception. The Social Interpretation Test (SIT) was used as a measure of social 
perception (Vijftigschild & Berger, 1969). The SIT consists of a coloured drawing, depicting 
a social situation (an accident and reactions of people in the street). Nine open questions 
are asked to the participant, such as “Can you tell me something about the picture?”; “Do 
you think there is something striking or strange in the picture?”; and “How are these 
people involved in the situation?”. The SIT contains a scoring system with 24 statements 
and correct answers are scored as 1 point. The SIT has a parallel version, using a different 
yet comparable drawing. Form A is used at pretest and Form B at posttest. A maximum 
131
6
SOCIAL COGNITIVE TRAINING FOR ADULTS WITH NOONAN SYNDROME: A FEASIBILITY STUDY
score of 21 could be obtained, because only those statements that were thought to be 
plausible analogies between the two forms were used. Performance on the two forms 
was highly correlated (r = 0.82) (Vijftigschild & Berger, 1969).
 Alexithymia. The Bermond-Vorst Alexithymia Questionnaire (BVAQ) was administered 
to measure alexithymia (Vorst & Bermond, 2001). This questionnaire consists of 40 items, 
which are rated on a 5-point Likert scale. The BVAQ includes five factor-based subscales 
(Emotionalising, Fantasising, Identifying, Analysing, and Verbalising), and two higher-order 
scales (Affective and Cognitive Dimension). The total score on the BVAQ (ranging from 40 
to 200) was used in this study, with higher scores reflecting higher levels of alexithymia. 
Patients in both groups completed a self-report version of this questionnaire. In addition, 
for participants in the treatment group, a partner or other person close to the patient (i.e., 
their training partner) was asked to complete a proxy version of this list, constructed by 
the researchers. The reliability and validity of the self-report version of the BVAQ are 
acceptable, and normative data of healthy participants are available (Müller, Bühner, & 
Ellgring, 2004; Vorst & Bermond, 2001).
 Social behavioural problems. Based on the factor-analytic study of Bodenburg & 
Dopslaff (2008) a subscale of the Dysexecutive Questionnaire was calculated, measuring 
social conventions and the ability to incorporate social interaction in one’s own behaviour 
(DEX-SC, Wilson, Alderman, Burgess, Emslie, & Evans, 1996). The subscale consists of four 
items. Total scores range from 0 to 16 with higher scores reflecting more social behavioural 
problems. Patients in the treatment and control group completed the self-report version 
of the DEX-SC and for participants in the treatment group, a proxy version of this list was 
completed by a partner or other person close to the patient (i.e., their training partner).
Secondary outcome measures
Speed of information processing and inhibition. The Stroop Colour Word Test (CWT) was 
assessed to measure processing speed and response inhibition (Bouma, Mulder, Altena, 
Schmand, & Lindeboom, 2012; Stroop, 1935). The average time to complete the first two 
conditions is used as a measure of mental speed. A ratio-score (completion time on third 
condition divided by the average time on conditions 1 and 2) was calculated to reflect the 
ability to inhibit an automatic response. Lower ratio-scores reflect better inhibition. The 
reliability of the Stroop CWT is considered good and construct validity sufficient (Egberink, 
Holly-Middelkamp, & Vermeulen, 2003). 
 Planning. An adapted version of the Modified Six Elements Test (MSET), a subtest of 
the Behavioural Assessment of the Dysexecutive Syndrome (BADS), was used to measure 
planning abilities (Bertens, Frankenmolen, Boelen, Kessels, & Fasotti, 2015; Wilson et al., 
1996). The adapted MSET was used, because it has two parallel forms (version 1 was used 
at pretest and version 2 at posttest), reduced ceiling effects in mildly impaired individuals, 
and a more differentiated scoring system (Bertens, Fasotti, Egger, Boelen, & Kessels, 2016). 
In the adapted MSET the original dictation subtask has been replaced with a sorting task. 
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The other subtasks include arithmetic (version 1), categorizing pictures (version 1), picture 
naming (version 2), and categorizing words (version 2). The test procedure of the adapted 
MSET is comparable to the original task. In this study, the scoring method of the adapted 
MSET (time of longest subtask(s) – time shortest subtask(s)) / (number of executed tasks 
– rule breaks)) was used (Bertens et al., 2016). Lower adapted MSET scores indicate better 
planning performance. Normative data of healthy participants are available (Bertens et al., 
2016).
 Social distress. The Scale for Interpersonal Behaviour (SIB) was used to reflect engagement 
in social behaviour and related distress (Arrindell et al., 2001). The SIB includes 50 items 
reflecting social behaviour, of which the participant has to evaluate (on two separate 
5-point scales) the probability of engaging in this behaviour (performance scale) and the 
level of stress it evokes (distress scale). For the purpose of this study, only the distress scale 
was used. Higher scores reflect higher levels of social distress. The construct validity and 
reliability of the SIB are considered good, and criterion validity sufficient (Egberink, Holly- 
Middelkamp, & Vermeulen, 1998). Normative data of healthy participants are available 
(Arrindell, De Groot & Walburg, 1984).
 Anxiety and depression. The Dutch version of the Symptom Checklist-90 Revised 
(SCL-90-R) was used to measure general psychological complaints (Arrindell & Ettema, 
2003). The questionnaire consists of 90 items, which are rated on a 5-point scale. For the 
purpose of this study, only the subscales Depression (16 items) and Anxiety (10 items) 
subscales were administered. Higher scores reflect a higher level of complaints. The 
reliability, construct validity, and criterion validity of the SCL-90-R are considered good 
(Egberink, Holly-Middelkamp, & Vermeulen, 2004). Normative data of healthy participants 
are available (Arrindell & Ettema, 2003). 
 Quality of life and self-efficacy. Two short self-report questionnaires of respectively 
quality of life (three items) and self-efficacy regarding social cognitive functioning (eight 
items) were administered. These questionnaires were developed by the authors, based on 
items of the Dutch version of the Acceptance and Action Questionnaire and the Lancashire 
Quality of Life Questionnaire (Jacobs, Kleen, de Groot, & A-Tjak, 2008; Van Nieuwenhuizen, 
Schene, Koeter, & Huxley, 2001), and adjusted to the NS population. Higher scores on these 
questionnaires reflect a higher level of quality of life or self-efficacy.
Data-analysis
Pretest scores on the primary and secondary outcome measures of the treatment and 
control groups were compared, using a Mann-Whitney U test. Wilcoxon Signed-Rank 
Tests were performed to investigate pre- vs. posttest differences in the treatment group 
and control groups. Effect sizes were calculated manually using the equation: r = z / (√N) 
(Perdices, 2018; Rosenthal, 1991). The analyses were performed with SPSS Version 23.0.0.0.
 For tests for which normative data of healthy participants were available and no 
adjusted scores were used in the current study (i.e., ERT, BVAQ, MSET, SIB, SCL-90-R), 
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individual test scores were classified as low (< -2 SD), below-average (-1.5 - -2 SD), 
above-average (1.5 – 2 SD), or high (> 2 SD). 
 A process evaluation (i.e., a structured exploration of each process of an intervention) 
was added, as it can provide valuable information regarding the understanding of both 
positive and negative outcome results (Reelick, Faes, Esselink, Kessels, & Olde Rikkert, 2011). 
In the current study, the process evaluation was structured into three components, as 
suggested by Reelick et al. (2011): 1) the success rate of recruitment and quality of the 
study population, 2) the quality of the execution of the complex intervention, and 3) 
the process of acquisition of the evaluation data. 
Results
Baseline testing
The results of the treatment group and control group at baseline are displayed in Table 3. 
On the primary and secondary outcome measures, no significant differences were found 
between the groups, even though medium to large effect sizes were present for the 
differences on the ERT, DEX-SC, Quality of Life, Self-efficacy, SCL-90-R Anxiety, and Stroop 
CWT Inhibition. 
Table 3  Baseline Performance of Treatment Group Compared to Control Group.
Outcome measures Treatmenta
(n = 6)
Controla
(n = 5)
U z p-value rb
ERT 47 52 9 -1.10 0.31 -0.33
TASIT-NL 49 52 11 -0.74 0.50 -0.22
SIT 12.5 13 11.5 -0.65 0.54 -0.20
BVAQ 119 104 12 -0.55 0.62 -0.17
DEX-SC 9 7 9.5 -1.02 0.37 -0.31
Stroop CWT Processing Speed 55.5 48.5 12 -0.55 0.66 -0.17
Stroop CWT Inhibition 1.75 1.59 6 -1.64 0.13 -0.49
Adapted MSET 18.5 15 11.5 -0.64 0.57 -0.19
SIB Distress 109 117 11 -0.31 0.84 -0.09
SCL-90-R Anxiety 17.5 12 9 -1.10 0.32 -0.33
SCL-90-R Depression 28 22 11 -0.73 0.51 -0.22
Quality of life 12.5 16 9 -1.11 0.33 -0.33
Self-efficacy 36 39 9.5 -1.01 0.35 -0.30
Note: aMedians; bEffect size measure; ERT, Emotion Recognition Task; TASIT-NL, Awareness of Social Inference Test 
(Dutch version); SIT, Social Interpretation Test; BVAQ, Bermond-Vorst Alexithymia Questionnaire; SIB, Scale for 
Interpersonal Behaviour; DEX-SC, Dysexecutive Questionnaire- social conventions; CWT, Colour Word Test; MSET, 
Modified Six Elements Test; SCL-90-R, Symptom Checklist-90 Revised.
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Compared to normative data, one patient in the treatment group had a below-average 
performance on the ERT and one patient in this group performed at a low level. Two 
patients had above-average alexithymia levels on the BVAQ and two patients had high 
levels. For two patients, proxy reports showed above-average levels of alexithymia, while 
for two patients high levels of alexithymia were reported by proxies. Two patients reported 
high levels of depression on the SCL-90-R. In the control group, two patients reported 
high levels of alexithymia. Two patients in this group reported high levels of depression on 
the SCL-90-R and one patient reported high levels of anxiety on the same questionnaire. 
One patient reported an above-average level of social distress on the SIB and one patient 
reported high levels of social distress. One patient showed a low planning performance 
on the MSET. The classifications are displayed in Tables 4-7. 
Pretest vs. posttest 
There appeared to be no significant differences on primary outcome measures between 
pre- and posttest scores in both the treatment group or in the control group (see Tables 4 
and 5). However, the effect size of improvement on the ERT was medium to large in the 
treatment group, while it was only small to medium in the control group. 
 Regarding secondary outcome measures, there were no significant differences 
between pre- and posttest scores in both groups, although the improvement on the 
adapted MSET in the treatment group and the faster performance of the control group on 
the Stroop CWT Processing Speed almost reached significance and effect sizes were large 
(Tables 6 and 7). Despite the lack of significant results, the effect size of the improvement 
in inhibition scores on the Stroop CWT in the treatment group was medium to large, while 
decreased performance on this task in the control group showed a large effect. Furthermore, 
large effects were found in the control group with regard to the (non-significant) 
improvement in planning abilities on the adapted MSET and the decrease in anxiety on 
the SCL-90-R, while a medium effect was found for the decrease in depression. Since both 
groups showed a (medium to) large effect on the improvement on the adapted MSET, 
this most likely reflects a practice effect. 
Process evaluation
In Table 2, detailed information regarding the process evaluation is displayed. The results 
of the process analysis regarding the selection of the study population showed that the 
number of included patients was smaller than intended. It is hypothesised that the lower 
inclusion may be influenced by the nature of the (social) cognitive deficits in patients with 
NS. There were no dropouts among the included patients. 
 With regard to the evaluation of the intervention itself, the results of the process 
evaluation indicated that all three phases of the training were delivered successfully. 
All participants reported benefiting from the training. Increased awareness of social 
cognitive difficulties (related to NS) and the acquisition of useful strategies to improve 
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social cognitive functioning were mentioned most frequently, though participants also 
reported that they had experienced the training as intensive and demanding in terms of 
the emotional load and practical issues (e.g., time investment). In addition to the content 
of the training, participants also benefited from the support they felt from their group 
members. It was observed that patients were inclined to spend much time on sharing 
their experiences in a detailed manner during the sessions, at the expense of training 
time. Supposedly, most patients with NS seldom meet other patients and greatly valued 
the recognition of one another’s experiences and (social cognitive) problems. Alternatively, 
the observed tendency to share experiences extensively may reflect avoidance of 
(potentially distressing) exercises during the training, or may be the result of verbosity, 
caused by difficulties in executive functioning. Although homework exercises were 
performed satisfactorily, participants tended to avoid the exercises with their training 
partners. Patients who involved their training partners, seemed to profit from the 
participation of their proxies. Three of the five training partners who shared their 
experiences after the training, reported that the participants benefited from the training 
in their opinion.
 Lastly, the results of the process evaluation of the outcome measures showed that 
the neuropsychological test data were complete, but that not all questionnaires were 
returned. This could suggest a difficulty with completing the questionnaires. The missing 
data may have influenced the findings in this study, because conservative methods were 
used to compensate for the missing data. The perceived benefit by patients and their 
training partners was not reflected by the quantitative data. 
Discussion
In the present study, applicability and feasibility of a new social cognitive training for adult 
patients with NS was evaluated. The training appeared to be feasible and promising 
results were found with regard to the enhancement of emotion recognition, although the 
overall effectiveness of the training could not yet be quantified due to the small sample. 
 With regard to the baseline measures, no significant differences were found between 
the treatment and control groups. However, several outcome measures showed medium 
to large effect sizes when comparing the two groups, which may suggest that meaningful 
differences between the treatment and control group on these variables could not be 
demonstrated due to a power problem. Baseline variables that potentially differed, were a 
higher age, poorer emotion recognition, lower levels of quality of life and self-efficacy, 
more social behavioural problems, more anxiety, and a worse inhibition score in the 
treatment group in comparison to the control group. Possible baseline differences 
between the groups might have resulted from the inclusion of patients with subjective or 
objective social cognitive impairments in the treatment group.
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Within each group, no significant differences between pre- and posttest were found for 
the primary outcome measures. However, the medium to large effect size of the 
pre- vs. posttest difference on the ERT in the treatment group, compared to the small 
to medium effect size in the control group, may indicate that the effects on emotion 
recognition were stronger in the treatment group. An improvement in emotion recognition 
was expected, because it is a consistent finding in other social cognitive interventions 
(Roelofs et al., 2017). Finding no significant improvement in the treatment group on 
subjective measures of social cognitive functioning, may reflect an increased awareness 
of social cognitive difficulties. Awareness of one’s (social) cognitive problems can be 
considered as an initial step towards behavioural change.
 Regarding the secondary outcome measures, no significant differences were found 
between pre- and posttest in either group. However, the improvement on the adapted 
MSET scores in the treatment group and faster processing speed on the Stroop CWT in 
the control group almost reached significance. In addition, the medium to large effect 
sizes of the (non-significant) improvement on the Stroop CWT Inhibition in the treatment 
group, and the (non-significant) improvement on the adapted MSET and SCL-90-R, and 
(non-significant) decrease on the Stroop CWT Inhibition in the control group, may reflect 
differences that could not be demonstrated by the Wilcoxon Signed-Rank Tests due to 
power problems. Moreover, large effects were found in both groups with regard to the 
(non-significant) improvement in planning abilities on the adapted MSET, which most 
likely reflects a practice effect. 
 The process evaluation showed that there were no dropouts, all three phases of the 
intervention were feasible, and patients reported benefits from the training. Strong 
aspects concerned the (small) group-based format, in which NS patients learned from 
one another’s experiences, gained more awareness of their social cognitive difficulties, 
and were able to practice strategies. The number of included patients in this study was 
smaller than intended, which could be related to the nature of the (social) cognitive 
deficits in patients with NS. Providing more information concerning the beneficial effects 
of group training and considering alternative training locations in order to reduce the time 
investment may be helpful in this regard. eHealth interventions can also be considered, 
although exercising social skills in real-life interaction remains necessary. The evaluation 
also showed that more time may be spent on practicing social cognitive skills and 
performing exercises and to a lesser extent on psychoeducation and discussion of 
experiences and social cognitive complaints. Additional exercises can be considered, 
focusing for instance on emotion regulation strategies, task concentration training, and 
elements of Acceptance and Commitment Therapy, which may be helpful in diminishing 
alexithymic problems and social anxiety, and in increasing acceptance of emotions. 
Furthermore, training partners were less involved in the training than intended, which 
could have hampered the generalisation of the training effects to daily life. The selection 
of appropriate training partners, their role, and the benefits of their involvement should 
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be addressed more elaborately during both the intake procedure and the sessions in 
which the training partners are present. It also appeared that patients had some difficulty 
with filling out the questionnaires. Supervised administration of the questionnaires and 
the use of shorter instruments – for instance replacing the BVAQ by the shorter Toronto 
Alexithymia Scale-20 may be helpful in this regard (Bagby, Parker, et al., 1994). Furthermore, 
a revision of the test battery is suggested. Although the TASIT has many benefits (i.e., 
alternate forms and videos of real-life social situations) and is used frequently, the Dutch 
version is still time-consuming and its suitability for repeated administration is questionable 
(McDonald, & Frith, 2017). Other ToM tasks may be considered, for instance a recognition 
of faux pas task (Corcoran et al., 1995; Gregory et al., 2002; Stone, Baron-Cohen, & Knight, 
1998).
 Despite the fact that this is the first controlled study to evaluate a new social cognitive 
training for adult patients with NS, there are also some limitations. Firstly, the study sample 
was small, which has consequences for the power. Furthermore, because subjective or 
objective social cognitive impairments were required for inclusion in the treatment group, 
a selection bias could be present, which limits the interpretation of the pre- vs posttest 
results to this group. Although no baseline differences were found between the groups, 
the presence of several medium to large effect sizes at baseline comparisons may suggest 
that meaningful differences between the groups could not be demonstrated due to 
limited statistical power. Also, patients were not randomly allocated to the groups and we 
emphasize that these preliminary findings should be interpreted with caution and 
replicated in a randomized controlled trial. Because only non-parametric analyses were 
performed, no interaction effects between group (treatment vs. control) and time (pre vs. 
post) could be explored. As a result of the large heterogeneity in cognitive functioning in 
the NS population, possible outliers may have influenced the results of the analyses. 
However, these effects are considered minimal due to the use of non-parametric testing. 
Lastly, all participants in the treatment group underwent neuropsychological assessment 
at the Centre of Excellence of Neuropsychiatry at different time periods before the training 
(ranging from approximately one to eight years). Some of the outcome measures in the 
current test battery overlapped with this neuropsychological assessment, which could 
have led to practice effects. 
Conclusion
In conclusion, this first social cognitive training for adult patients with NS, based on 
existing evidence-based and best-practice social cognition and alexithymia interventions, 
has proven to be a feasible training for this population. Moreover, encouraging results 
were found with regard to the enhancement of emotion recognition. Based on the 
process evaluation, some alterations in the training protocol and test battery may be 
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helpful in order to optimise the procedure. Future studies are needed, using a larger 
sample and randomised controlled design, in order to evaluate further the effectiveness 
of the training.
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SUMMARY AND DISCUSSION
The aim of this thesis was to come to further delineation and understanding of the neuro-
psychological and psychopathological phenotype of adult patients with Noonan syndrome 
(NS), and to develop an NS-specific neuropsychological treatment, targeting social cognitive 
functioning. In this chapter, the main findings will be presented and discussed.
Main findings 
Cognitive functioning has been studied more frequently in children with NS than in 
adults. The cognitive problems that children demonstrate seem to be more diffuse and 
extensive (Pierpont, 2016; Wingbermühle et al., 2009). This could indicate that cognitive 
development is delayed - but not structurally impaired – in NS and that patients outgrow 
their cognitive problems over time. However, no longitudinal studies concerning cognitive 
functioning in NS had yet been performed to support this hypothesis. Therefore, 
in Chapter 2 intellectual development in NS was investigated in a retrospective longitudinal 
study, by comparing intelligence scores in childhood with IQ in adulthood. It appeared 
that performance IQ increased significantly over time, reaching an average intelligence 
level in adulthood. Verbal IQ did not change significantly and showed low-average scores 
in both childhood as well as adulthood, resulting in a verbal-performance discrepancy 
in adulthood. Childhood IQ, especially performance IQ, appeared to be a significant 
predictor of adult full-scale IQ. The findings of this study are in accordance with the 
hypothesis of a delay in cognitive development in NS, most likely of executive functioning 
and motor functioning, which is outgrown in adulthood. 
 To investigate the specificity of the social cognitive profile of patients with NS, Chapter 3 
compared affective information processing in women with NS to that of matched groups 
of women with Turner syndrome (TS), a condition with a different genetic aetiology that 
shares phenotypic characteristics with NS, and typically developing women. Individuals 
with TS demonstrated higher levels of (affective) alexithymia – that is, lower emotional 
arousal, more difficulties in identifying their emotions, and more problems in seeking 
explanations for their emotional reactions – in comparison with women with NS and 
typically developing women. Women with NS showed less accuracy in recognising angry 
facial expressions in comparison with the control group, but no higher levels of alexithymia. 
The three groups reported equal levels of social distress and engagement in social 
situations. This study showed that it is possible to discriminate different profiles of social 
cognitive functioning in women with NS and TS. This may suggest that the difference in 
genetic aetiology between the syndromes contributes to the social cognitive profiles. 
Finding no significantly higher levels of alexithymia in the NS group compared to the 
control group was unexpected and could be understood as the result of including solely 
women in this study, while alexithymia was previously found in (larger) mixed sex-samples 
of NS patients. 
148
CHAPTER 7
In Chapter 4, personality and psychopathology was first studied in adult patients with NS 
by comparing the results on the MMPI-2-RF between patients with NS and matched, 
typically developing controls. Regarding personality characteristics, higher (yet subclinical) 
levels of introversion were found in patients with NS in comparison with matched controls, 
mainly reflecting a lack of positive emotional experiences. Lower levels of extraversion 
were also found in a previous study in children with NS (Bizaoui et al., 2018). These findings 
may suggest that introversion is a pervasive personality characteristic in NS patients. 
Introversion is known to correlate with mood and anxiety problems and might predispose 
patients with NS to internalising problems. Concerning psychopathology, indeed more 
internalising difficulties – although again within the non-clinical range – were reported by 
NS patients. Patients showed especially higher levels of demoralisation, which is a pervasive 
and affect-laden dimension of unhappiness and life dissatisfaction. Demoralisation might 
reflect the experienced burden of living with a chronic condition. Finding higher levels of 
demoralisation in the patient group contrasts with earlier reports of unimpaired quality of 
life in patients with NS (Binder et al., 2012). In the present study, alexithymia was correlated 
with elevated levels of negative emotionality and internalising problems in the patient 
group, while the correlation with internalising problems almost reached significance in 
the control group. Poor emotion regulation skills due to alexithymic problems may result 
in a diminished capacity to regulate negative feelings (Preece, Becerra, Allan, Robinson, & 
Dandy, 2017). However, no significant differences were found in the level of alexithymia 
between the patient group and the control group. The results of this study advocate that 
clinicians should pay special attention to the mental health of patients with NS, especially 
of patients with an introvert personality style or alexithymic characteristics. Patients may 
benefit from psychological treatment aimed at decreasing internalising problems and 
introversion, when these complaints interfere with daily functioning. 
 Alexithymia and poor social cognition have been associated with psychological 
problems, interpersonal difficulty, and a diminished quality of life (Beauchamp & Anderson, 
2010; Kennedy & Franklin, 2002; Taylor & Bagby, 2012). As a result, many neuropsychological 
interventions for improving social cognition have been developed for different patient 
populations over the years. Chapter 5 provides an overview of the effects of social cognitive 
interventions for neuropsychiatric patients on social cognition (i.e., emotion perception, 
social perception, Theory of Mind (ToM), and social functioning). A meta-analysis was 
performed, including 41 controlled studies of social cognitive interventions for adult patients 
with schizophrenia, autism spectrum disorders, and acquired brain injury. The meta-analysis 
showed that these interventions were overall effective (moderate-to-large effect) in 
improving social cognition. Emotion perception was trained most effectively, followed by 
ToM, social perception, and social functioning. Targeted interventions (training of one 
social cognitive function) showed large effects, while broad-based interventions (training 
of social and non-social cognition simultaneously), and comprehensive interventions 
(training of several social cognitive functions) showed moderate effects. Targeted and 
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comprehensive interventions were most effective in improving emotion perception. 
Targeted interventions also trained ToM most effectively. Broad-based interventions 
appeared to be most effective in training social functioning. Most of the included 
interventions focused on patients with a schizophrenia spectrum disorder, while the 
number of eligible studies aimed on adult patients with autism spectrum disorder or 
acquired brain injury were limited. Interestingly, no alexithymia interventions for neuro-
psychiatric patients could be included in the meta-analysis, although alexithymia seems 
to be a relevant treatment target for this population. Based on the current meta-analysis, 
important ingredients for effective social cognitive interventions appear to be training of 
emotion perception and social functioning. The ability to practice in everyday situations 
is essential for generalisation and maintenance of training effects. 
 Previous studies of our research group in adult patients with NS demonstrated a 
slower processing speed, subjective executive difficulties, slight emotion recognition 
problems, higher levels of alexithymia, and more social distress in comparison with 
matched controls (Wingbermühle, Egger, et al., 2012; Wingbermühle, Roelofs, et al., 2012). 
Existing social cognitive treatments are not sufficient for NS patients, because they do not 
incorporate interventions to decrease alexithymia. Moreover, in the Dutch mental health 
system, these treatments are not accessible for patients with NS, because social cognitive 
problems frequently exist in the absence of a strict psychiatric classification, like for instance 
ASD. Therefore, based on the specific cognitive profile of patients with NS, the first 
NS-specific social cognitive intervention was developed, based on existing evidence-based 
and best-practice social cognitive and alexithymia interventions. In Chapter 6, this intervention 
has been described and its feasibility was evaluated. The comprehensive training consists 
of ten weekly group sessions, which followed three phases: 1) perception of one’s own 
emotions and the emotions of others, 2) interpretation of affective and socially relevant 
information, and 3) regulation of emotions and social behaviour. The training protocol 
included psycho-education and in-session exercises. In addition, patients performed 
homework exercises and selected a training partner to increase practice opportunities in 
daily life. A controlled proof-of-principle study was performed in which the performance 
on measures of social cognition, non-social cognition, and psychopathology were 
compared between NS patients in the treatment group and control group. Although the 
sample was yet too small to detect significant effects, the intervention appeared to be 
feasible for the NS population and encouraging results were found regarding emotion 
recognition. Moreover, patients mentioned that sharing their experiences and social 
cognitive difficulties with other NS patients was helpful. Participants reported an increased 
awareness of social cognitive difficulties and were able to practice strategies in daily life. 
A process evaluation revealed some improvements that could be made to the training 
protocol to optimise the procedure. In the future, the effectiveness of this training should 
be further evaluated in a larger sample, preferably using a randomised controlled design. 
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Developmental perspective 
NS is a lifelong developmental disorder, that seems to have a different appearance at the 
neuropsychological level at various points in life. Although several questions regarding 
the neuropsychological profile of NS patients remain and studies in adult patients are still 
scarce, it appears that children with NS are confronted with more diffuse cognitive 
difficulties than adult patients. No prototypic cognitive profile seems to emerge from the 
literature overview presented in Chapter 1, but problems in motor functioning, language 
abilities, attention, executive functioning, and social cognition seem to occur most 
frequently in children with NS. Based on the literature and clinical observations, it appears 
that while in early childhood, the development of motor functioning and language is 
usually delayed, intellectual functioning is mostly in the (low)average range in later childhood. 
In school-aged children and adolescents, problems in attention, executive functioning, 
and social cognition are most frequently described, while only a slower information 
processing speed, subjective executive difficulties, and social cognitive problems have 
been found in adulthood. Overall, cognitive problems seem to be related to the general 
level of intellectual functioning (Pierpont, 2016; Wingbermühle, Roelofs et al., 2012). 
 Altered brain maturation, connectivity, and functioning due to dysregulation of the 
RAS/MAPK pathway may provide an explanation for finding a developmental delay in NS, 
in which the limbic structures, basal ganglia, and frontal regions may be involved. 
Functional neuroimaging studies would be helpful to understand the influence of brain 
maturation on cognitive functioning in NS. Also, NS-specific health problems – such as 
chronic heart disease - may contribute to problems in cognitive development. Studies in 
children with chronic heart disease have shown an increased risk of neurodevelopmental 
disorders, including cognitive, adaptive, motor, speech, behavioural, and executive 
functioning deficits, as well as ASD symptoms and psychiatric disorders (Nattel et al., 2017). 
According to Nattel et al. (2017), genetic abnormalities both influencing heart and brain 
development, alterations in foetal cerebral circulation and metabolism, and impaired 
oxygen supply during critical periods in early life may contribute to these findings, while 
surgical factors do not seem to play a significant role. Furthermore, specific and changing 
demands from the environment might interact with these developmental processes (for 
instance, increasing educational demands and development of intimate social relationships 
in adolescence may appeal more strongly to planning abilities and social cognition than 
in early childhood), which can result in a relative delay in comparison with peers. Also, 
a neuropsychological explanation may be provided for outgrowing this developmental 
delay in NS. Over time, patients with NS may gain more insight into their cognitive 
strengths and weaknesses and learn to compensate them (hence underlining the relevance 
of clinical neuropsychological assessment), coping abilities may have improved, as well as 
acceptance of the syndrome. 
 The literature suggests that although more cognitive problems seem to be present 
in children with NS at group level as compared to typically developing individuals, most 
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patients do not show severe cognitive impairments. However, the interpretation of the 
results in the present literature is still challenging because samples are small and could 
reflect incidental findings. Most control groups are still not matched regarding IQ, or 
controls are not included at all. Furthermore, studies in children with NS often include 
large age ranges, including both pre-schoolers, school-aged children, and adolescents. 
Although problems in different cognitive functions may exist in patients with NS and 
overlap between these functions has been suggested (for instance, regarding visual-per-
ception and motor functioning), mediating influences of underlying cognitive functions 
have not yet been studied systematically. Last, a selection bias may lead to an 
overestimation of cognitive and behavioural difficulties in the NS literature.
 Clinicians and researchers are provided with the challenge to integrate the developmental 
perspective in their diagnostics, treatments, and scientific research. Even though at group 
level, certain difficulties seem to arise at different ages, the cognitive profile of individual 
patients with NS can still vary largely and (repeated) individual clinical neuropsychological 
assessment is therefore advised. Ideally, the organisation of mental health care for this 
population would be easily accessible throughout the lifespan. Patients would be seen at 
crucial moments in their development and when problems (threaten to) occur. As a result, 
continuation of health care would be guaranteed and care could be intensified or scaled 
down, depending on the specific needs and treatment aims. Repeated clinical neuropsy-
chological assessment in different phases of life would be advised, which is already 
included in the international clinical guidelines for the management of NS (DYSCERNE- 
Noonan Syndrome Guideline Development Group, 2010). Scientific group studies are 
relevant and provide us with information concerning general patterns of cognitive 
functioning in NS. However, by focusing on average group results, information regarding 
the (individual) developmental perspective is lost. Future research could tackle this 
problem by including detailed and repeated assessment of individual patients to provide 
a unique cognitive profile over time. The comparison of these individual profiles of 
cognitive development could provide interesting and relevant insights regarding neuro-
psychological development in NS. 
Contextual factors
The specific problems that patients with NS may encounter in daily life appear to result 
from a complex interaction between genetic, somatic, cognitive, psychological, and 
environmental factors. The large heterogeneity in cognitive functioning in NS patients 
can partly be explained by differences in genotype. To date, mutations in almost 20 genes 
have been associated with NS and there are indications of differential intellectual profiles 
within these genotypes (Pierpont, 2016). However, the variability in the expression of a 
RASopathy seems not to depend solely on genotype. For instance, there are studies of 
individuals with a clinical presentation of NS, while their genotype matches NF1 or CFC 
(mutations in NF1, KRAS, BRAF, and MAP2K1) (Croonen, Yntema, Van Minkelen, Van den 
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Ouweland, & Van der Burgt, 2012; Nishi et al., 2015; Pierpont, 2016; Pierpont, Pierpont, et al., 
2010; Pierpont, Semrud-Clikeman, & Pierpont, 2017; Sarkozy et al., 2009; Schubbert et al., 
2006). Regarding the heterogeneity in cognitive and behavioural functioning in NS, 
potentially relevant factors may be the degree of somatic problems, family factors, 
relationships with peers, bullying victimisation, psychological resilience, personality 
 characteristics, and psychopathology. A contextual clinical neuropsychological approach 
helps placing information processing in a broader perspective, by regarding cognition in 
the context of personality characteristics, psychopathology, interpersonal functioning, 
genetic influences, and somatic problems. A multidisciplinary approach and intensive 
collaboration between clinical geneticists, cardiologists, paediatricians, clinical neuro-
psychologists, and physiotherapists is necessary. In the Netherlands, such a collaboration 
has recently been formalised in a centre of expertise for patients with genetic developmental 
disorders, such as NS (www.radboudumc.nl/expertisecentra/zeldzame-aangeboren- 
ontwikkelingsstoornissen). In this centre, different professionals with NS-expertise are 
joined together to facilitate and improve health care of patients with NS.
Social cognition in NS: clinical observation versus scientific evidence 
Previous studies have shown social cognitive difficulties in children and adults with 
Noonan syndrome (Pierpont, 2016; Pierpont et al., 2018; Verhoeven et al., 2008; 
Wingbermühle, Egger, et al., 2012). The identification of higher levels of alexithymia in 
patients with NS corresponds with the clinical observation that social cognitive problems 
(especially the identification, verbalisation, and regulation of one’s own emotions) are 
frequently recognised by patients with NS and/or their caregivers (Wingbermühle, Egger, 
et al., 2012). However, alexithymia is not systematically found in two of the studies in this 
thesis (Chapters 3 and 4). Several explanations can be given for this disparity between 
clinical observation and scientific evidence. The characteristics of the specific study 
samples, for instance sex and intelligence, may have been related to the results on social 
cognition tasks. Boys with NS seem to display more social cognitive and social 
communication problems than girls with NS (Garg et al., 2017; Pierpont, Weismer, et al., 
2010). In general, higher levels of alexithymia are found in men compared to women 
(Levant, Hall, et al., 2009). Possibly, alexithymia is present especially in men with NS. This 
could explain why previous studies - including mixed-sex samples - showed higher levels 
of alexithymia in NS compared to control participants, while no significant differences 
were found between a group of women with NS and typically developing women 
(Chapter 3). Also, lower verbal intelligence has been related to higher levels of alexithymia 
(Lamberty & Holt, 1995; Montebarocci, Surcinelli, Rossi, & Baldaro, 2011). This may clarify 
why alexithymia was not found in a sample of patients with slightly higher intellectual 
abilities than the general NS population (Chapter 4). Also, due to the large heterogeneity in 
the NS population, group studies might not adequately reflect problems of patients at the 
individual level. Besides the consequences of small sample size for statistical power, the 
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use of self-report instruments for measuring alexithymia may also be related to the mixed 
findings. Patients with alexithymic tendencies may have less affective insight and hence 
be less able to reflect on their affective functioning. The additional use of structured 
interviews (e.g., Toronto Structured Interview of Alexithymia; Bagby, Taylor, Parker, & 
Dickens, 2006) or observer-based instruments (e.g., Observer Alexithymia Scale; Haviland, 
Warren, & Riggs, 2000) might be helpful in this regard. In addition, the use of implicit 
measures of social cognition should be considered. Implicit measures attempt to capture 
underlying mechanisms of social cognition that may not be accessible through 
introspection or self-reports. In implicit measures, the construct of interest is usually 
inferred through a within-subject experimental design in which behavioural performance 
(e.g., response latency, visual scanning patterns, skin conductance) is compared between 
different conditions. In this way, implicit measures can circumvent limitations of explicit 
social cognitive measures, such as limited verbal abilities and affective awareness (Nosek, 
Hawkins, & Frazier, 2011). Interesting implicit measures that might provide more insight 
into affective information processing in NS are, for instance, the Implicit Association Test 
(Greenwald et al., 1998) and the deictic Implicit Relational Assessment Procedure (IRAP, 
Barbero-Rubio, López-López, Luciano, & Eisenbeck, 2016), the latter investigating perspec-
tive-taking. 
Strengths and limitations
An important strength of these studies is their unique focus on the neuropsychological 
and psychopathological profile of well-characterised adult patient with NS. While previous 
studies focused predominantly on the medical and genetic aspects of children with NS, 
more knowledge regarding cognitive and psychological functioning in adults with NS is 
still very much needed. The inclusion of matched control groups (also with regard to 
intellectual functioning) is a strong aspect of these studies and benefits the interpretation 
of the results. Also, the first longitudinal study regarding cognitive functioning in NS has 
provided additional insight into cognitive development in this population. Furthermore, 
the use of a therapeutic neuropsychological assessment strategy – i.e., developing an 
NS-specific social cognitive intervention based on the established pattern of cognitive 
functioning in NS – contributed to new treatment options for this population and 
improved mental health care for NS patients. Despite these notable strengths, the studies 
also have some limitations. Studies regarding relatively rare genetic developmental 
disorders, such as NS, generally encounter three issues that may impede the generalisation 
of the findings, namely: selection bias, small sample size, and population heterogeneity. 
The patients that were included in the current studies volunteered to participate in 
scientific research or were referred because of present neuropsychological or behavioural 
problems. As a result, this sample may represent a subset of patients with more cognitive 
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and behavioural problems, hence leading to an overestimation of the amount of problems 
in the general NS population. Furthermore, because NS is a relatively rare disorder, it is 
harder to achieve sufficient sample size than in patient groups with more common 
disorders. Moreover, due to the introverted personality style of patients with NS, they may 
be more hesitant to participate in scientific research. Relatively small sample sizes have 
consequences for the statistical power of the studies, which can result in an increased 
probability of making a Type II error (i.e., failing to reject a null hypothesis that is not true, 
hence failing to detect effects that are present). Last, NS is a very heterogeneous condition. 
Physical and cognitive phenotypes vary across patients with different genetic mutations, 
but also within patients with similar genotypes lots of variation exists. In addition, the 
phenotype of patients with NS seem to differ throughout the life span. This large 
heterogeneity is inherent to NS, but hampers the reliability and validity of the results of 
group studies, including patients with different genotypes and age ranges. Even though 
group studies provide relevant insight into general patterns of cognitive and psychological 
functioning in NS, detailed and repeated assessment of the individual patient over time 
can overcome this difficulty. 
Future directions
Although cognitive and behavioural functioning in NS have been studied more extensively 
in the past decade, there are still issues that need to be addressed. First, future studies 
should incorporate the developmental perspective of NS by performing individual, 
longitudinal studies (including both measures of cognitive functioning as well as psycho-
pathology), which allow for profile comparisons over time. Furthermore, cognitive aging 
has not yet been addressed. Investigation of the cognitive profile of older adults with NS 
can provide additional information regarding cognitive development in NS. Additionally, 
comparing the cognitive profiles of patients with different RASopathies might improve 
our understanding of the influence of this signal transduction cascade on cognitive 
functioning. Functional neuroimaging studies in patients with NS (as well as in other 
Rasopathies) could be helpful to understand the relation between brain maturation and 
cognitive functioning in disorders of the RAS/MAPK pathway. Also, the inclusion of implicit 
measures of social cognition might shed light on the underlying mechanisms of the 
problems in social functioning and cognition that are found in NS patients. As language 
functioning tends to develop slower in NS and verbal abilities are known to be related to 
social cognition and alexithymia (Lindquist et al., 2015), future studies should investigate 
whether language abilities mediate social cognitive functioning in NS. Regarding 
treatment, future studies should develop (social) cognitive interventions for children and 
adolescents with NS. Social cognitive and executive functioning problems have both 
been frequently described in children and adolescents with NS (Pierpont, 2016). Given the 
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relation between executive functioning and both social cognition and alexithymia (Koven 
& Thomas, 2010; Zelazo & Carlson, 2012), training of executive functioning might improve 
social cognitive functioning as well. Elaborating on this hypothesis, it would be interesting 
to investigate the effects of an executive functioning training for children and adolescents 
with NS on executive function and social cognition (e.g., alexithymia). 
Conclusions
In this thesis, a review of the current literature on cognitive and behavioural functioning in 
NS is provided as well as additional information regarding the neuropsychological profile 
by studying cognitive development, specificity of the social cognitive profile, and 
personality and psychopathology in NS. The cognitive profile of NS patients formed the 
basis for the development of an NS-specific social cognitive intervention. 
 In NS, a delay in cognitive development seems to be present, which can be outgrown 
in adulthood. The social cognitive profile of women with NS appears to be different from 
that of women with Turner syndrome in terms of alexithymia and emotion recognition. 
On average, patients with NS are more introvert than typically developing individuals, 
which may predispose them to internalising problems. These problems indeed appear to 
be more common in NS patients and alexithymia is related to both internalising difficulties 
and negative emotionality. The literature on social cognitive interventions for the general 
neuropsychiatric population shows that treatment of social cognition is effective. Based 
on the established cognitive profile, the first NS-specific neuropsychological treatment, 
aimed to improve social cognitive functioning, is developed and its feasibility is demonstrated. 
 In all, NS is a complex neurodevelopmental disorder, in which cognitive and behavioural 
problems should be regarded in the context of the interaction between genetic, somatic, 
cognitive, psychological, environmental, and developmental factors. Hence, a clinical 
neuropsychological perspective has proven to be pre-eminently relevant in care for 
patients with NS. Developing neuropsychological treatments based on the specific 
cognitive profile of patients with genetic developmental disorders is a useful strategy to 
improve the treatment options for this population. 
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Het noonansyndroom (NS) is een genetische aandoening die voorkomt bij 1 op de 1000 
tot 2500 levendgeborenen. Bij 60% van de patiënten is het syndroom het gevolg van een 
spontane mutatie in één van de betrokken genen. Het NS wordt gekarakteriseerd door 
een fenotypische triade, bestaande uit typische gelaatskenmerken (zoals wijd uit elkaar 
staande ogen, een anti-mongoloïde oogstand, hangende oogleden, laagstaande oren en 
een webbed neck), aangeboren hartafwijkingen en een geringe lengte. Bij 70 tot 80% van 
de patiënten kan er een genetische mutatie worden aangetoond, die verantwoordelijk is 
voor het ontstaan van het syndroom. De diagnose wordt echter primair vastgesteld op 
basis van klinische criteria. Het NS wordt veroorzaakt door mutaties in genen die coderen 
voor eiwitten in de RAS/mitogen-activated protein kinase (RAS/MAPK) pathway. Deze 
signaalketen is betrokken bij de regulatie van ontwikkelingsprocessen in lichaamscellen 
en is dan ook essentieel voor een normale ontwikkeling. Op dit moment is er van 17 
verschillende genen bekend dat mutaties in deze genen kunnen leiden tot het NS (PTPN11, 
SOS1, RAF1, KRAS, NRAS, SHOC2, CBL, RRAS, RIT1, BRAF, RASA2, SOS2, MAP3K8, SPRY1, MYST4, 
LZTR1, A2ML1). Mutaties in PTPN11 (50%), SOS1 (10%), en RAF1 (10%) komen het meest vaak 
voor (Tajan et al., 2018; Tidyman et al., 2016a). Het NS behoort tot de zogenaamde 
RASopathieën, een familie van aandoeningen veroorzaakt door mutaties in genen die 
betrokken zijn bij de RAS/MAPK-signaalketen. Andere RASopathieën zijn het noonan-
syndroom met multipele lentigines, noonansyndroom met loose anagen hair, cardio- 
facio-cutaan syndroom, costellosyndroom, legiussyndroom en neurofibromatose type 1. 
Het NS kan gepaard gaan met een verscheidenheid aan somatische problemen. Voedings-
problemen en groeistoornissen komen frequent voor, evenals een verhoogde bloedings-
neiging, lymfoedeem, afwijkingen van het borstbeen, verminderde spierspanning, oog-
afwijkingen en chronische pijnklachten. Er zijn tot op heden geen duidelijke aanwijzingen 
gevonden voor structurele afwijkingen van het centrale zenuwstelsel. 
 Tot voor kort richtte klinisch genetisch wetenschappelijk onderzoek naar het NS zich 
voornamelijk op de genetische en somatische aspecten. De afgelopen tien jaar is het 
aantal studies naar cognitie en gedrag echter fors toegenomen. Voor patiënten met 
minder ernstige somatische complicaties lijken de cognitieve, sociale en gedragsmatige 
gevolgen van het syndroom immers de grootste impact op het dagelijks leven te hebben. 
Het neuropsychologische perspectief is dan ook essentieel gebleken voor het begrijpen 
van de relatie tussen hersenen en gedrag bij het NS, door het bestuderen van het cognitieve 
functioneren. 
 Het cognitieve profiel van patiënten met het NS kenmerkt zich over het algemeen 
door grote heterogeniteit. Het intelligentieniveau is overwegend (laag)gemiddeld en naar 
schatting komt bij 6 tot 23% van de patiënten een verstandelijke beperking voor. Ongeveer 
een derde van de patiënten met het NS heeft speciaal onderwijs genoten en 20% heeft 
extra ondersteuning nodig in het regulier onderwijs. Het adaptief gedrag (oftewel een 
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verzameling van vaardigheden die noodzakelijk is voor het dagelijks functioneren) lijkt 
derhalve van een lager niveau te zijn bij kinderen en volwassenen met het NS in vergelijking 
met mensen zonder het syndroom. Er zijn aanwijzingen dat de cognitieve problemen 
bij kinderen met het NS uitgebreider en meer diffuus zijn dan bij volwassenen. Er kan 
bij kinderen geen NS-specifiek cognitief profiel worden onderscheiden, maar problemen 
in de motorische functies, taalvaardigheden, aandacht, executieve functies en sociale 
cognitie lijken het meest frequent voor te komen. Bij jonge kinderen met het NS lijkt de 
vertraagde taal- en motorische ontwikkeling op de voorgrond staan, terwijl schoolgaande 
kinderen en adolescenten vooral lijken te kampen met aandachtsproblemen, executieve 
beperkingen en sociaal-cognitieve moeilijkheden. Op de volwassen leeftijd is tot nu 
toe vooral een vertraagde informatieverwerking aangetoond, subjectieve executieve 
beperkingen en sociaal cognitieve problemen (met name alexithymie, oftewel moeite met 
het herkennen en verwoorden van eigen gevoelens). Ten aanzien van psychopathologie 
lijken gedragsproblemen, stemmings- en angstklachten en symptomen van aandachts-
deficiëntie-/hyperactiviteitsstoornis (ADHD) en autismespectrumstoornissen (ASS) vaker 
voor te komen bij patiënten met het NS dan bij patiënten zonder het syndroom. Alhoewel 
de kwaliteit van leven door NS-patiënten over het algemeen als bevredigend tot goed 
wordt ervaren, kunnen pestervaringen (frequent gerapporteerd door patiënten) en het 
hebben van een chronische lichamelijke aandoening risicofactoren vormen voor psychisch 
onwelbevinden.
 Ondanks dat de kennis over het cognitieve profiel van NS-patiënten het afgelopen 
decennium is toegenomen, richten de meeste studies zich nog steeds op het cognitieve 
functioneren van kinderen en adolescenten en zijn er tot op heden nog geen neuro-
psychologische behandelingen beschikbaar voor patiënten met het NS. Bestaande 
behandelingen voor andere doelgroepen zijn niet voldoende toereikend voor patiënten 
met het NS, omdat deze interventies zich niet richten op het verminderen van alexithymie. 
Daarnaast zijn in het Nederlandse zorgsysteem dergelijke behandelingen meestal niet 
toegankelijk voor patiënten met het NS, aangezien hun sociaal-cognitieve problemen 
doorgaans niet (volledig) voldoen aan de criteria van een psychiatrische stoornis zoals 
ADHD of ASS. Een neuropsychologische behandeling, gericht op het verminderen van 
alexithymie en het verbeteren van het sociaal-cognitieve functioneren zou het 
welbevinden van deze doelgroep aanzienlijk kunnen verbeteren. Het doel van het huidige 
proefschrift was dan ook om onze kennis over het neuropsychologische en psychopa-
thologische profiel van volwassenen met het NS verder uit te breiden en vervolgens een 
neuropsychologische behandeling te ontwikkelen, gebaseerd op het specifieke (sociaal-)
cognitieve profiel van patiënten met het NS. 
 Zoals gezegd lijkt de mate van cognitieve problematiek omvangrijker en diffuser bij 
kinderen in vergelijking met volwassenen met het NS. Dit zou kunnen wijzen op een 
vertraagde cognitieve ontwikkeling, zonder dat er sprake hoeft te zijn van een structurele 
beperking, waar patiënten met het NS met de tijd overheen zouden kunnen groeien. 
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Er bestonden echter nog geen longitudinale studies, die deze hypothese hebben 
onderzocht. In Hoofdstuk 2 werd dan ook de intellectuele ontwikkeling van patiënten 
met het NS onderzocht door middel van een retrospectieve longitudinale studie, waarin 
intelligentiescores in de kindertijd werden vergeleken met IQ-scores in de volwassenheid. 
Het performaal IQ bleek significant toegenomen over de tijd, waarbij de performale 
vaardigheden een gemiddeld niveau bereikten in de volwassenheid. Het verbaal IQ 
veranderde niet significant en toonde beneden gemiddelde scores in zowel de kindertijd 
als de volwassenheid, waardoor er op groepsniveau een significant verschil ontstond 
tussen performaal en verbaal IQ in de volwassenheid. Intelligentie op de kinderleeftijd, 
met name het performale capaciteitenniveau, bleek het totale IQ op volwassen leeftijd te 
voorspellen Deze bevindingen ondersteunen de hypothese van een vertraagde cognitieve 
ontwikkeling, meest waarschijnlijk van executieve en motorische vaardigheden, die patiënten 
kunnen ontgroeien richting de volwassenheid. 
 Om het sociaal-cognitieve profiel van volwassenen met het NS nader te onderzoeken, 
werd in Hoofdstuk 3 een groep vrouwen met het NS vergeleken met vergelijkbare groepen 
vrouwen met het turnersyndroom (TS) en gezonde vrouwelijke controles. Het TS is net 
zoals het NS een aangeboren aandoening, weliswaar met een andere genetische etiologie, 
maar met vergelijkbare fenotypische eigenschappen. Deze studie toonde aan dat 
vrouwen met het TS meer alexithyme kenmerken vertoonden dan vrouwen met het NS 
en gezonde controles. Vrouwen met het NS hadden meer moeite met het herkennen van 
boze gezichtsuitdrukkingen in vergelijking met de controlegroep, maar toonden geen 
hogere mate van alexithymie. De groepen verschilden niet van elkaar in de mate van 
spanning, die zij ervoeren in sociale situaties of in de frequentie van het uitvoeren van 
sociaal gedrag. Deze studie toonde aan dat de sociaal-cognitieve profielen van vrouwen 
met het NS en het TS aldus gedifferentieerd kunnen worden in termen van emotiere-
cognitie en alexithymie. Deze bevinding wijst erop dat de verschillen in genetische 
etiologie bijdragen aan het ontwikkelen van deze sociaal-cognitieve profielen. Het was 
echter onverwacht dat er geen verschil in de mate van alexithymie werd aangetoond 
tussen de patiënten met het NS en controles. Mogelijk kan deze bevinding verklaard 
worden door de inclusie van enkel vrouwen in deze studie, terwijl eerder een verhoogde 
mate van alexithymie werd gevonden in een groep met zowel vrouwelijke als mannelijke 
patiënten met het NS. 
 In Hoofdstuk 4 werden psychopathologie en persoonlijkheid bestudeerd bij volwassenen 
met het NS middels het gebruik van de MMPI-2-RF, een veelgebruikte zelfrapportage-
vragenlijst. Ten opzichte van een vergelijkbare, gezonde controlegroep bleken volwassenen 
met het NS introverter te zijn (doch niet op stoornisniveau). Een hogere mate van 
introversie werd eerder beschreven in een studie bij kinderen met het NS, weliswaar in 
vergelijking met een controlegroep met hogere intellectuele vaardigheden. Een introverte 
persoonlijkheidsstijl zou mogelijk op groepsniveau beschouwd kunnen worden als 
kenmerkend voor het NS. Introversie hangt vaak samen met stemmings- en angstklachten 
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en kan patiënten ontvankelijk maken voor het ontwikkelen van internaliserende problemen. 
De in dit hoofdstuk beschreven studie toonde ten aanzien van psychopathologie inderdaad 
een verhoogde mate van internaliserende problemen aan – weliswaar in de subklinische 
range -  in vergelijking met de controlegroep. Patiënten rapporteerden met name een 
verhoogde mate van demoralisatie, in andere woorden een algemeen gevoel van 
ongelukkigheid en ontevredenheid. Mogelijk weerspiegelt deze verhoogde mate van 
demoralisatie de belasting die patiënten met het NS ervaren als gevolg van de chronische 
aandoening. Deze bevinding contrasteert echter met eerdere studies, die geen verminderde 
kwaliteit van leven rapporteerden bij patiënten met het NS. Tot slot was alexithymie 
gecorreleerd met een verhoogde mate van negatieve emotionaliteit en internaliserende 
problemen in de patiëntengroep, terwijl de correlatie met internaliserende problemen 
bijna significant was in de controlegroep. De resultaten van deze studie pleiten ervoor 
dat clinici betrokken bij de zorg voor patiënten met het NS, zoals huisartsen, medisch 
specialisten, maar ook psychologen, extra aandacht besteden aan de psychische 
gezondheid van patiënten met het NS, vooral als zij een introverte persoonlijkheidsstijl 
hebben of alexithyme kenmerken tonen. 
 Alexithymie en sociaal-cognitieve problemen hangen samen met psychische 
klachten, interpersoonlijke problemen en een verminderde kwaliteit van leven. Er is over 
de jaren heen dan ook een verscheidenheid aan neuropsychologische behandelingen 
ontwikkeld om de sociaal-cognitieve vaardigheden van verschillende patiëntengroepen 
te verbeteren. In Hoofdstuk 5 werd een overzicht gepresenteerd van de effecten van so-
ciaal-cognitieve behandelingen voor neuropsychiatrische patiënten op sociale cognitie 
(namelijk, emotieperceptie, sociale perceptie, Theory of Mind (ToM), en sociaal functioneren). 
Er werd een meta-analyse uitgevoerd, waarin 41 gecontroleerde studies zijn opgenomen 
die sociaal-cognitieve interventies onderzochten voor patiënten met schizofrenie, ASS en 
hersenletsel. De geïncludeerde studies richtten zich voornamelijk op patiënten met 
schizofrenie en opvallend genoeg konden er geen alexithymie interventies worden 
geïncludeerd. De meta-analyse toonde aan dat de interventies over het algemeen 
effectief waren (gemiddeld tot groot effect) in het verbeteren van sociale cognitie. 
Emotieperceptie kon het meest effectief getraind worden, gevolgd door ToM, sociale 
perceptie en sociaal functioneren. Specifieke, gerichte behandelingen (bestaande uit het 
trainen van één sociaal-cognitieve functie) lieten een groot effect zien, terwijl brede 
behandelingen (waarin zowel sociale cognitie als niet-sociale cognitie getraind werd) en 
uitgebreide behandelingen (bestaande uit het gelijktijdig trainen van verschillende so-
ciaal-cognitieve functies) gemiddelde effecten lieten zien op de sociaal-cognitieve 
functies. Gerichte en uitgebreide behandelingen waren het meest effectief in het 
verbeteren van emotieperceptie. Gerichte behandelingen verbeterden ToM het meest, 
terwijl de brede interventies het effectiefst bleken te zijn voor het verbeteren van het 
sociaal functioneren. Belangrijke elementen voor een sociaal-cognitieve behandeling 
bleken training van emotieperceptie en sociaal functioneren, waarbij het van belang 
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bleek om te oefenen in alledaagse situaties om de generalisatie naar het dagelijks leven te 
bevorderen en de effecten van de training vast te houden. 
 Gebaseerd op de bevindingen in Hoofdstuk 5 en de literatuur over reeds bestaande 
alexithymie interventies, werd in Hoofdstuk 6 de eerste NS-specifieke sociaal-cognitieve 
behandeling beschreven en onderzocht op zijn haalbaarheid. De training bestond uit tien 
wekelijkse groepssessies, die verdeeld waren over de drie fases van affectieve informatie-
verwerking, namelijk: 1) het waarnemen van eigen emoties en de emoties van anderen, 
2) het interpreteren van sociaal relevante informatie, en 3) het reguleren van emoties en 
sociaal gedrag. Het trainingsprotocol bestond uit psycho-educatie, oefeningen tijdens de 
sessies en huiswerkoefeningen. Daarnaast selecteerde iedere patiënt een zogenaamde 
trainingspartner, die tweemaal werd uitgenodigd voor een sessie en waarmee patiënten 
thuis oefeningen uitvoerden. Een gecontroleerde pilotstudie werd uitgevoerd om het 
effect van de training op verschillende maten van sociale cognitie, niet-sociale cognitie en 
psychopathologie te vergelijken met een controlegroep, bestaande uit NS-patiënten die 
niet deelnamen aan de training. Ondanks dat het niet mogelijk was om de groepen te 
randomiseren en de groepsgrootte niet voldoende was om significante effecten te 
detecteren, bleek de training – mede op basis van een uitgevoerde procesanalyse - haalbaar 
te zijn voor de NS-populatie en waren de effecten op emotieherkenning veelbelovend. 
Bovendien ervoeren patiënten de training als leerzaam, zo vonden ze het prettig om hun 
ervaringen en sociaal-cognitieve problemen te delen met medepatiënten, nam het inzicht 
in de eigen sociaal-cognitieve moeilijkheden toe en konden zij aangeboden strategieën 
toepassen in het dagelijks leven. De huidige bevindingen dienen gerepliceerd te worden 
middels vervolgonderzoek, bij voorkeur in de vorm van een gerandomiseerde gecontroleerde 
trial (RCT).
 In Hoofdstuk 7 werden de bevindingen van de huidige studies bediscussieerd en 
werden hun beperkingen belicht. Aangezien bij het NS sprake lijkt van een vertraagde 
cognitieve ontwikkeling, werd het belang besproken van het ontwikkelingsperspectief. 
Zo is herhaald klinisch neuropsychologisch onderzoek op cruciale momenten in het leven 
van patiënten belangrijk om gepaste begeleidingsadviezen te kunnen formuleren en 
dient wetenschappelijk onderzoek zich meer te richten op longitudinale studies. Voorts 
werd aangehaald dat de specifieke problemen van patiënten met het NS in het dagelijks 
leven bezien dienen te worden tegen de achtergrond van een complexe interactie tussen 
verschillende contextuele factoren (zoals genetische, somatische, cognitieve, psychologische 
en omgevingsfactoren). Het klinisch-neuropsychologisch perspectief en een multi-
disciplinaire samenwerking worden als onontbeerlijk beschouwd om deze problemen goed 
te kunnen begrijpen. Tevens werd de discrepantie bediscussieerd tussen de aanwezigheid 
van problemen in het duiden en reguleren van eigen emoties bij NS-patiënten in de 
klinische praktijk en de bevindingen van twee van de studies in dit proefschrift, waarin – 
in tegenstelling tot eerder onderzoek – geen verhoogde mate van alexithymie werd 
gevonden ten opzichte van een vergelijkingsgroep. Verschillende verklaringen werden 
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beschreven voor deze bevinding, zoals verschillen tussen de kenmerken van de onderzochte 
groepen en de gebruikte meetinstrumenten. Ondanks dat de studies in dit proefschrift 
hebben bijgedragen aan de kennis over het neuropsychologische en psychopatholo-
gische profiel van patiënten met het NS en aan de ontwikkeling van toegesneden behan-
delmogelijkheden voor deze doelgroep, hebben de studies ook enkele beperkingen. 
Deze kanttekeningen betreffen de aanwezigheid van een mogelijke selectiebias, de 
beperkte groepsgrootte en een heterogene onderzoeksgroep. Zo kan er mogelijk sprake 
zijn van een vertekening in de resultaten, doordat wellicht juist patiënten met neuro-
psychologische of psychische klachten meer geneigd waren om deel te nemen aan de 
huidige studies. Daarnaast is de groepsgrootte van de onderhavige studies beperkt, wat 
gepaard gaat met een lagere statistische power. Tot slot is het NS een zeer heterogene 
aandoening en kan deze variabiliteit gevolgen hebben voor de betrouwbaarheid en 
validiteit van de bevindingen van groepsstudies. Overigens zijn deze kanttekeningen niet 
uniek voor de studies in dit proefschrift, maar vormen zij een uitdaging waar onderzoek 
naar patiënten met relatief zeldzame aandoeningen vaker mee geconfronteerd wordt. 
 Samengevat, op basis van de informatie in het huidige proefschrift lijkt er bij patiënten 
met het NS sprake te zijn van een vertraagde cognitieve ontwikkeling (meest waarschijnlijk van 
motorische en executieve vaardigheden), die zij lijken te ontgroeien in de volwassenheid. 
Verder blijkt het sociaal-cognitieve profiel van vrouwen met het NS te onderscheiden te 
zijn van dat van vrouwen met het TS in termen van alexithymie en emotierecognitie, waarvoor 
verschillen in genetische etiologie deels verantwoordelijk lijken te zijn. Ten aanzien van 
persoonlijkheid en psychopathologie blijkt dat patiënten met het NS gemiddeld genomen 
introverter zijn dan mensen zonder het syndroom, wat hen mogelijk kwetsbaarder maakt 
voor het ontwikkelen van internaliserende problemen, die ook daadwerkelijk vaker 
voorkomen in deze doelgroep. Alexithymie blijkt daarnaast samen te hangen met inter-
naliserende problemen en negatieve emotionaliteit. Sociaal-cognitieve behandelingen 
zijn een effectieve manier om de sociale cognitie te verbeteren bij patiënten met neuro-
psychiatrische aandoeningen. Gebaseerd op het cognitieve profiel van patiënten met het 
NS en gebruikmakend van evidence-based en practice-based sociaal-cognitieve technieken, 
is de eerste NS-specifieke sociaal-cognitieve training ontwikkeld en werd de haalbaarheid 
van deze interventie voor de NS-doelgroep aangetoond. Gezien de complexiteit en 
heterogeniteit van het NS en de continue interactie tussen somatische, cognitieve, en 
psychologische factoren over het ontwikkelingsbeloop heen, maakt het een aandoening 
die bij uitstek bezien dient te worden vanuit het klinisch-neuropsychologisch perspectief 
om zo tot toegesneden behandel- en begeleidingsadviezen te komen. Daarnaast blijkt 
het ontwikkelen van een neuropsychologische behandeling, gebaseerd op het specifieke 
cognitieve profiel van een patiëntengroep met een genetische ontwikkelingsstoornis 
zinvol te zijn en biedt het mogelijkheden om de geestelijke gezondheidszorg voor deze 
doelgroep te verbeteren.  
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Op het moment van de studiekeuze in het laatste jaar van de middelbare school speelde 
ik met de gedachte om me in te schrijven voor de Kunstacademie. Toen ik me echter 
tijdens een open dag realiseerde dat het beroepsperspectief kunstenaar zou zijn, sloeg de 
twijfel toe en koos ik voor de psychologie. Desalniettemin heb ik – al zeg ik het zelf – zo’n 
vijftien jaar later toch een kunstwerk afgeleverd. Een kunstenaar zou ik mezelf echter niet 
durven noemen, want dit werk heb ik niet alleen tot stand gebracht. Gaandeweg mijn 
traject zijn er veel bijzondere mensen geweest die op verschillende manieren een bijdrage 
hebben geleverd aan de totstandkoming van dit proefschrift. Zonder jullie kennis, steun, 
aanmoediging, hulp en gezelligheid had ik dit niet voor elkaar gekregen!
Allereerst valt of staat een kunstwerk met geschikte modellen, in dit geval alle patiënten 
die aan mijn studies hebben deelgenomen. Ik ben jullie enorm dankbaar voor het 
vertrouwen in ons streven om de zorg te verbeteren en de bijdrage die jullie daaraan 
hebben geleverd. Graag wil ik ook de patiëntenvereniging, Stichting Noonansyndroom, 
bedanken voor de prettige samenwerking en betrokkenheid. 
En dan mijn begeleidingsteam, bestaande uit prof. dr. Jos Egger, prof. dr. Roy Kessels en 
dr. Ellen Wingbermühle. Om in schilderstermen te blijven, leerden jullie mij de nodige 
technieken, zoals het belang van een juiste lijnvoering, het aanbrengen van diepte en 
perspectief, het schetsen van heldere kaders en het vormen van een correcte compositie. 
Beste Jos, ik wil je bedanken voor het vertrouwen dat je mij hebt geschonken en de rol die 
je hebt gespeeld in mijn professionele loopbaan in het algemeen en in mijn pro-
motieonderzoek in het bijzonder. Je weet me altijd uit te dagen om net een stapje verder 
te zetten. Dankzij jou heb ik veel kansen gekregen om mezelf op professioneel en 
persoonlijk vlak verder te ontwikkelen. Ik heb bewondering voor jouw kritische blik, snelle 
denkvermogen, betrokkenheid, enorme kennis, tactische vermogens en verbale kracht. 
Bedankt dat je me hebt opgenomen in het team van het Centrum voor Neuropsychiatrie, 
een bijzondere afdeling waar onderzoek en patiëntenzorg samengaan en waar we kritisch 
kunnen en mogen nadenken om ons gezamenlijke streven, namelijk het bieden van de 
juiste zorg aan onze patiënten, te bewerkstelligen.
Beste Roy, ik wil je graag bedanken voor de aangename begeleiding. Zo fijn hoe jij met 
jouw analytische manier van denken en positieve blik de – voor mij – complexe 
vraagstukken weer overzichtelijk en praktisch kon maken. Ook al was je iets meer op 
afstand betrokken, je was altijd op de hoogte en bereikbaar. 
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En natuurlijk, beste Ellen, van scriptiebegeleidster tot co-promotor, ik wil je bedanken dat 
je altijd voor me klaar stond met raad of een luisterend oor. Wanneer ik het even niet meer 
wist, kon een gesprek met jou me altijd enorm opluchten en weer met de neus de goede 
kant opzetten. Ik ben dankbaar dat ik me door jouw hartelijkheid, zorgzaamheid en 
geduld in combinatie met jouw vertrouwen, deskundigheid en humor gesteund mocht 
voelen. Ik heb veel geleerd van onze samenwerking op professioneel vlak en koester 
daarnaast ook leuke herinneringen aan de verschillende bijzondere ervaringen die we in 
het kader van het onderzoek mochten delen. Zo weet ik nog goed hoe zenuwachtig ik 
was voor mijn eerste internationale praatje, maar dat ‘shoptherapie’ met jou in Milaan 
wonderen deed. Ook zaten we samen in de schuilkelders in een congreshotel in Jeruzalem, 
terwijl de raketten ons om de oren vlogen en deden we veldwerk voor de ontwikkeling 
van SENS door samen naar de – emotioneel educatieve - film Inside Out te gaan.
Leden van de manuscriptcommissie, prof. dr. A.H.N. Cillessen, prof. dr. H.G. Brunner en 
prof. dr. J.M. Spikman, bedankt voor het beoordelen van dit proefschrift.
Gedurende de totstandkoming van mijn proefschrift heb ik binnen het Vincent van Gogh 
op verschillende afdelingen mogen samenwerken met veel leuke en fijne collega’s, die – 
om in de metafoor van het kunstwerk te blijven - voor de klinische lichtinval en kleuring 
hebben gezorgd. Het strekt helaas te ver om iedereen hier te noemen, dus licht ik er de 
volgende mensen uit:
Allereerst de lieve ‘neurootjes’, Wouter, Laureen, Anke, Max, Joep, Hanneke, Hanneke, 
Linde, Anja, Claudette, Iris, Kim, Jennifer, Ynès, Mareike, Johanna en Carry. Bedankt voor 
jullie sparring-tijd, aanmoediging en gezelligheid! Loes, jou wil ik in het bijzonder 
bedanken voor je warme betrokkenheid, lach en hulp op de momenten dat het nodig 
was. Henriette, bedankt voor alle praktische ondersteuning. 
Lieve collega’s van de Korsakov kliniek, in het bijzonder Serge en Gwenny, bedankt voor 
alles wat ik van jullie heb mogen leren. Ook gaat mijn dank uit naar dr. Arie Wester, helaas 
niet meer onder ons, wie ik erkentelijk ben voor de rol die hij heeft gespeeld in de start 
van mijn klinische werk en onderzoeksactiviteiten.
Collega’s van de poli SAP en het Centrum voor Angst en Dwang, van harte bedankt voor 
de leerzame tijd op jullie afdelingen, jullie interesse en bemoedigende steun! 
Dank ook aan alle collega’s die tijdens mijn GZ-opleidingsperiode een speciale rol van 
betekenis hadden in mijn professionele en persoonlijke ontwikkeling, in het bijzonder de 
positiviteit van Judith Duijkers en Lindsey Ossewaarde, de inzichtgevende woorden van 
Paul Runge en de prettige supervisie en werkbegeleiding van Anke de Klerk, Iris Westers 
en Ivanka van Ophoven. 
Tevens wil ik scriptiestagiaires Nikki, Floor, Marieke, Jennifer en Ynès hartelijk bedanken 
voor jullie hulp en enthousiasme. Jennifer, fijn dat we blijven samenwerken, nu in het 
kader van jouw eigen promotieonderzoek!
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De Raad van Bestuur van het Vincent van Gogh wil ik graag bedanken voor het faciliteren 
van wetenschappelijk onderzoek binnen onze organisatie.
Dr. Jan-Pieter Teunisse, dr. Hans Berger, prof. dr. Judith Prins en em. prof. dr. Henny van 
Schrojenstein-Lantman de Valk wil ik bedanken voor het vertrouwen en de mogelijkheid 
die zij mij gaven om, na mijn afstuderen, binnen het Radboudumc de eerste stappen te 
zetten in onderzoeksland.
Mijn GZ-groepsgenootjes, ook jullie bedankt voor de gezelligheid, interesse en steun van 
de afgelopen twee jaar! Inmiddels hebben we de opleiding allemaal met succes afgerond 
en hoop ik dat we elkaar af en toe nog blijven zien. 
Mijn Topklas-collega’s, een bijzondere groep van gedreven scientist-practitioners die 
elkaar motiveert, stimuleert en inspireert. Ik hoop nog vele interessante masterclasses 
en intervisies met jullie te mogen beleven. Prof. dr. J.T. Swaab en (weer opnieuw) prof. dr. 
J.I.M. Egger, beste Hanna en Jos, bedankt voor de vormgeving van dit innovatieve traject 
waarin jonge professionals gestimuleerd én gefaciliteerd worden om hun persoonlijke 
ontwikkeling in de patiëntenzorg gelijktijdig te combineren met wetenschappelijk 
onderzoek. 
En natuurlijk dank aan mijn dierbare vrienden en familie, die zowel de imprimatura als de 
finishing touch van dit kunstwerk vormden. 
Lieve Marije en Dymphie, we leerden elkaar kennen tijdens onze gezamenlijke stages 
bij het Vincent van Gogh en ik ben blij dat we sindsdien vriendinnen zijn gebleven. 
Ik waardeer jullie betrokkenheid en oprechte interesse. 
Lieve Rachelle, ook jou heb ik leren kennen tijdens mijn stagetijd, waar jij mij wegwijs 
maakte in de testkast. We zijn daarna bevriend gebleven en ik vind het altijd gezellig om 
je te zien. 
Lieve neuromeisjes, Madelon, Femke, Michelle, Meriël en Kim, samen delen we onze 
passie voor de neuropsychologie, maar ook voor thee en zelfgemaakte baksels.
Mijn lieve vriendinnen van groep V, Kirsten, Michelle, Cindy, Ilse en in het bijzonder mijn 
paranimfen Geertje en Kim. Onze vriendschap begon tijdens de introductie Psychologie 
en inmiddels gaan we alweer op naar ons derde lustrum, wat ben ik blij met jullie! 
Lieve Geer en Kim, bedankt voor jullie hulp bij de voorbereiding van mijn promotie en ik 
ben super trots dat jullie op deze bijzondere dag naast mij staan! Ik vrees alleen dat ik na 
vandaag echt geen excuus meer heb om niet mee te gaan bootcampen.
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Lieve Pascal en Luuk, bedankt voor de gezellige spelletjesavonden, frustrerende potjes 
AoE en jullie humor! En fijn dat Thom bij jullie terecht kon als ik de ruimte nodig had om 
rustig te schrijven!
Lieve Maaike, samen fietsten we naar het Lingecollege, gaven we Franse presentaties over 
zelfbedachte goede doelen en gingen we op stap in The Wiz. Ondanks dat we elkaar nu 
minder vaak zien, is het altijd gezellig en onze jaarlijkse Appelpop-avonturen blijven een 
groot succes!
Lieve Iris, hoe bijzonder is het dat we al bijna 30 jaar vriendinnen zijn! Ik heb veel waardering 
voor jouw positiviteit, de aandacht die je hebt voor de mensen om wie je geeft en de 
warmte waarmee jij voor hen klaar staat. Onze vriendschap is mij dan ook zeer dierbaar. 
Lieve familie Dee, Nanda, Peter, Sanne, Reamon, Lotte en Tristan, bedankt dat ik onderdeel 
mag uitmaken van jullie familie. Ik hecht veel waarde aan jullie optimisme, humor, warmte, 
vertrouwen en relativeringsvermogen. Sanne, fijn dat ik af en toe een beroep mocht doen 
op jouw kennis van de Engelse taal!
Lieve paps en mams, ik ben jullie ontzettend dankbaar voor alle kansen die jullie mij 
hebben gegeven en dat ik kon doen wat ik graag wilde. Bedankt voor de warme en 
gezellige thuisbasis die jullie me geboden hebben, jullie liefde, goede zorgen, openheid, 
interesse, vertrouwen, voelbare steun en trots. Bedankt dat jullie er altijd zijn.
Lieve Renske, in de woorden van de - door ons zo gewaardeerde en immer wijze - 
Backstreet Boys: ‘Though the distance that’s between us, now may seem to be too far. 
It will never separate us.’
Liefste Thom, wat ben ik blij met jou! Waarschijnlijk was jij dat de afgelopen tijd iets minder 
met mij, aangezien de voorbereidingen voor deze dag geregeld gepaard gingen met 
verstoringen van jouw nachtrust! Ik ben je zo dankbaar voor jouw nuchterheid en 
vermogen om – mij te helpen – de zaken weer in een breder perspectief te plaatsen. 
Je maakt me aan het lachen, bent tegelijkertijd eerlijk of juist geduldig als ik dat nodig heb 
en kan me tot rust manen. Ik heb grote bewondering voor jouw doorzettingsvermogen, 
veerkracht en dapperheid. Ik houd van ons team en ik kijk met veel plezier uit naar ons 
verdere leven samen, te beginnen met ons mooie nieuwe huis! 
De laatste woorden van dit dankwoord zijn voor onze poezenkinderen, Lex en Olaf, 
zonder hun aanwezigheid – soms letterlijk liggend op het toetsenbord – zou het schrijven 
van dit proefschrift een stuk minder aangenaam zijn geweest. 
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